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Tissue damage initiates the release of a complex, interacting collection of chemical 
signals. The coordinated function of these signals gives rise to an inflammatory event, 
whereby circulating immune cells are recruited to clear pathogens. Invertebrate models 
of tissue damage have revealed a key role for damage-associated signals, specifically 
hydrogen peroxide (H2O2), in attracting immune cells to sites of tissue damage. The 
Src family kinase (SFK), Lyn, is oxidised by H2O2 in zebrafish wound models, and 
subsequent activation of Lyn triggers directed cell motility. In mammalian systems, 
H2O2 is an important second messenger, however, its role as a damage signal and its 
association with SFK signalling remains unclear.  
The aims of this thesis are to investigate how immune cell function and migration in 
response to damage-associated signals transfers into other models. To address this, 
we have used an in vivo Drosophila melanogaster embryonic wounding model and in 
vitro assays of human innate cell function and migration.  
The migration of Drosophila hemocytes in response to a wound was impaired in 
embryos lacking functional Src42A or Shark kinase. However, hemocyte motility was 
impaired in embryos bathed in exogenous H2O2. In vitro, H2O2 inhibited human innate 
cell motility, chemotaxis, actin reorganisation and phagocytosis, but activated 
intracellular signalling pathways and did not affect receptor expression or cell viability. 
Exogenous ATP activated chemokinesis and rapid actin reorganisation. The in vitro 
effects of immune-related ligands were inhibited by pharmacological inhibition of SFK, 
Syk, and PI3K signalling. In particular, inhibition of class IA PI3K isoforms p110β and 
p110δ, but not p110α, disrupted monocyte MCP-1-mediated actin reorganisation and 
spreading.  
SFKs are required for Drosophila immune cell migration to a wound and for human 
innate cell migration to chemoattractants. While endogenous ROS production is 
important for immune cell function, exogenous H2O2 may negatively modulate 
downstream mediators of chemokine signalling. H2O2 and ATP are distinct in their 
abilities to activate immune cells and initiate chemokinesis. Intracellular kinases 
regulate basal and chemoattractant-mediated motility and are therefore attractive 














ADP Adenosine diphosphate 
ANOVA Analysis of variance 
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Asp Aspartic acid 
ATP Adenosine 5’-triphosphate 
cAMP Cyclic adenosine monophosphate 
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COOH Carboxylic acid 
Cys Cysteine 
DAG Diacyl-glycerol 
DAMP Damage associated molecular pattern 
DAPI 4’-6’-diamidino-2-phenylindole 
DCFDA 2’,7’-dichlorofluorescein diacetate 
DMEM Dulbecco’s’ modified eagle’s medium 
DPI Diphenyleneiodonium  
Duox Dual oxidase 
ECM Extracellular matrix 
EGF Epidermal growth factor 
EMS Ethyl methanesulfonate 
ER Endoplasmic reticulum 
ERK Extracellular signal-regulated kinase 
FAK Focal adhesion kinase 
FGF Fibroblast growth factor 
fMLP N-formyl-methionyl-leucyl-phenylalanine 
FPR Formyl peptide receptor 
GAP Guanine activating protein 
G-CSF Granulocyte colony stimulating factor 
GDI Guanine dissociation inhibitor 
GDP Guanosine diphosphate 
GEF Guanine exchange factor 
GFP Green fluorescent protein 
Gly Glycine 
GPCR G protein couple receptor 
GRK G protein coupled receptor tyrosine kinase 
GTP Guanosine triphosphate 
H+ Hydrogen ion 
H2O2 Hydrogen peroxide 
HBSS Hank’s balanced salt solution 
IBD Irritable bowel disease 
ICAM-1 Intercellular adhesion molecule-1 
IFN Interferon 
IL-8 Interleukin 8 
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ITAM Immunoreceptor tyrosine-based activation motif 
ITIM Immunoreceptor tyrosine-based inhibition motif 
LAD Leukocyte adhesion deficiency 
LFA-1 Lymphocyte-function associated antigen-1 
LPS Lipopolysaccharide 
LT Leukotriene 
LXA4 Lipoxin A4 
M-CSF Monocyte-colony stimulating factor 
MAPK Mitogen activate protein kinase 
MCP-1 Monocyte chemoattractant protein-1 
MMP Matrix metalloproteinase 
MO Morpholino oligonucleotide 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
NAD Nicotinamide adenine dinucleotide 
NADPH Nicotinamide adenine dinucleotide phosphate-oxidase 
NET Neutrophil extracellular trap 
NLR Nod-like receptor 
NOX NADPH oxidase 
O2- Superoxide 
PAF Platelet activating factor 
PAMP Pathogen associated molecular pattern 
PBMC Peripheral blood monocytic cell 
PBS Pulbeco’s buffered saline 
Pct Piceatannol 
PDGF Platelet derived growth factor 
PFA Paraformaldehyde 
PH Pleckstrin homology 
PI(3,4,5)P3 Phosphatidylinositol (3,4,5)-triphosphate 
PI(3,4)P2 Phosphatidylinositol (3,4)-bisphosphate 
PI(4,5)P2 Phosphatidylinositol (4,5)-bisphosphate 
PI3K Phosphoinositide 3-kinase 
pKa Acid dissociation constant 
PKC Protein kinase C 
PLC Phospholipase C 
PRR Pathogen recognition receptor 
PS Phosphatidylserine 
PSGL-1 P selectin glycoprotein-1 
PTEN Phosphatase and tensin homologue 
PTP Protein tyrosine phosphatase 
PVF PDGF/VEGF-like growth factor 
pY Phosphotyrosine 
RA Rheumatoid arthritis 
ROCK Rho kinase 
ROS Reactive oxygen species 
RPMI Roswell park memorial institute (cell growth medium) 
SEM Standard error of the mean 
Ser Serine 
SERCA Sarco/endoplasmic reticulum Ca2+-ATPase 
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SFK Src family kinase 
SH Src homology 
Shark SH2 ankyrin repeat kinase 
SHIP-1 SH2 containing inositol phosphatase-1 
SOD Superoxide dismutase 
Thr Threonine 
TIM T-cell immunoglobulin mucin 
TLR Toll-like receptor 
TNF Tumour necrosis factor 
Tyr Tyrosine 
UAS Upstream activating sequence 
UV Ultraviolet 
VCAM-1 Vascular cell adhesion molecule-1 
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1.1 Innate immunity and inflammation 
 
1.1.1 The immune system 
 
The immune system is essential for the protection of an organism against tissue 
damage and invasion from external pathogens. It relies on the coordinated efforts of 
multiple tissues and organs, specialised cell types and soluble factors whose 
interactions culminate in the maintenance of a healthy organism, as well as a primed 
system ready to respond to potential threats to homeostasis. Skin and epithelial 
membranes form physical barriers to invasion and act in concert with more dynamic, 
induced components of the immune system, such as activated leukocytes and changes 
to receptor expression. The immune system has two critical roles: (a) to identify, locate 
and neutralize external pathogens, and (b) to remove damaged or diseased tissue.  
 
The temporal stages of immunity can be classified into the immediate, first line 
response, termed innate immunity, and the later, more specific response, termed 
adaptive immunity. Innate immunity relies heavily on recognition of pathogenic 
patterns, leukocyte activation and recruitment, and rapid release of soluble neutralizing 
factors, which is discussed in more detail below. Adaptive immunity also involves both 
cell-mediated and humoral components, which create an immunological memory 
following an initial exposure to a specific pathogen. It is dependent on the ability of the 
body to recognise specific ‘non-self’ antigens in the presence of ‘self’ antigens. The 
production and storage of antigen specific antibodies gives rise to an acquired immune 
system, leading to an enhanced response to subsequent exposure to the same 
pathogen. The dysregulation of any of these processes can give rise to inefficient 
responses to pathogens and increased susceptibility to infection, or overactive immune 
responses leading to chronic autoimmune diseases. 
 
 
1.1.2 The innate immune response and inflammation 
 
Inflammation occurs when the immune system is activated. It can be considered a 
classic stimulation-response system. Inflammation was first described as four cardinal 
signs: heat, pain, redness and swelling, by Celsus in AD. 25 [1]. These processes have 
been highly characterised in recent years and are the subject of target validation in 
many clinical trials. There are two types of inflammatory responses: acute inflammation 
or chronic inflammation. Acute inflammation is a rapid and temporary host response 
that delivers leukocytes and plasma proteins to the infected or injured tissues. Chronic 
inflammation is persistent and characterised by tissue injury and attack with a longer 
recovery time. The chronic response may increase damage to tissues and organs, 
resulting in the onset of further disease, such as rheumatoid arthritis (RA), tuberculosis 
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Figure 1.1: The inflammatory response.  Following epithelial injury and infection (1), the release of damage- and pathogen- associated signals activate 
tissue resident inflammatory cells. Upon activation, mast cells degranulate (2) and release inflammatory mediators that act on local vasculature to increase 
permeability and promote endothelial expression of adhesion molecules. Endothelial inflammation promotes leukocyte recruitment from the circulation (3) 
through a cascade of leukocyte tethering, rolling, firm adhesion and extravasation into the tissue. In the tissue, leukocytes migrate along gradients of 
chemoattractants (4) towards the source of damage or infection. Monocytes differentiate into macrophages (5), and release key intermediary signals, including 
ROS, chemokines and cytokines to further amplify the inflammatory response (6). Phagocytes clear damage by engulfing cell debris and pathogens (7). 
Activated neutrophils release neutrophil extracellular traps (NETs) that capture and immobilise pathogens (8). Finally, tissue dendritic cells capture antigen (9), 
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Leukocytes continuously patrol the vasculature and tissues, monitoring for signs of 
bacterial infection or tissue damage [2]. When tissue is injured, the loss to skin integrity 
allows bacteria and other pathogens to enter local tissue. Resident tissue mast cells 
and macrophages are alerted to the event by detection of damage-associated 
molecular patterns (DAMPs), e.g. adenosine 5’triphosphate (ATP), and pathogen 
associated molecular patterns (PAMPs), e.g. lipopolysaccharide (LPS) [3]. DAMPs and 
PAMPs can initiate signalling via Toll-like receptors (TLRs) and Nod-like receptors 
(NLRs). TLRs recognise microbial products, for example, TLR4 recognises LPS. NLRs 
sense peptidoglycan breakdown products and drive caspase activation via assembly 
and activation of the inflammasome. TLRs and NLRs also sense products of inflamed 
tissue, such as hyaluronic acid and uric acid [3].  
 
Mast cell activation triggers degranulation and release of inflammatory mediators such 
as histamine, leukotrienes and prostaglandins [4]. Histamine acts on local vasculature 
to increase permeability and loosen tight junctions at points of cell contact. If 
vasculature is ruptured, clotting factors are rapidly activated and dispersed [5]. 
Activated macrophages release soluble paracrine factors such as cytokines and 
chemokines that diffuse throughout the tissue, establishing signal gradients to guide 
the recruitment of leukocytes towards the area of damage and infection. Other 
chemotactic agents include N-formylated peptides, the complement C5a fragment, 






Following activation by tissue resident cells, the immune response is amplified by 
recruitment of more cells to the affected area. Endothelial cells present chemokines on 
their luminal surface to attract and activate circulating leukocytes and enable their 
capture and tethering on the vascular wall. Positively charged chemokine molecules 
are anchored onto the endothelium by binding to negatively charged heparan 
sulphates, preventing chemokine from being washed away by shear forces [7]. This 
results in gradients of chemokines becoming established in the vasculature. At the 
luminal surface, inflammatory mediators act on the endothelium of blood vessels to 
upregulate the expression of adhesion molecules such as E-cadherin, vascular cell 
adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) [8].  
 
Selectins are required for the rolling phase of leukocyte adhesion and transmigration 
cascade. Selectins are single chain transmembrane glycoproteins that recognise 
carbohydrate moieties and mediate transient interactions between leukocytes and the 
vessel wall [9]. L-selectin is expressed on leukocytes and its primary role appears to be 
in promoting lymphocyte homing to lymph nodes [10]. E-selectin is expressed on 
endothelial cells and P-selectin is expressed on platelets and endothelial cells during 
inflammation. Upon detection of inflammation, selectin expression is upregulated, 
either from pre-stored sources or synthesised de novo [11]. Various selectin ligands 
bind to selectin receptors, most notably P-selectin glycoprotein-1 (PSGL-1) which is 
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expressed on leukocytes [12]. These interactions lead to tethering and rolling of 
circulating leukocytes to the surface of the endothelium. Despite the brief nature of the 
selectin receptor-ligand interactions, they can trigger intracellular signal transduction 
processes. A prime example of this is when PSGL-1 binds to E-selectin to induce the 
activation of CD11a/CD18 integrin and induce slow rolling of leukocytes on the vessel 
wall [13]. 
 
Integrins are heterodimeric transmembrane glycoproteins that are required for 
leukocyte slow rolling, firm adhesion to the vessel wall and chemotaxis [14]. 
Leukocytes express β2 integrin family members, formed by the β2 (CD18) integrin chain 
plus a unique α chain. Mac-1 (αMβ2 – CD11b/CD18) is expressed on myeloid cells such 
as neutrophils, monocytes and macrophages. LFA-1 (αLβ2 – CD11a/CD18) is 
expressed on all circulating leukocytes. Mac-1 and LFA-1 bind to endothelial ICAM-1 
and are involved in different phases of neutrophil adhesion and transmigration [15]. 
LFA-1 binding to ICAM-1 is essential for firm adhesion [16]. Leukocytes also express 
VLA-4 (α4β1) integrin that binds to VCAM-1 on endothelial cells.  
 
Integrin signalling can be triggered by integrin ligation (outside-in signalling) and the 
regulation of integrin ligand binding by intracellular signals (inside-out signalling). 
Integrin outside-in signalling can be triggered by placing cells on integrin ligand-coated 
surfaces (e.g. fibronectin) in the presence of a pro-inflammatory stimulus [17]. This 
triggers cell spreading and respiratory burst, which is dependent on cell surface β 
integrins. Activation of chemokine receptors on leukocyte surfaces induces changes in 






To leave the vasculature, leukocytes must cross the endothelium, followed by the 
basement membrane. Transmigration involves integrins, adhesion molecules, and 
junctional molecules. Transmigration can occur paracellularly, between endothelial 
cells, or transcellularly, through an endothelial cell. During transmigration, cells 
undergo cytoskeletal changes and rearrange their attachment to the extracellular 
matrix (ECM) via focal adhesions [19]. The basement membrane comprises collagens 
and laminins and poses a barrier through which transmigrating leukocytes must pass. 
Neutrophils contain specific proteases including matrix metalloproteinases (MMPs) and 
serine proteases which enzymatically digest ECM molecules [20]. However, protease 
inhibitors have failed to show that this is the only mechanism by which leukocytes can 
penetrate the basement membrane. Intravital microscopy has revealed that neutrophils 
preferentially migrated through regions of basement membrane that exhibit low levels 
of ECM molecules [21]. Interestingly, these regions overlapped with gaps between 
pericyte regions, suggesting that they represent a path of least resistance for 
emigrating neutrophils [22]. 
 
Following transmigration, emigrated neutrophils or monocytes must move away from 
any endothelium associated gradients and towards new tissue related gradients. This 
suggests that leukocytes are able to prioritise different chemokine signals. In fact, when 
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placed in opposing gradients in vitro, neutrophils prioritise end target chemoattractants 
derived from pathogenic sources, (e.g. bacterial derived N-formyl-methionyl-leucyl-
phenylalanine (fMLP)), over intermediary chemoattractants produced by activated 
leukocytes, (e.g. neutrophil derived IL-8) [23]. This process is described in more detail 





Phagocytosis is defined as the ingestion by cells of large (≥0.5µm) particles [24] and 
encompasses a diverse range of related yet distinct molecular mechanisms. 
Phagocytosis is important in homeostasis and tissue remodelling, as well as in innate 
immune responses where pathogens, cell corpses and cell debris are cleared and 
destroyed. Professional phagocytes can also present antigens derived from the 
degradation of engulfed particles to lymphoid cells and activate adaptive immunity. 
Fibroblasts, epithelial cells and endothelial cells are able to ingest apoptotic bodies, but 
not microbes [24]. Phagocytosis is a very complex process and typically involves three 
key steps: a) particle recognition, b) particle internalisation and c) phagosome 
maturation. 
 
Phagocytosis is a receptor-mediated event. Given the huge variety of particles that can 
be ingested, many receptors types are involved. Receptors that engage foreign bodies 
include pathogen recognition receptors (PRRs) [25] and opsonic receptors (e.g. FcγRs) 
that recognise soluble molecules such as extraneous antigens and complement 
components circulating in the blood and interstitial fluid [26]. Apoptotic cells release 
mediators such as ATP and lysophosphatidylcholine, and these act as ‘find me’ signals 
to recruit phagocytes. Apoptotic cells also display ‘eat me’ signals on their surfaces; 
phosphatidylserine (PS) is the most characterised example [27]. Multiple receptors bind 
PS, e.g. TIMs (T-cell immunoglobulin mucin family) and stabilin-2 [28].  
 
Phagocytic receptors drive different intracellular signalling cascades; in some 
conditions several receptors are activated in parallel so multiple cascades are triggered 
concomitantly. Internalisation of IgG-opsonised particles by FcγRs is the most well 
understood model of phagocytosis. This involves binding of ligand-coated particles to 
receptors, clustering of FcγRs, which induces a signalling cascade, and the engulfment 
of the particle by an actin driven process. Receptor activation and extension of 
pseudopods is replicated at many sites surrounding the pathogen [29]. Aggregation of 
FcγRs leads to activation of tyrosine kinases including Src family kinases (SFKs), 
followed by recruitment of adaptor proteins (e.g. Grb2, LAT). The resulting signalling 
platforms activate multiple lipid-modification enzymes (e.g. phosphoinositide 3-kinase 
(PI3K)) and guanine exchange factors (GEFs) that drive pseudopod extension [24].  
 
The internalisation process culminates in the formation of a membrane-bound vacuole 
termed the phagosome. Following scission from the plasma membrane, the 
phagosome becomes a potent microbicidal organelle. The phagosome becomes very 
acidic, pH ~4.5 via delivery of H+ ions into its lumen via the vacuolar ATPase  [30]. The 
phagosome is also highly oxidative [31]. Phagocytosis is accompanied by the 
production of two types of free radicals by neutrophils: reactive oxygen intermediates 
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formed by the activity of NADPH oxidase; and reactive nitrogen intermediates including 
nitric oxide produced by nitric oxide synthase. Phagosomes are enriched with 




Resolution of inflammation 
 
Once the main threat has been cleared, inflammatory processes are terminated and 
resolution programs begin. Resolution of inflammation involves remodelling and repair 
of damaged tissues and vasculature, and clearance of leukocytes. Resolution involves 
(a) withdrawal of survival signals; (b) normalisation of chemokine gradients; (c) 
induction of resolution mechanisms that promote leukocyte apoptosis or exit through 
draining lymphatics [33]. Here, antigen presenting cells opsonise bacteria and travel 
through draining lymph towards secondary lymphatic organs to activate the adaptive 
immune response. Fibroblasts begin remodelling damaged tissue. Macrophages 
release anti-inflammatory mediators to halt cell recruitment and activated neutrophils 
die by apoptosis. In addition to leukocytes, parenchymal and stromal cells revert back 
to a non-inflamed phenotype.  
 
Resolution begins with an anti-inflammatory phase involving the release of IL-10 and 
down regulation of NF-κB activity and production of cytokine receptor antagonists (e.g. 
IL-1Ra) [33]. This is followed by the resolving phase. Here, leukocytes release ‘pro-
resolving’ lipid mediators, such as lipoxin A4 (LXA4). This inhibits neutrophil migration 
and initiates phagocytosis of apoptotic neutrophils by macrophages. LXA4 also induces 
changes in phosphorylation of cytoskeletal proteins, leading to inhibition of neutrophil 
migration [34]. Other pro-resolving mediators include resolvins and protectins produced 
by neutrophils, and maresins produced by macrophages [34].   
 
Resolution is strictly controlled to protect the host from overt tissue damage and 
prevent the development of chronic, on-going inflammation and its associated 
complications. Leukocytes must be removed from the tissue before they cause 
excessive damage. Pro-apoptotic neutrophils release ‘find me’ signals that attract 
phagocytes and eventually lead to phagocytosis of the dying neutrophil [35]. This can 
be via macrophages and dendritic cells in the tissue, or by Kuppfer cells in the liver 
vasculature [36]. Neutrophils therefore promote their own removal by contributing to the 
resolution of inflammation and promoting tissue repair. Leukocytes can also leave an 
inflamed site by returning to systemic circulation. Studies in mice and zebrafish larvae 
have identified a novel mechanism of inflammation by reverse migration of neutrophils 
from wounded tissue back toward the vasculature [37], [38]. This represents a novel 
target for managing inflammatory resolution, and is the focus of continuing studies.  
 
If resolution of inflammation is absent, wound healing and regeneration will not occur 
and severe inflammatory pathologies such as irritable bowel disease (IBD), RA and 
Crohn’s disease may ensue. Inherited human diseases including leukocyte adhesion 
deficiency (LAD) are associated with impaired wound healing due to persistent 
infection and have been successfully recapitulated in the zebrafish [39]. Some 
pathological states present unresolved inflammation despite the absence of inciting 
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triggers. An ideal drug to target inflammation would be able to stop the inflammatory 
response and activate the resolution process. Glucocorticoids, as well as being anti-
inflammatory, promote resolution by stimulating macrophages to induce the uptake of 
apoptotic neutrophils [40]. Similarly, aspirin (which has an anti-inflammatory role in 
blocking prostaglandin production via modulation of cyclooxygenase activity) is also 




1.1.3 Cells of the innate immune system 
 
The innate immune system comprises many different cell types with complementary 
and contrasting functional duties. A lineage tree depicting cells of the immune system 
is illustrated in figure 1.2. Neutrophils, monocytes and macrophages are key mediators 
of innate inflammation and the focus of studies described in this thesis. These cells are 
defined in more detail below. 
 
 
Figure 1.2:  Hematopoietic cell lineage tree. Stemming from a common hematopoietic stem 
cell progenitor, three main branches are generated: lymphoid cells (left branch), myeloid cells 





Neutrophils are the most abundant cell of the immune system, the fastest responding 
leukocyte to a pathogen and are critical effectors of innate immunity. Neutrophils are 
continuously generated in the bone marrow from myeloid precursors, a process 
controlled by granulocyte colony stimulating factor (G-CSF) [42], with daily production 
reaching up to 2x1011 cells [43]. Neutrophils are polymorphonuclear leukocytes and 
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vesicles [43]. Neutrophil granules contain pro-inflammatory proteins including 
myeloperoxidase, lactoferran and MMPs. These proteins play a key role in neutrophil 
migration through tissues, as proteases can digest basement membrane or ECM [20].  
 
Several classes of receptors are expressed on the surface of neutrophils, including 
chemokine G-protein coupled receptors (GPCRs), adhesion molecules, cytokine 
receptors and C-type lectins [15].  Neutrophils also express TLRs and can directly 
detect foreign pathogens. Activation of neutrophil surface receptors leads to a plethora 
of events including phagocytosis, degranulation, reactive oxygen species (ROS) 
generation, NETosis and chemokine release. In the absence of inflammation, 
neutrophils can be found in the bone marrow, spleen, liver and lung. This pool of cells 
is considered to be a reservoir of mature neutrophils ready to be deployed to sites of 
tissue damage or infection. Tissue resident neutrophils may also be patrolling organs 
and have a homeostatic function. Recently, this has been observed using intravital 
microscopy of the mouse lung [44]. There has been speculation as to the existence of 
distinct neutrophil subsets and whether these represent distinct lineages or instead 
develop from a single neutrophil precursor. In a human study, differential subsets of 
neutrophils were shown to be present in the circulation of volunteers following LPS 
injection compared with untreated controls [45], [46]. It was demonstrated that this 
CD11cbright/CD62Ldim/CD11bdim/CD16bright subset of neutrophils was capable of 
suppressing human T cell proliferation [46]. 
 
Neutrophils have multiple killing mechanisms to eliminate pathogens during 
inflammation. Neutrophils phagocytose pathogens and kill them intracellularly using 
NADPH-oxidase dependent mechanisms or antibacterial proteins such as defensins 
[47]. Antibacterial proteins can also be released from granules into the extracellular 
space and act on extracellular pathogens. Additionally, activated neutrophils can 
release neutrophil extracellular traps (NETs) that comprise a core DNA element to 
which histones, antibacterial proteins and enzymes are attached. Pathogens are 
immobilized in NETs and this process limits their spread and also facilitates 
phagocytosis [48].  
 
Neutrophils also demonstrate regulatory, ‘healing’ features. Neutrophils can clear cell 
debris and phagocytose dead cells at a wound site. Removing neutrophils from a 
wound site results in worsened tissue pathology, even in sterile injury [49]. 
Furthermore, neutrophils directly release growth factors, e.g. vascular endothelial 
growth factor-A (VEGF-A), which have been shown to promote angiogenesis in a 
model of pancreatic islet transplantation [49]. Potentially, cancer cells could exploit this 
pro-angiogenic function of neutrophils to promote their survival and spread [50]. 
Therefore, the role of neutrophils in the tumour microenvironment is now of renewed 
attention.  
 
Neutrophils also have a role in regulating adaptive immunity and have been identified 
in the lymph nodes [51]. Neutrophils can mediate suppression of T cell proliferation and 
activity, which may be a result of degranulation [4]. Neutrophils can also act as antigen 
presenting cells. One recent study identified neutrophils carrying injected modified 
vaccinia Ankara virus from skin to the bone marrow, resulting in an alternative source 
of primed CD8+ T cells [52]. Generally it appears that neutrophils affect adaptive 
   Chapter 1 | Introduction 
10 
immunity by promoting humoral immune responses but suppressing cellular immune 
responses.  
 
Although neutrophil recruitment during infection is likely to be essential for protective 
immunity, excessive accumulation and subsequent inflammatory signalling may be 
detrimental. Upon activation neutrophils release oxidants, proteases and antimicrobial 
proteins and can cause indirect injury [53]. Over activation of the neutrophil response 
underlies the pathogenesis of various diseases including ischemia, reperfusion-induced 
tissue damage, and auto-inflammatory diseases [54]. Neutrophil-specific expression of 
Fc-receptors, C5a-receptors and LFA-1 [55], as well as Syk kinase [56], have been 
shown to be required for autoantibody-mediated arthritis. In contrast, absent or reduced 
neutrophil function in response to inflammation is associated with primary 
immunodeficiency [57].  
 
 
Monocytes and macrophages 
 
Monocytes are a subset of circulating myeloid cells that are derived from monoblast 
precursors in the bone marrow. They are amoeboid in shape with clear cytoplasm and 
bean-shaped nuclei. Monocytes circulate in the blood, bone marrow and spleen before 
entering tissues [58]. Cells of the monocyte lineage are characterised by considerable 
phenotypic plasticity and diversity. Monocyte subsets can be identified based on their 
surface receptor expression. Three types of monocyte subset have been identified in 
human blood: a) classical monocytes are characterised by high CD14 expression; b) 
non-classical monocytes have low CD14 and additional co-expression of CD16; c) 
intermediate monocytes have high CD14 and low CD16 expression [59]. Further 
studies have shown that in mice, expression of LY6C and CD11b identifies a monocyte 
subset that expresses high levels of CCR2 but low levels of CX3CR1. These 
monocytes are often referred to as inflammatory monocytes and are rapidly recruited to 
sites of infection and inflammation [60].  
 
Monocytes are efficient immune effector cells, equipped with chemokine receptors (e.g. 
CCR2) and pathogen recognition receptors (e.g. TLRs) that mediate migration from 
blood to tissues during inflammation and infection. Monocytes replenish tissue 
macrophages and dendritic cells in the steady state, and are recruited to infected 
tissues and mediate direct antimicrobial activity at these sites [60]. Monocytes or 
monocyte-derived cells can also enter draining lymph nodes and promote adaptive 
immune responses [58]. Monocyte chemoattractant protein-1 (MCP-1/CCL2) is the 
main chemokine that mediates monocyte chemotaxis via CCR2 binding. CCR2 
deficiency reduces inflammatory monocyte trafficking to sites of inflammation, 
indicating a crucial role for this chemokine receptor in trafficking of these monocytes 
[61]. The properties of MCP-1 are described in more detail in section 1.1.4. 
 
Blood levels of monocytes can rise during infection or inflammation, or also in response 
to stress and other factors. A sizable fraction of circulating monocytes enters the 
tissues of the body during inflammation, differentiating into inflammatory dendritic cells 
or macrophages [62]. Macrophages evolved in simple multicellular organisms to 
perform phagocytic clearance of dying cells and to protect the host through innate 
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immunity, both as resident tissue macrophages and monocyte derived recruited cells 
during inflammation [63]. Once differentiated, macrophages become long-lived cells 
and develop specialised functions. Macrophages are resistant to constitutive apoptosis 
[64] and cell number is further maintained by additional recruitment of monocytes into 
the tissues [65], [66]. Macrophages show distinct phenotypic heterogeneity and 
plasticity, even after differentiation, which is dependent upon the environment in which 
they are placed [67]. Macrophages have different names depending on their location, 
for example, Kupffer cells in the liver, alveolar macrophages in the lung, microglia in 
the central nervous system, and osteoclasts in the bone.  
 
Historically, inflammatory macrophages have been divided into two classes: classically 
activated type 1 (inflammatory/M1 cells) and alternatively activated type 2 (wound-
healing/M2 cells) [68]. This was based on the roles of macrophages as key modulator 
and effector cells in the immune response, and because their activation influences and 
responds to other arms of the immune system.  
 
Inflammatory macrophages are activated by TLR ligands (e.g. LPS) and cytokines and 
stimulate increased production of ROS and inflammatory cytokines, and higher 
expression of MHCII [69]. M1 cells function as inducers and effectors of resistance 
against intracellular parasites and tumours. These macrophages are able to assemble 
the inflammasome complex leading to IL-1β production and secretion [70]. IL-4 and IL-
13 induce the alternate M2 macrophage population, and these cytokines inhibit M1 
macrophages. M2 cells are poor at antigen presentation, suppress Th1 adaptive 
immunity, actively scavenge debris, have efficient phagocytic activity and contribute to 
the dampening of inflammation to promote wound healing, angiogenesis, and tissue 
remodelling [71].  
 
More recent evidence from in vivo studies has challenged this simplistic model and it 
has been suggested that a third class, regulatory macrophages, are also operational in 
tissues. Regulatory macrophages are able to present antigen and regulate the immune 
system with specific, targeted responses [72]. Furthermore, a series of other 
chemokines, cytokines, and growth factors can elicit functional responses which share 
overlapping properties with M1 and M2 phenotypes [72]. M1 and M2 phenotypes can 
also be reversed in certain immunological conditions, [73] [74]. These reports indicate 
that macrophage subclasses are to some extent interconvertible and represent a 
spectrum of phenotypes. Classification of macrophage activation should therefore 
consider two important aspects: the in vitro effects of immune related ligands on 
macrophage phenotype; and in vivo evidence for distinct macrophage phenotypes in 
disease. We must consider the context and environment in which the cells are 
functioning, and their interactions with other macrophage populations. Studying the 
behaviour of macrophages in vivo will uncover more information about different subsets 
and the plasticity of macrophages.  
 
The study of monocytes and macrophages in disease settings has confirmed their 
ability to have plasticity in different environments. Antibodies against CCL2 or its 
receptor CCR2 have been investigated in preclinical models and support a role for anti-
CCL2 therapy in some cancers [75]. There is substantial evidence to suggest that 
macrophages play an important role in wound healing and in tumour progression. 
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Recent zebrafish studies have indicated that depletion of macrophages results in a 
build up of debris and impairs regeneration at a wound site [76]. Monocyte and 
macrophage function has also been implicated in settings as diverse as cardiovascular 
disease, neurological disorders and atherosclerosis.  
 
 




Chemokines are chemotactic cytokines that are small heparin-binding proteins 
belonging to a large family whose main function is to regulate cell trafficking. 
Chemokines can be classed into four key subfamilies based on the number and 
location of cysteine residues at the N-terminus of the molecule (Table 1.1). The 
structure of chemokines comprises three distinct domains – a highly flexible N-terminal 
domain that is constrained by disulphide bonding between the N-terminal cysteine, a 
long loop that leads into three antiparallel β-pleated sheets, and an α-helix that overlies 
the sheets [77]. Sequence motifs in the vicinity of the first two cysteine residues 
determine receptor recognition and activation. Most chemokine ligands have a 
molecular mass between 8-12kDa and contain 1-3 disulfide bonds, although the 
sequence homology of chemokine ligands is highly variable [78]. In addition to 
structural classification, chemokines can be categorised according to functional 
properties. For example, amongst inflammatory chemokines, CXC chemokines with an 
ELR (Glu-Leu-Arg) motif prior to the first cysteine residue are angiogenic. In contrast, 
the ligands CXCL4, CXCL9, CXCL10 and CXCL11, which do not contain the ELR 
motif, function as angiostatic chemokines [79].  
 
 




Table 1.1: The chemokine superfamily. Chemokine ligands and their receptors are classed 
into families based on the location of cysteine residues. Atypical chemokine receptors can 
influence the activity of other chemokine ligands, but do not signal via classical pathways. T= T 
cell; Mo= Monocyte; Eo= Eosinophil; Ba=Basophil; D=Dendritic cell; Tmem= Memory T cell; Th2= 
Th2 T cell; P= Platelet; Treg= Regulatory T cell; MC= Mast cell; N= Neutrophil; En= Endothelial 
cell; Th= Helper T cell; NK= Natural killer cell; Mac= macrophage; SMC= Smooth muscle cell, 




Chemokine Ligand Receptor 







CCR1 CCL5 (RANTES), CCL3 (MIP1A), CCL7 (MCP-3), CCL8 (MCP-2), CCL13 (MCP-4), CCL14, CCL15, CCL16, CCL23 
T, Mo, Eo, 
Ba 
CCR2 CCL2 (MCP-1), CCL8 (MCP-2), CCL13 (MCP-4), CCL7, CCL16 Mo, D, Tmem 
CCR3 CCL11 (Eotaxin), CCL5, CCL7, CCL13, CCL14, CCL15, CCL24, CCL26, CCL28 
Eo, Ba, MC, 
Th2, P 
CCR4 CCL17 (TARC), CCL22 (MDC) Th2, D, Ba 
CCR5 CCL4 (MIP-1B), CCL3, CCL5, CCL7, CCL11, CCL16 T, Mo 
CCR6 CCL20 (MIP-3A) Treg, Tmem, B, D 
CCR7 CCL19 (ELC), CCL21 (SLC) T, DC 
CCR8 CCL1 (I-309) Th2, Mo, D 
CCR9 CCL25   













CXCL7 (NAP-2), CXCL5 (ENA78), CXCL1 (Gro-a), CXCL2 
(Gro-b), CXCL3 (Gro-g), CXCL6 (GCP-2), CXCL8 (IL-8), 
ACPGP, MIF 
N, Mo, En 
CXCR3 CXCL10 (IP-10), CXCL9 (MIG), CXCL11 (I-TAC), CXCL4, CXCL13 Th, MC 
CXCR4 CXCL12 (SDF-1), MIF, Ubiquitin Ubiquitous 
CXCR5 CXCL13 (BCA-1) B, Th 
CXCR6 CXCL16 CD8+ T, NK, Tmem 
CX3C 















CXCR7 CXCL11, CXCL12  En 
CCBP2 CCL2, CCL3, CCL4, CCL5, CCL7, CCL8, CCL11, CCL12, CCL13, CCL14, CCL17, CCL22, CCL23, CCL24 
  
CCRL1 CCL19, CCL21, CCL25, CXCL13  B 
CCRL2 CCL19   
DARC CXCL1, CXCL2, CXCL3, CXCL7, CXCL8, CCL2, CCL5, CCL11, CCL13, CCL14, CCL17 
 En 
D6 Agonists of CCR1-CCR5 
Mac, HSc, 
En, Mo, Neut, 
B, D 
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Chemokines are also grouped into two main functional subfamilies – inflammatory and 
homeostatic, although some chemokines overlap both fields and are called dual-
function chemokines. Inflammatory chemokines control the recruitment of leukocytes 
during inflammation. Homeostatic chemokines navigate leukocytes to and within 
secondary lymphoid organs as well as in the bone marrow and thymus during 
hematopoiesis. Chemokines also have critical roles in development, lymphocyte 
trafficking and homing, angiogenesis and malignancy [78].  
 
During inflammation, chemokines are secreted in response to pro-inflammatory 
mediators and have an important role in selectively recruiting monocytes, neutrophils 
and lymphocytes. The directed migration of activated cells expressing appropriate 
chemokine receptors occurs along a chemokine gradient. Chemokines within each 
chemokine subfamily can competitively bind to the same receptor on target cells and 





IL-8 is the prototypical member of the family of CXC chemokines and is one of the most 
potent neutrophil chemoattractants in inflammation. IL-8 is synthesised as an inactive 
99 amino acid precursor protein, with N-terminal cleavage producing a 77 amino acid 
(fibroblasts and endothelial cells) or 72 amino acid (leukocytes) protein. The 77 amino 
acid isoform secreted from non-immune cells is further cleaved to produce the active 
72 amino acid IL-8 protein, with a molecular weight of approximately 8kDa  
 
IL-8 is secreted from a range of cell types including leukocytes, fibroblasts, endothelial 
cells and malignant cancer cells. [82]. IL-8 can exist in monomer or dimer forms, which 
are capable of differentially activating and regulating its two cell surface receptors [83]. 
It binds to two different chemokine receptors on leukocytes and endothelial cells – the 
GPCRs CXCR1 and CXCR2. While CXCR1 is specific for IL-8, CXCR2 also interacts 
with CXCL1, 2, 3, 5, 6, and 7 [84]. Both receptors are also expressed on cancer cells. 
Binding of CXCR1 and CXCR2 activates specific intracellular signalling cascades 
including MAPK, PI3K, protein kinase C (PKC) and Src family kinase (SFK) signalling. 
This can lead to phosphoinositide hydrolysis, intracellular Ca2+ mobilisation, 
chemotaxis and exocytosis [85]. IL-8 signalling also activates multiple transcription 
factors including NFκB, AP-1, STAT3 and HIF-1 [86].  
 
As neutrophils are the fastest and most rapidly responding innate cell, IL-8 is 
consistently among the first signals to be expressed and released by cells during 
inflammation. IL-8 signalling is induced by inflammatory signals, ROS, death receptors 
and steroid hormones [86]. As well as many other disease settings, IL-8 expression is 
increased during IBD where it is a major contributor to the increased numbers of 
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Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) 
 
MCP-1 is a C-C chemokine family member and a potent chemotactic factor for 
monocytes. It belongs to a family composed of three other members (MCP-2, -3, and -
4) [78]. MCP-1 is composed of 76 amino acids and is 13kDa in size. It is produced by a 
variety of cell types, either constitutively or after induction by cytokines, growth factors 
or oxidative stress, and include endothelial cells, fibroblasts, epithelial cells, smooth 
muscle cells, monocytic and microglial cells [78].  
 
MCP-1 has been demonstrated to recruit monocytes into foci of active inflammation, 
including sites of bacterial, fungal and viral infection, as well as sites of sterile 
inflammation [88]. Another key role of MCP-1 is in orchestrating monocyte egress from 
the bone marrow into the circulation. Recent studies have shown that the increase in 
circulating monocyte number associated with infection or sterile inflammation is 
mediated by MCP-1-mediated signalling in monocytes in the bone marrow [89].  
 
MCP-1 mediates its effects through its receptor CCR2, which is expressed on multiple 
cell types. CCR2 can have dual roles in both pro-inflammatory and anti-inflammatory 
settings. CCR2 deficient mice are resistant to the induction of sensory neuropathies 
[90]. Furthermore, CCR2 null mice immunised with type II bovine collagen were found 
to be more susceptible to collagen-induced arthritis than the wild-type mice [91]. MCP-
1 has been implicated in a range of inflammatory and cancerous pathologies. MCP-1 is 
involved in leukocyte recruitment to vessels during formation of atherosclerotic plaques 





fMLF is the correct abbreviation for N-formyl-methionyl-leucyl-phenylalanine, as 
described by Dorward et al (2013) [94]. fMLP is a common misnomer and fMLF will be 
referred to as fMLP throughout this thesis.  
 
Small formyl peptide derivatives, obtained as bacterial metabolites or derived from 
disrupted mitochondria, are potent chemoattractants. fMLP is a formylated peptide that 
was the first to be demonstrated as the natural chemotactic product of E. coli [95], and 
is now the most extensively studied member of the formyl peptide family. fMLP is highly 
lipophilic and has conformational flexibility which allows efficient interactions with its 
receptor [96].  
 
Formyl peptides bind to the high affinity formyl peptide receptor (FPR) and its low 
affinity variant FPR-like 1. FPR is activated by picomolar to low nanomolar 
concentrations of fMLP and is functionally coupled to G proteins. FPR activation results 
in phospholipase C (PLC) and PI3K signalling leading to Ca2+ mobilisation from 
intracellular stores and tyrosine phosphorylation [97]. Ca2+ release into the cytoplasm is 
the earliest evidence of neutrophil stimulation by fMLP and occurs in close association 
with an apparent membrane hyperpolarisation [98].  
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fMLP can activate directed cell movement, phagocytosis, release of proteolytic 
enzymes and generation of ROS. fMLP activates the transcription factor NFKB in 
leukocytes [99]. This appears to be essential for pro-inflammatory cytokine synthesis in 
phagocytes and is cell-specific and different to TNFα-mediated NFκB activation [100]. 
fMLP induces the secretion of IL-1 and IL-6 in human mononuclear cells [101]. Upon 
exposure to fMLP neutrophils develop a characteristic surface ruffling and adopt an 
elongated shape in which modifications in the actin cytoskeleton are implicated [102]. 
Mitochondrial formyl peptides are potent immune activators and are septic mediators 
implicated in clinical systemic inflammatory response syndrome [103]. 
 
Neutrophils from patients with localised juvenile periodontitis (LJP) show decreased 
binding and responsiveness to various chemotactic agents, including fMLP, possibly 
due to a polymorphism in the FPR [104]. FPR-deficient mice display increased 
bacterial burden in the liver and spleen, and earlier death, when challenged with L. 
monocytogenes, versus healthy littermates, suggesting a role for fMLP signalling in 
host defence through regulation of innate immunity [105].  
 
 
Leukotriene B4 (LTB4) 
 
Leukotrienes are a family of eicosanoid inflammatory mediators. Leukotrienes are 
named after their cells of origin (leukocytes) and the presence of three positional 
conserved double bonds (trienes). The leukotriene family includes leukotriene A4 
(LTA4), a short-living intermediate product of the leukotriene synthesis pathway, 
leukotriene B4 (LTB4) and the group of cysteinyl leukotrienes: C4 (LTC4), D4 (LTD4) and 
E4 (LTE4) [106]. Leukotrienes are produced by the oxidation of arachidonic acid by 
arachidonate 5-lipoxygenase. Neutrophils mainly produce LTB4 while monocytes and 
macrophages can generate LTB4 and cysteinyl leukotrienes. Other cell types, such as 
epithelial cells, can synthesise leukotrienes, but to a lesser extent [107].  
 
LTB4 has three receptors with different binding affinity. BLT1 is a high affinity receptor 
for LTB4 and is expressed by neutrophils, monocytes, T lymphocytes, eosinophils and 
mast cells. BLT is a low affinity receptor for LTB4 that is expressed on CD8+ and CD4+ 
T lymphocytes and monocytes [108]. Thirdly, peroxisome proliferator-activated 
receptors (PPARs) are another group of LTB4 receptors that are expressed in the 
nucleus and function as lipid homeostasis factors and controllers of inflammatory 
responses [109].  
 
All leukotriene receptors link to G proteins upon activation and decrease intracellular 
cAMP, increase cytosolic Ca2+, and stimulate MAPK and ERK phosphorylation. LTB4 
stimulation leads to a number of functional responses important during inflammation, 
including degranulation, ROS production, chemotaxis and phagocytosis [110]. LTB4 
also stimulates expression of β2 integrins (CD11b/CD18), likely related to leukocyte 
migration [106]. LTB4 has been implicated in a variety of inflammatory disorders, 
including RA [109]. LTB4 stimulates neutrophil infiltration resulting in emphysematous 
lung tissue and is significantly implicated in the progression of chronic obstructive 
pulmonary disease [111]. 
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1.2 Signalling pathways in innate immune cell function 
 
Innate cells must be able to effectively recognise and eliminate pathogens and dying 
cells. This relies on complex intracellular signal transduction pathways that inform the 
cells of their environment or drive necessary processes, such as chemotaxis, that are 
required for the restoration of homeostasis. Therefore, intracellular signal transduction 
processes need to convey a large amount of complex information to support an 
efficient inflammatory response. SFK and PI3K signalling are heavily involved in 
immune responses and are described in more detail below. 
 
 
1.2.1 Src family kinase (SFK) signalling 
 
Cytoplasmic tyrosine kinases are crucial for innate immune cell signalling. Two major 
kinase families that operate in the proximal intracellular signalling pathways in innate 
cells are the Src-family kinases and the Syk-ZAP70 family [112]. Src family kinases are 
signalling enzymes that have long been recognised to regulate critical cellular 
processes such as proliferation, survival, migration and metastasis.  
 
 
SFK family members, structure and discovery 
 
Src kinase is a proto-oncogene encoding a non-receptor protein tyrosine kinase. The 
Src gene is similar to the v-Src from the Rous sarcoma virus [113]. Subsequent studies 
of viral and constitutively active forms of Src have increased our understanding of the 
processes involved in malignant transformation. In addition, studies of signalling 
pathways leading to the activation of Src and its closely related SFK homologues have 
been central towards understanding normal growth-regulatory processing, including 
proliferation, apoptosis, cell cycle control, angiogenesis and cell-cell adhesion and 
communication [114].  
 
SFKs are classified as non-receptor tyrosine kinases consisting of nine structurally 
related molecules: Src, Blk, Fyn, Yes, Lyn, Hck, Fgr, Yrk and Lck [115]. SFK 
expression can differ between different innate cell types [116]. Monocytes, 
macrophages, granulocytes and dendritic cells primarily express Hck, Fgr, Lyn and to a 
lesser extent, Src. These SFKs have been implicated as primary signalling molecules 
downstream of a host of immune cell receptors, such as immunoreceptors, cytokine 
receptors, integrins and pathogen receptors. 
 
Each SFK member has conserved peptide domains, termed Src homology (SH) 
domains, four of which have been defined in all SFKs [117]. The structural components 
of SFK are illustrated in figure 1.3. SH domains allow SFK participation in signalling 
complexes and also regulate SFK kinase activity through intramolecular interactions. 
SH-1 is the enzymatic domain of the molecule and possesses intrinsic tyrosine kinase 
activity [118]. The SH-1 domain also contains an activation loop that has an 
autophosphorylation site at Tyr416 and regulates the association with substrates. The 
SH-2 domain allows interaction with phosphotyrosine residues on proteins, specifically 
with its own C-terminal tyrosine phosphorylated amino acid (Tyr527) in its inactive 
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conformation [116]. The SH-3 domain recognises proline rich motifs, present on many 
signalling and structural molecules [119]. Analysis of crystal structures have indicated 
that SH-2 and SH-3 domains facilitate intermolecular interactions between Src and 
proteins with which it forms complexes [120]. The NH2-terminal domain, or the SH-4 
domain, can be myristoylated and is responsible for membrane association of SFKs 




Figure 1.3: The structure of SFKs and conformational changes during SFK activation.  (A) 
The SFK structure comprises regulatory SH-1 domain, interactive SH-2 domain and the SH-3 
domain that coordinates substrate binding. (B) During the inactive conformation, C-terminal 
Tyr527 is phosphorylated and bound to SH-2 domain. (B) Phosphorylation of active loop Tyr416 




SFK activation and signalling 
 
SFK activity is regulated by the autophosphorylation and dephosphorylation of their 
own tyrosine residues [122]. Through interaction of the SH-2 or SH-3 domain with the 
other domains, SFKs change their structure and exhibit different levels of activity. In the 
inactive state, C-terminal Tyr527 is phosphorylated and interacts with the SH-2 domain, 
resulting in a closed conformation. Autophosphorylation at Tyr416 in the SH-1 domain 
results in an open conformation and active state protein [122]. Figure 1.3 illustrates 
conformational changes in SFKs during activation. 
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SFK activity can be regulated by other tyrosine kinases. The C-terminal Src kinase 
(Csk) and the Csk homology kinase (Chk) are two main tyrosine kinases responsible 
for the phosphorylation of the auto-inhibitory Tyr527 in Src [123]. Chk forms a non-
covalent bond with the auto-phosphorylated form of SFKs that blocks kinase activity. 
Many other phosphatases, e.g. phosphatase-1B and phosphatase-α, are capable of 
removing the Tyr527 phosphate group from the C-terminal tyrosine and ‘opening up’ 
the catalytic SH-1 site. This is often after the C-terminal phosphorylated tyrosine is 
‘exposed’ following intermolecular interaction of Src with binding proteins in signalling 
complexes [120]. 
 
SFKs phosphorylate tyrosine residues on target proteins. Historically, the study of SFK 
signalling has focused on immunoreceptor and integrin signalling, however SFKs were 
later shown to participate in other signal transduction pathways including at 
chemoattractant receptors and integrin receptors. Figure 1.4 illustrates the role of SFKs 
at various receptor types. SFKs communicate to various downstream mediators, 
including Tec-family members, e.g. Btk, Bmx and Tex in innate cells [112]. SFKs also 
activate the FAK/Pyk2 tyrosine kinase family, which plays a major role in integrin 
signalling [124]. Pathways can be initiated in different spatial and temporal rates or 
activated indirectly, for example through the production of cytokines and not through 
direct intracellular biochemical interactions. Regulation through distinct protein domains 
and post translational modifications accounts, in part, for the multiple roles SFKs play 
in signalling complexes, where they serve both as a scaffolding protein and as a 
protein tyrosine kinase. 
 
SFKs control NADPH oxidase activation and ROS production. Activated NADPH 
oxidase is a multimeric protein consisting of at least three cytosolic subunits: p47phox, 
p67phox, and p40phox. The p47phox subunit displays a significant role in the acute 
activation of NADPH oxidase; the phosphorylation of p47phox by Src kinase is thought 
to inhibit intracellular interactions and to promote the binding of p47phox to p22phox, 
thereby inducing the activation of NADPH oxidase [125]. SFKs also promote 
endothelial permeability in inflammatory processes. Excessive cytokine production and 
growth factor release can result in vascular endothelial damage and may incite 
dysfunction of paracellular and transcellular transport mechanisms, leading to 




SFK signalling at immunoreceptors  
 
Typically, immunoreceptor engagement leads to activation of SFKs, which in turn 
phosphorylate immunoreceptor tyrosine-based activation motifs (ITAMs) present on the 
receptor or associated subunits [126]. This leads to recruitment of Syk via binding of 
the Syk SH-2 domain to the phospho-ITAM residues, and activation of Syk allowing it 
to phosphorylate downstream substrates. These substrates include PI3K, which in turn 
generates PI(3,4,5)P3 and FAK/Pyk2 kinases that activate the Rho/WASP pathway of 
actin polymerisation. Together all of these pathways can impact many downstream 
factors, including MAP kinases (leading to gene transcription), Rac/Rho (modulating 
cytoskeletal function), and inositol triphosphate (IP3) and diacyl-glycerol (DAG) 
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(regulating Ca2+ entry and PKC activation). This prototypical immunoreceptor pathway 
is similar in both innate and adaptive immune cells [127], [128]. SFKs and Syk tyrosine 
kinases also activate inhibitory signalling pathways. Lyn is primarily responsible for 
immunoreceptor tyrosine-based inhibitory motif (ITIM) phosphorylation, which serves 
as a docking site for phosphatases such as SHP-1 or SHIP-1 [129].  
 
Phagocytosis occurs through the binding of FcγR to immunoglobulins [24]. FcγR cross-
linking is induced by the phosphorylation of ITAMs located in the cytoplasmic tail of the 
tyrosine kinase receptors. SFKs expressed in phagocytes form complexes with 
inactivated FcγRs. Src deficient cells are less effective than WT cells at mediating 
phagocytosis [130].  
 
 
SFK signalling at non-ITAM containing receptors 
 
SFKs also have important signalling roles in pathways where ITAMs are not involved. 
Some studies suggest that SFKs work with Jak kinases in supporting cytokine 
responses, possibly by phosphorylation of receptor subunits or STAT molecules [131]. 
In the case of growth factor receptors, such as GM-CSF receptors, SFKs have been 
found to physically associate with the receptor via SH-3 interactions [132]. In other 
cytokine responses, SFKs may be acting further downstream of the receptor, for 
example through TRAF signalling molecules. A number of studies have demonstrated 
the involvement of SFKs downstream of the M-CSF receptor in macrophages and 
myeloid progenitors, with their function being to couple receptor activation to 
downstream PI3K pathways [133]. SFKs have also been shown to signal downstream 
of selectin receptors, membrane bound receptors and TLRs [112].  
 
Recent developments have led to the demonstration that many innate immune 
receptors utilise the ‘immunoreceptor pathway’ despite lacking ITAMs and not actually 
being immunoreceptors. This has evolved from studies of innate cells lacking the 
ITAM-signalling adaptors DAP12 and the FcγR [134]. Typically, DAP12 and FcγR are 
coupled to immunoreceptors through charged amino acid interaction within the 
transmembrane regions of each protein. A number of non-immunoreceptor pathways, 
for example neutrophil integrin signalling or basophil IL-3 responses, are lost in innate 
cells derived from mice lacking DAP12 or FcγR [14], [135]. The mechanisms by which 
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Figure 1.4: SFK and Syk signalling in the activating signalling pathways utilizing ITAM-containing adaptors. Examples of immunoreceptors, hemi-ITAM C-type 
lectin receptors, and non-immunoreceptors that utilize ITAM-signalling adapters and the cytoplasmic tyrosine kinases. Classical immunoreceptors refers to those signalling 
molecules that are directly coupled to ITAM adaptors FcγR or DAP12.  Dectin-1 is an example of a C-type lectin receptor that has ITAM-like sequences as imbedded 
domains with its cytoplasmic tail. Leukocyte integrins are the best example of receptors that link to or co-opt the ITAM pathway. Typically, SFKs phosphorylate the ITAM 
adaptors, creating docking sites for Syk kinase that then phosphorylates a number of substrates including scaffolding proteins LAT and NTAL that subsequently recruit 
further proteins to initiate downstream responses. Syk function is also critical for PI3K activation, which leads to generation of PIP3 and recruitment of Tec-family kinases. 
Together, these all contribute to downstream pathways of calcium signalling, MAPK activation and NFκB activation. SFKs and Syk also contribute to FAK/Pyk2 activation, 
leading to actin polymerisation required for migration and adhesion processes. Additionally, SFKs can act downstream of GPCRs by binding to G proteins, and possibly via 
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SFK signalling at GPCRs 
 
SFKs have also been implicated in the regulation of chemokine signalling, mediated by 
GPCRs. Ma et al (2000) report that G proteins Gαs and Gαi directly stimulate Src 
kinase activity of down-regulated c-Src, and similarly modulate Hck. This was proposed 
to be via direct binding to the catalytic domain and a subsequent conformational 
change, leading to increased accessibility of the active site to substrates [136]. SFK 
activation has been identified downstream of several chemokine receptors. For 
example, Lyn kinase is activated in macrophages downstream of both CXCR4 and 
CCR5, and is thought to couple these GPCRs to the MAPK and PI3K pathways [137]-
[139]. Furthermore, recent reports using pharmacological inhibitors have suggested 
that SFKs may act downstream of MCP-1 signalling via CCR2 [140], and downstream 
of IL-8 signalling via CXCR1 [141]. Neutrophils derived from Hck-/-Fgr-/- double mutant 
mice show significant functional defects following fMLP stimulation, which involves 
signalling through GPCR-coupled FPRs [142]. fMLP-induced degranulation is 
decreased significantly in neutrophils treated with the Src inhibitor PP1 and in Src-
deficient cell lines [143].  
 
 
SFK signalling in migration and adhesion 
 
SFKs and Syk play a positive role in regulation of migration of different leukocyte 
subtypes including granulocytes and macrophages/monocytes [115]. Roles of SFKs in 
innate immune cell migration are summarised in table 1.2.  
 
β2 integrin ligation leads to SFK activation [144] and β2 integrin-mediated neutrophil 
activation also requires the Syk tyrosine kinase. Integrin mediated Syk activation is 
facilitated by two ITAM-bearing adaptor molecules, DAP12 and FcγR, in a classical 
phospho-ITAM-mediated manner [14]. Loss of SFK activity results in complete 
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Fgr-/- Hck -/- neutrophils display normal 
chemotactic responses to chemokines. 
Fgr-/- Hck-/- macrophages display a reduced 
chemokinetic and chemotactic ability. 






Hck expression in U937 monocytic cell line 
enhances cell migration. 
Neutrophils expressing constitutively active 








Neutrophil stimulation with chemoattractants 
activates a Lyn/Shc/PI3K pathway. 
SDF-induced cell migration is defective in Lyn-
deficient bone marrow cells. 
Lyn-deficient neutrophils and macrophages 




Fyn Mast cells, cell 
lines 
CSF-induced cell migration is reduced in Fyn-
deficient mast cells 
[154], [155] 
Yes Ubiquitous Yes activation drives LTB4-mediated 
degranulation of human neutrophils. 
 
[156] 
    
Syk Lymphocytes, 
cell lines 
Syk is required for cytoskeleton remodelling 
and cell migration of macrophage cell line 
RAW264.7 in response to CX3CL1. 
[157] 
 
Table 1.2: Selected roles of SFKs and Syk in the regulation of innate cell migration.  
 
 
Focal adhesion kinase (FAK) and Pyk2 are expressed in innate cells, amongst other 
cell types. FAK can drive cell adhesion signalling downstream of integrin activation 
[158]. FAK and Pyk2 are both substrates for SFKs following integrin ligation and their 
subsequent phosphorylation leads to protein unfolding and activation of their enzymatic 
activity. In innate cells, FAK and Pyk2 are found in podosomes, the main contact sites 
in leukocytes [159]. Macrophages lacking FAK display elevated protrusive activity, 
altered adhesion dynamics, elevated Rac activity and impaired chemotaxis, all of which 
greatly impairs directional migration [160], [161]. A similar phenotype is observed in 
macrophages derived from Pyk2-deficient mice [160]. This involvement of FAK and 
Pyk2 could also affect phagocytosis mechanisms, because siRNA mediated knock 
down of FAK and/or Pyk2 can reduce uptake of bacteria [162]. The story is similar in 
neutrophils, where FAK and/or Pyk2 deficiency leads to impaired adhesion, migration, 
and bacterial uptake [163], [164]. These reports strongly suggest FAK/Pyk2 signalling 





The Syk-ZAP70 family of tyrosine kinases has two members and only Syk is found in 
innate cells. Syk kinase is involved in all innate immune cell signalling involving ITAM 
or ITAM-like signalling adaptors [112]. This includes signalling from classical 
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immunoreceptors, non-immunoreceptors (e.g. integrins, selectins), and those C-type 
lectin receptors that have hemi-ITAMs embedded in their C-terminal domains (e.g. 
dectin). Syk is activated by engagement of its two SH-2 domains by phospho-ITAM 
domains, so it functions only in ITAM-like pathways. It is also likely that Syk is only 
involved in pathways that also include SFKs. However, differences in phenotypes have 
been observed when Syk and SFKs are separately inhibited. For example, SFK 
deficient macrophages have a moderate defect in phagocytosis, caused by a reduction 
in initial actin polymerisation at the phagocytic cup [148]. In Syk deficient cells, 
however, phagocytosis is completely blocked due to a block in fusion of the arms of the 
phagocytic cup, a step subsequent to actin polymerisation events [165]. In light of this, 
SFKs could be signalling to other pathways besides ITAM-mediated Syk activation. Syk 
has also been linked to activation of intracellular pattern recognition receptors, which in 
turn activate the inflammasome leading to IL-1β production [166]. Genetic deficiency of 
Syk, as well as a novel Syk inhibitor, protects mice from auto-antibody induced arthritis 
but also prevents neutrophil activation in various assay systems [15]. Interestingly, 
some reports suggest that it is likely that Syk does not signal in cytokine or GPCR 
linked pathways. Lack of functional Syk has no effect on neutrophil, macrophage or 
mast cell recognition of several cytokine growth factors or GPCR agonists, including 
fMLP or ATP [167].  
 
SFKs have broad effects on overall signalling, while Syk has more defined roles. This 
is echoed in the fact that deficiencies in single SFKs tend to produce limited signalling 
defects in innate cells. However, loss of Syk has very defined broad functional effects. 
SFKs tune responses in a graded fashion, whereas Syk acts more like a signalling 
switch – being an absolute requirement in certain pathways. 
 
 
Targeting SFKs for therapeutics 
 
Given the wide ranging roles of SFKs and the more defined role of Syk in signalling 
pathways, targeting Syk may be a more rational therapeutic strategy with reduced side 
effects. Importantly, the production of Syk kinase inhibitors is underway for the 
treatment of immune-mediated disease such as RA and type 1 diabetes [168], [169]. 
SFK inhibitors have proved to be far more broadly acting and target enzymes besides 
just SFKs, which is problematic for the treatment of immune diseases [112]. A future 
target is to create inhibitors that can distinguish between SFK members, although this 
seems particularly chemically challenging.  
 
Novel inhibitors of Src have been designed for therapeutic purposes particularly for use 
in tumorigenesis. Bosutinib (SKI-606), dasatinib (BMS-354825), saracatinib 
(AZD0530), KX2-391, and NVP-BHG712 are examples of recently developed Src 
inhibitors exhibiting IC50 values ranging from 1nM-300nM. Most of these have been 
tested in cancer disease settings [170]. Fostamatinib, an orally active pro-drug of a Syk 
inhibitor has recently produced promising effects in a phase II clinical trial in human 
rheumatoid arthritis [171]. Dasatinib, a combined Abl/Src inhibitor used for the 
treatment of chronic myelogenous leukaemia also shows robust inhibitory effects on 
certain neutrophil functions and may prove to be a suitable starting point of 
development of novel tyrosine kinase inhibitor anti-inflammatory molecules [172].  
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1.2.2 Phosphoinositide 3-kinase (PI3K) signalling 
 
Phosphoinositide 3-kinase (PI3K) is a conserved family of lipid kinase enzymes known 
to play non-redundant roles in multiple cell processes. PI3K isoforms can be divided 
into three classes (class I, II and III) based on their structure and lipid substrate 
specificities. While class I PI3Ks are the most extensively studied, less is known about 
class II PI3Ks. Class III PI3Ks have been implicated in vesicle trafficking and 
phagocytosis [173].  
 
The structural domains of class I PI3K are illustrated in figure 1.5. Class I PI3Ks are 
composed of a p110 catalytic subunit and a tightly associated regulatory subunit, which 
is responsible for the recruitment of the complex to the plasma membrane upon 
receptor ligation [174]. Class I PI3Ks are composed of four isoenzymes subdivided into 
class IA (p110α,β,δ) and class 1B (p110γ) which pair with five (p85α, p50α, p55α, p85β 
and p55γ) and two (p101 and p84) regulatory subunits, respectively [175]. Class IA 
isoforms are activated downstream of a variety of receptors that are phosphorylated by 
tyrosine kinases upon cognate stimulation. The class IB PI3Kγ is activated by G-protein 
βγ subunits and signals downstream of GPCRs. However, recent evidence suggests 
that PI3Kβ can couple to GPCRs and PI3Kγ can couple to tyrosine-kinase coupled 
receptors [176], [177].  
 
 
Class I PI3K signalling  
 
Class I PI3K enzymes phosphorylate the D3 position on the inositol ring of 
phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] to generate PI(3,4,5)P3 which controls 
signalling cascades in many cellular responses. PI(3,4,5)P3 is located in the plasma 
membrane and acts as a docking site to recruit and activate pleckstrin homology (PH) 
domain containing proteins (see figure 1.5). PH-domain containing proteins that are 
activated by PI3K signalling include PKB/Akt, PDK1, guanine nucleotide exchange 














Figure 1.5: PI3K signalling cascade and structural domains of class I PI3Ks. (A) Following 
GPCR or RTK activation, class I PI3K enzymes phosphorylate the D3 position on the inositol 
ring of PI(4,5)P2 to generate PI(3,4,5)P3 which is located in the plasma membrane and acts as a 
docking site to recruit and activate pleckstrin homology (PH)-domain-containing proteins that in 
turn regulate downstream effector proteins and promote a host of cellular responses. (B) 
Structural domains of PI3K class I enzymes. Class IA and IB share core domain structure of 
single Ras binding, C2, helical and catalytic domains. Class IA has a p85 regulatory subunit-





The PI3K/Akt/mTOR cascade is the most common effector pathway downstream of 
PI(3,4,5)P3. PI(3,4,5)P3 recruits 3-phosphoinositide-dependent protein kinase 1 (PDK1) 
which in turn phosphorylates and activates Akt at Thr308 [178]. Akt signals to mTOR, a 
complex of proteins that functions as serine/threonine kinases. mTORC2 can 
phosphorylate Akt at Ser473 and this leads to the complete activation of Akt, which 
exhibits fivefold more activity than phosphorylation at Thr308 alone [179].  
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PI3K signalling is regulated by at least two lipid phosphatases – SH2-domain 
containing inositol 5-phosphatase (SHIP) and phosphatase and tensin homologue 
(PTEN). SHIP dephosphorylates PI(3,4,5)P3 at the D5 position of the inositol ring to 
create phosphatidylinositol 3,4-bisphosphate [PI(3,4)P2]. Multiple forms of SHIP have 
been reported. Importantly, SHIP-1 expression is restricted to differentiated cells of the 
hematopoietic system, endothelial cells and stem cells [180]. PTEN dephosphorylates 
the D3 position to create PI(4,5)P2 [181]. PTEN is expressed in both hematopoietic and 
non-hematopoietic tissues.  
 
 
PI3K signalling in the immune system 
 
PI3Ks are activated by an array of receptors expressed on leukocytes across innate 
and adaptive immunity. The significance of PI3K during inflammation was highlighted 
by the generation of kinase inactive PI3Kγ or PI3Kδ mice. Although the mice appear 
viable and healthy, upon immune challenge the mice are unable to mount sufficient 
inflammatory responses, indicating that these kinases have non-redundant functions in 
leukocytes, and that they play a critical part in inflammatory disease [173]. It appears 
that PI3Kγ or PI3Kδ act in partnership to regulate immune cell signalling and function. 
Several studies have suggested that PI3K inhibition or genetic ablation of PI3Kγ 
causes a reduction in chemotactic responses of lymphocytes, neutrophils, 
macrophages and eosinophils in both in vitro and in vivo migration assays [174]. PI3Kγ 
is crucial for morphological changes associated with cell polarisation by generating 
PI(3,4,5)P3 at the leading edge and regulating Rac activity and the cytoskeleton 
reorganisation [182]. PI3Kδ has also been shown to regulate neutrophil migration as 
demonstrated by the ability of a PI3Kδ-specific inhibitor to induce directional neutrophil 
movement in response to chemotactic gradients [183], [184]. PI3K activity in 
endothelial cells can also regulate neutrophil interactions with an inflamed vessel wall 
[183]. PI3Kγ and PI3Kδ also coordinate neutrophil respiratory burst [185] 
 
In vivo models of neutrophil migration have revealed that while PI3Kγ is important in 
early chemokine-induced emigration, PI3Kδ replaces PI3Kγ and maintains the delayed 
chemokine-induced neutrophil recruitment into inflamed tissues [186], suggesting that 
their coordination is temporally distinct. However, despite this coordination between 
isoforms, genetic targeting has revealed that each isoform has distinct contributions 
that are dependent upon the receptor and/or cell type involved. For example, although 
both PI3Kγ and PI3Kδ are required for neutrophil migration towards LTB4, only PI3Kγ is 
responsible for migration towards fMLP [187]. The requirement for PI3K during 
neutrophil chemotaxis is context dependent in vitro. PI3Kγ is essential for murine 
neutrophil migration on fibrinogen-coated surfaces, but is dispensable for migration on 
glass [188]. Treatment of human neutrophils in vitro with PI3K inhibitors abolishes 
migration towards selected chemoattractants such as IL-8 and LTB4, but not towards 
others including fMLP or C5a [189]. 
 
Using both genetic and pharmacological approaches in zebrafish, it has recently been 
reported that PI3K activity is required for both random and directed neutrophil motility 
[190]. This suggests that PI3K and the generation of PI(3,4,5)P3 acts as a key motor at 
the leading edge that drives cell protrusion and is necessary for motility. Live imaging 
of the dynamic localisation of PI(3,4,5)P3 and PI(3,4)P2 in zebrafish neutrophils has 
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revealed that PI3K is activated at the cell front regardless of the direction of cell 
movement, either towards or away from a wound [190]. Therefore, although 
accumulation of PI(3,4,5)P3 at the leading cells is an early marker of cell polarity and 
gradient sensing, it is likely to be a key player in mediating localised protrusion and 
motility rather than gradient sensing.  
 
Despite their importance in mounting successful inflammatory responses, overactive 
PI3K signalling can induce immune related pathologies including cancer [191], [192]. 
This suggests that therapeutic targeting of PI3Ks may be beneficial in these disease 
settings.  Furthermore, there is evidence for a role of PI3K in autoimmune pathology 
including RA, systemic lupus erythematous, multiple sclerosis and type I diabetes 
[193]. 
 
Negative regulators of PI3K have also been studied in immune settings. Upon receptor 
stimulation, PI3K negative regulator SHIP-1 translocates to the plasma membrane and 
hydrolyses the PI3K-generated second messenger PI(3,4,5)P3 to PI(3,4)P2. SHIP-1 is 
therefore able to influence PI(3,4,5)P3 mediated signalling and control proliferation, 
differentiation, survival and migration of hematopoietic cells [181]. Analysis of SHIP-1 
mutant mice and cells has shown a key role for SHIP-1 in regulating the myeloid cell 
response to bacterial mitogens and regulating leukocyte polarisation during migratory 
responses [178], [194].  
 
 
Pharmacological targeting of PI3K signalling 
 
Our understanding of the PI3K signalling pathway has been improved by the 
development of compounds that can block their activity; the first generation of which 
include the natural product wortmannin and Eli Lilly compound LY294002. Commonly 
used PI3K inhibitors are listed in table 1.3. These tools have allowed researchers to 
explore structural components of PI3K interactions and have influenced the later 
development of more selective and potent new compounds. Inhibitors targeting the full 
cohort of PI3K isoforms are currently in trials for the treatment of cancers where the 
PI3K pathway is a key driver of disease [174].  
 
Due to our increased understanding of specific isoform contribution to immune 
disorders it is necessary to focus efforts into creating inhibitors with higher isoform 
selectivity. This will reduce side effects and increase potency of potential therapeutics 
in the clinic. Such attempts are underway and on going. The ICOS compound IC87114 
has an IC50 value of approximately 100nM for PI3Kδ lipid kinase activity, but has 
negligible potency against the PI3Kα and PI3Kβ isoforms [193]. Calistoga, a spinout of 
ICOS, created CAL101, a PI3Kδ-specific inhibitor that has been successful in proof of 
concept trials for B cell malignancies [195]. This compound (now owned by Gilead and 
renamed GS1101) exhibits 40-300 fold selectivity over other isoforms. Inhibitors that 
are selective for PI3Kγ have also been generated, including Merck Serono SA 
compound AS605240 [174]. PI3Kγ and PI3Kδ have overlapping roles within 
inflammation, so it would be very useful to target them together with a single 
compound. To explore this, TargeGen has described two diaminopteridine-diphenol-
based compounds (TG101-110, TG100-115) that have good selectivity for PI3Kδ and 
PI3Kγ [193].  
   Chapter 1 | Introduction 
29 
 
 IC50 value (nM)  
 PI3K isoform  
Compound p110α p110β p110δ p110γ Reference 
LY294002 183 98 227 1967 [196] 
ZSTK474 16 44 4.6 49 [197] 
A66 32 >12,500 >1250 3480 [198] 
GSK2636771 2000 13 79 1000 [199] 
TGX-221 5000 5 100 >10,000 [198] 
IC87114 >100,000 1820 70 1240 [200] 
AS-605240 3400 >20,000 >20,000 190 [200] 
 
Table 1.3: IC50 values of commonly used PI3K inhibitors. Individual IC50 values from in vitro 
assays with either purified or recombinant protein. 
 
 
SHIP-1 is also an ideal target for immune disorders because of its restricted expression 
in hematopoietic cells. Given the known mechanisms, we would predict that SHIP-1 
activation would lead to a reduction of cellular PI(3,4,5)P3 and mimic the effect of PI3K 
inhibitors. Aquinox Pharmaceutical Inc. is currently developing a small molecule SHIP-
1 activator for intended clinical use. Their lead compound, AQX-1125, has been shown 
to inhibit Akt phosphorylation, inflammatory mediator production and leukocyte 
chemotaxis in vitro [201]. Conversely, a small molecule inhibitor of SHIP-1 has been 
recently identified – 3 α-aminocholestane (3AC) [202]. SHIP-1 inhibition should lead to 
activation of PI3K and promote PI(3,4,5)P3 formation. Consistent with observations 
from SHIP-1 deficient mice, treatment with 3AC led to increased numbers of myeloid 
suppressor cells and reduced ability of peripheral lymphoid tissues to prime myeloid-
associated responses and protected against Graft Versus Host Disease [202]. 3AC 
also increased the number of granulocytes, red blood cells, and platelets in mice and 




1.2.3 Rho-GTPase signalling 
 
GTPases are molecular switches that control a wide variety of signal transduction 
pathways in all eukaryotic cells. They regulate the actin cytoskeleton, cell polarity, 
microtubule dynamics, membrane transport pathways and transcription factor activity 
[203].  
 
The association of GTPases with guanosine triphosphate (GTP) or guanosine 
diphosphate (GDP) controls their activity. GTPases cycle between two conformational 
states: ‘Active’ – bound to GTP, and ‘inactive’ – bound to GDP. GTPases hydrolyse 
GTP to GDP. In the active state, GTPases recognise target proteins and generate a 
response until the GTP hydrolysis returns the switch to the inactive state [203]. The 
exchange of bound GDP for GTP (activation) is regulated by guanine exchange factors 
(GEFs), which catalyse GDP dissociation and promote GTP binding. GTPase 
deactivation is catalysed by GTPase activating proteins (GAPs), which stimulate 
hydrolysis of bound GTP to GDP and inorganic phosphate. Rho GTPases are also 
regulated by guanine dissociation inhibitors (GDIs), which result in inactivation by 
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sequestering the GDP-bound GTPase away from the membrane and stabilising GDP 
binding [204]. These processes are illustrated in summary figure 1.6. 
 
Mammalian cells contain hundreds of different GTPases, but the Ras superfamily is 
particularly implicated in many aspects of cell behaviour. The Ras superfamily 
comprises over 60 different GTPases, which can be categorised into five major groups: 
Ras, Rho, Rab, Arf and Ran. Rho GTPases are of particular interest given the insights 
they are providing into molecular mechanisms that underlie cell biology [203]. Of these, 
Rho, Rac and Cdc42 are the three best-characterised members of the Rho GTPase 
family. Constitutively activated mutants of Rho and Rac were found to induce the 
assembly of contractile actin and myosin filaments and actin rich surface protrusions 
when introduced into fibroblasts [205]. Cdc42 was later shown to promote the formation 
of actin-rich, finger-like membrane extensions (filopodia) [206].  
 
Rho GTPases may also regulate other signal transduction pathways in addition to 
those linked to the actin cytoskeleton. They participate in the regulation of cell polarity, 
gene transcription, cell cycle progression, microtubule dynamics, vesicular transport 
pathways and many enzymatic activities including NADPH oxidase activity in 
phagocytes. The main targets for Rac and Cdc42 that mediate actin polymerisation in 
protrusions are the WASP/WAVE family of Arp2/3 complex activators. Rac stimulates 
lamellipodial extensions by activating WAVE proteins [207], and Cdc42 binds to WASP 
proteins. In vitro this stimulates the Arp2/3 complex to induce dendritic actin 
polymerisation [208]. WAVE/WASP proteins may themselves regulate the activity of 
Rac and Cdc42 by binding to GAPs and GEFs. They could thereby generate positive or 
negative feedback loops to regulate the extent of Cdc42/Rac-induced actin 
polymerisation [209].  
 
The role of Rho GTPase signalling in leukocyte polarisation is described in more detail 
in section 1.3. 
 
 
Figure 1.6: The Rho GTPase cycle. Rho GTPases cycle between GTP-bound ‘active’ and 
GDP-bound ‘inactive’ conformations. In the active state, they interact with many different 
effector proteins. Rho GTPase activity is regulated by GEFs, which catalyse nucleotide 
exchange and mediate activation, and GAPs, which stimulate GTP hydrolysis, leading to 
inactivation and inorganic phosphate (Pi) production. GDIs extract the inactive GTPase from 
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1.2.4 Calcium signalling 
 
Calcium acts as a second messenger in a variety of cell processes in different 
organisms. Transient variations in intracellular calcium have been linked to key 
immunological processes including ROS production, chemotaxis, phagolysosome 
formation, degranulation, adherence, and integrin recycling [210].  
 
 
Mobilisation of calcium  
 
Physiological agonists such as chemokines and ATP can induce calcium mobilisation. 
Receptor agonists activate initial rapid calcium release from intracellular stores, 
followed by a sustained plateau due to calcium entry through plasma membrane 
calcium channels. Activation of pertussis toxin-sensitive G-proteins activates several 
enzymes, including PLCβ [211]. Hydrolysis of PI(4,5)P2 in the plasma membrane by 
PLC yields the second messengers IP3 and DAG [212]. Binding of IP3 to its receptor 
causes depletion of calcium stores within the endoplasmic reticulum (ER) and 
relocation of the calcium-binding type I transmembrane protein STIM-1 from the ER to 
structures near the plasma membrane [213]. STIM-1 then activates the plasma 
membrane calcium-release-activated calcium channel (CRAC) to cause an influx of 
calcium into the cell. Elevated intracellular calcium together with PKC activation by 
DAG is important for vesicle exocytosis, superoxide production by NADPH oxidases, 
leukotriene synthesis and JNK activation [214]. A protein tyrosine kinase dependent 
pathway can also activate PLC. Comparative studies using Syk- and Lyn-negative 
DT40 cells revealed that Syk and Lyn regulate calcium mobilisation and IP3 production 
in B cells in response to oxidative stress, most likely through tyrosine phosphorylation 
of PLCγ2 [215].  In addition to receptor activation, calcium signals have been observed 
following tissue damage in epithelial cells in vitro [216], [217], in the C. elegans embryo 
epidermis  [218], the zebrafish larvae [219] and recently in Drosophila embryos [220]. 
These wave-like signals are thought to be propagated through cell-cell contact; gap 
junctions allow calcium waves to spread via diffusion of IP3 from cell to cell [221].  
 
Calcium release via the IP3 pathways can be blocked using xestopongin-C, or 2-APB 
which inhibits the IP3-R [222]. Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) 
blockers such as thapsigargin will deplete the ER calcium stores, and will indirectly 
block calcium release through IP3-dependent stores [223]. Ethylene glycol tetraacetic 
acid (EGTA) is a calcium chelator that depletes extracellular calcium [224]. Despite the 
identification of various pharmacological modulators of calcium signalling that we can 
use in the laboratory, calcium signalling is not a specific target for therapeutics.  
 
 
1.3 Mechanisms driving cell motility and migration 
 
1.3.1 Cell migration and chemotaxis 
 
Cell migration is a fundamental process that occurs in many physiological and 
pathological settings including development, immune responses and cancer 
metastasis. In a physiological setting, four key features influence the movement of 
leukocytes: a) anatomical borders, b) adhesion to other cells or extracellular matrix, c) 
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signals that trigger motility, and d) directional signals that guide the cells [225]. 
Leukocytes are able to migrate in the absence of chemoattractants; this ability is 
fundamental to immunological surveillance by tissue resident macrophages. 
Hematopoietic cells constantly shuttle between tissue compartments: bone marrow, 
blood stream, tissues and lymph [226]. Cells have adapted to cope with changing 
environments by carrying out fast migration. They can survive without being adherent, 
become autonomous from their environment, and appear to behave like single celled 
organisms. 
 
Successful, coordinated directional migration depends on the formation of 
chemoattractant gradients, which are detected and prioritised by individual cells. The 
cells respond by developing a polarised morphology, from which internal signalling 
initiates directed locomotion in the direction of the gradient. The processes that drive 
motility are common throughout most cell types, although migration varies from one cell 
type to another in terms of speed, directionality and coordination.  
 
Chemotaxis is the ability of a cell to undergo directed locomotion along a chemical 
gradient. Chemotaxis was first described in leukocytes by Metchnikoff in 1893 [227]. 
Since then, chemotaxis has been extensively studied in a host of cell types including 
bacteria, Dictyostelium, fibroblasts and neurons. Interestingly, most in vitro models of 
chemotaxis show differences between modes of cell locomotion and signal 
transduction pathways. However, these models all share several general principles: (a) 
cells often exhibit intrinsic random motility; (b) exposure to a chemoattractant gradient 
leads to small spatial or temporal differences in receptor activation that are amplified 
within the cells to induce Rac-mediated actin polymerisation and protrusion towards the 
gradient source; (c) cell polarity is stabilised by positive-feedback loops combined with 
long-range inhibitory signals that restrict protrusion towards the cell front and increase 
its sensitivity to chemoattractants along the gradient [228].   
 
 
1.3.2 Establishing a chemoattractant gradient 
 
Factors that can influence gradient formation include size, polarity, diffusion rate, and 
reactivity of the chemoattractant and the nature of the surrounding environment. 
Chemoattractants may be produced in discrete spatial domains from where they diffuse 
and exert their graded effect over short or long distances [229]. Additionally, a stable 
gradient of immobilised chemoattractant is formed after diffusion, as observed for 
mouse chemokine CCL21, which is released by lymphatic vessels and attracts 
dendritic cells through a decay-mediated gradient of CCL21 bound to heparin 
sulphates [230].  
 
Most in vitro models (and some in vivo models) assume that the chemotactic gradient 
encountered by cells is at steady state, static and spatially stable, and it is generally 
assumed that the gradient is created by diffusion of the chemoattractant from the 
source site towards the target cells. However, in the physiological milieu, gradients of 
chemoattractants might be a) non linear, with rapid decay of concentration as a 
function of distance from secreting source, b) sequestered by extracellular matrix, c) 
degraded, d) self generated and amplified, and e) modified by extracellular enzymes 
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[229]. These conditions may give rise to unstable, dynamic and discontinuous 
gradients.   
 
Additionally, cells may encounter more than one chemoattractant with different 
diffusion rates and must therefore adapt to multiple cues. It has been proposed that 
secondary chemoattractants (e.g. IL-8) are secreted in sequential waves allowing 
recruitment of neutrophils far away from primary attractants [231]. Signal relay can also 
occur between cells. For example, LTB4 is actively secreted by neutrophils as they 
migrate towards inflammation sites, therefore acting as a signal relay between 
neutrophils [232]. The release of secondary signals amplifies the chemotactic 
landscape of primary chemoattractants by relaying signals to neighbouring cells that 
are too far away to sense the primary signal.  
 
Gradients of small highly diffusible molecules pose a potential problem because of their 
rapid diffusivity and inability to persist and reach far enough to convey spatial 
information to target cells. However, H2O2 has proved contradictory to this theory. H2O2 
has been shown to extend ~100-200µm into injured zebrafish tail fin epithelium [233]. 
Other diffusible molecules include H+ ions. A gradient of H+ was identified between 
adenocarcinoma xenografts to blood vessels [234]. Reaction diffusion of 
chemoattractants by delimiting product concentration is one of the most widely used 
mechanisms to maintain gradients of highly diffusible molecules, as is the case for the 
degradation of H2O2 by extracellular dismutase. Gradients may also be maintained 
through the spatially graded production of chemoattractants by neighbouring cells. For 
example, the NADPH oxidase dual oxidase (Duox) produces H2O2 in a graded manner 
in tissues and is responsible for H2O2 generation at wound sites in zebrafish [233].  
 
 
1.3.3 Gradient sensing and polarisation 
 
The ability of a cell to sense an external gradient of chemotactic factors governs 
directed cell migration. Cells constantly monitor the chemical concentrations over time 
or through spatial sampling. Directional sensing does not require actin polymerisation 
and is mediated by recognition of chemoattractants by their cell surface receptors 
(usually GPCRs). Various theories exist that attempt to explain how receptor activation 
leads to formation of polarised protrusions. The ‘chemotactic compass’ model suggests 
that gradient sensing results in local asymmetric accumulation of intracellular signalling 
molecules, such as PI(3,4,5)P3, towards the highest chemoattractant concentration. 
This localised signalling occurs upstream of Rac and is used as a compass to adjust 
the actual cell polarity by turning the cell front towards the gradient [235], [236]. An 
alternative model describes ‘chemotactic bias’. Here, chemoattractants simply bias the 
dynamic and self-organising autocatalytic nature of protrusions towards the gradient 
without the need for a compass [237]. This theory takes into account recent 
observations that membrane tension resulting from actin polymerisation acts as a long 
range physical signal that inhibits protrusion formation in regions other than the cell 
front [238]. 
 
Historically, it was understood that activation of a single pathway (PI3K) controlled 
chemotaxis. When activated by chemoattractant ligands, PI3K phosphorylated 
PI(4,5)P2 into PI(3,4,5)P3 at the leading edge of migrating cells, and this promoted 
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directional migration [239]. The asymmetric distribution of the PI3K product PI(3,4,5)P3 
at the front of the cell is a hallmark of cell polarisation in neutrophils and other 
amoeboid cells, and is illustrated in figure 1.7. It is now known that a hierarchy of 
intracellular signals exists and while intermediate chemoattractants can signal via the 
PI3K pathway, end-target chemoattractants can induce signals that involve the p38 
MAPK pathway [189]. This is summarised in figure 1.8c. Heit et al (2002) demonstrated 
that when faced with opposing gradients of end target (e.g. fMLP) and intermediary 
(e.g. IL-8) chemoattractants, Akt (protein kinase B) activation was significantly reduced 
within neutrophils, and cells migrated preferentially toward end-target chemoattractants 
[189]. Furthermore, p38 MAPK inhibition reversed this hierarchy, and allowed 
neutrophils to be drawn out of a local end target chemoattractant gradient and towards 
an intermediary chemoattractant environment [189].  
 
The main characteristic of front-rear polarity in cells migrating on 2D surfaces is the 
production of membrane protrusions in the form of broad lamellipodia and finger-like 
filopodia [209]. Lamellipodia have highly branched actin filaments, while filopodia 
contain long parallel bundles of actin filaments. In vivo imaging with actin probes has 
revealed that dynamic F-actin localises to the leading edge and stable F-actin 
predominantly localises to the tail of rapidly migrating zebrafish neutrophils in vivo 
[190].  
 
The acquisition of polarity is controlled by small GTPases such as Cdc42, Rac and 
RhoA. Cdc42 is active towards the front of the cell and both activation and inhibition of 
Cdc42 can disrupt directional migration [203]. The main output of Cdc42 is local 
activation of Rac. As active Cdc42 and Rac are at the front of the cell, molecular 
feedback loops and mechanical tensile forces work together to maintain protrusions in 
the direction of migration [240]. Working together at the back of the migrating cell are 
Rho, myosin II and Ca2+-activated proteases. Active Rac at the front of the cell 
suppresses Rho activity, but at the sides and back of the cell Rho is more active and 
suppresses Rac activity. RhoA affects actomyosin contractility via Rho kinase (ROCK) 
[241]. Furthermore, strong adhesions at the back of the cell increase tension, open 
stretch activated Ca2+channels and promote subsequent activation of proteases that 
have the potential to cleave focal adhesion proteins [228]. To move forward, the cell 
retracts its trailing edge by combining actomyosin contractility and disassembly of 
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Figure 1.7: Signalling pathways in leukocyte polarisation. In the presence of a 
chemoattractant gradient, PIP3 is enriched at the leading edge, leading to Rac and Cdc42 
activation and subsequent actin polymerisation. This generates lamellipodia. At the back of the 
cell, phosphatase and tensin homologue (PTEN) prevents PI3K-mediated PIP3 accumulation. 





Several mechanisms of leukocyte locomotion have been identified. Leukocytes can use 
retrograde actin flow to migrate. Here, the leading edge pulls the cell forward by 
coupling the retrograde force of the actin cortex – through transmembrane receptors – 
to the extracellular environment [242]. Two mechanisms drive the retrograde force of 
the actin cytoskeleton. First, actin grows at the leading plasma membrane and 
filaments get pushed backward into the cell body where the actin network is 
disassembled in a process termed ‘treadmilling’ [243]. Next, myosin II – located behind 
the leading edge – pulls the cortex backward, supporting the polymerization driven 
retrograde movement [244].  
 
Locomotion may also be driven by cell blebbing. Here the cell generates hydrostatic 
pressure by actomyosin contraction [245], which is dependent on myosin II motor 
activity that contracts the cortical actin network. Increased pressure and increased 
cortical tension are eventually freed, either by rupture of the actin cortex or by 
detachment of the cellular membrane from the underlying cortex. This membrane bleb 
can generate transient membrane protrusion. Leukocytes can also move entirely by 
deformation of the cell body, stimulated by deformatins that are generated by actin 
polymerisation [246]. 
 
In some models, integrins seem to have a role in locomotion. Neutrophils migrating 
through interstitium of mouse peritoneum or rat cremaster muscle have been shown to 
decelerate by 30% in the presence of antibodies against β1 integrin [247]. However, in 
other models integrins seem to be indispensible. New evidence suggests that there 
exists plasticity of migratory modes, and cells are able to switch between adhesion-
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Figure 1.8: Features of leukocyte migration and polarisation. (A) Cells on 2D surfaces show 
intrinsic random migration driven by multiple cell protrusions. This behaviour can be transformed 
into directed migration via a single lamellipodial projection either by lowering total activated Rac 
levels, or by local activation of Rac by chemical and physical guidance cues, e.g. 
chemoattractant gradient. Figure adapted from Reig et al (2014) [228]. (B) Cell shape, adhesive 
structures and migratory behaviour is altered when cells are studied in 2D or 3D environments. 
In 3D matrices, cells become elongated and display more directional movement than those 
migrating on 2D surfaces. Fibroblasts on 2D develop prominent and stable focal adhesions with 
the ECM, however the formation of focal adhesions in 3D is still a matter of debate and can only 
be detected under particular conditions. Figure adapted from Reig et al (2014) [228]. (C) 
Proposed model of PTEN, PI3K and p38 MAPK function of neutrophil chemotaxis. When cells 
are placed in opposing gradients, PTEN antagonises any PIP3 accumulation so all chemotaxis 
occurs through p38 MAPK. Figure adapted from Phillipson and Kubes (2011) [249]. 
 
 
1.3.5 Migration in the absence of chemoattractant gradients 
 
Historically, our insight into cell migration has come from time-lapse studies of 
fibroblasts cultured in vitro. Fibroblasts quickly polarise when placed on 2-dimensional 
(2D) surfaces and migrate in a seemingly random, exploratory fashion. In this 
environment, they display high levels of activated Rac, which promotes the formation of 
multiple peripheral lamellae and subsequent random migration [250]. When neutrophils 
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that branch, and subsequently one pseudopod can become stabilised to determine the 
direction of migration [237]. Random motility is also a feature of embryonic cells during 
tissue morphogenesis and accounts for tissue patterning [251]. Figure 1.8a compares 
random and directed migration. 
 
Additionally, crawling does not require a chemotactic gradient. In vitro, in the absence 
of gradient, neutrophils were shown to crawl in straight lines that were perpendicular to 
the shear forces applied and cells returned to a random pattern of migration when 
shear flow was terminated [18].  
 
 
1.3.6 Physical and environmental influence on motility and chemotaxis 
 
The environment in which a cell is studied can considerably influence phenotypes 
observed. Besides chemoattractants, guided cell locomotion in vitro can be 
manipulated by topographical features of a substrate, such as grooves, physical forces 
such as rigidity, and cell-cell contact [228]. Plasticity in migration strategies allows 
leukocytes to adapt to the geometry and molecular composition of their environment. 
 
When comparing fibroblasts on 2D surfaces (e.g. petri dishes, glass coverslips) and 3-
dimensional (3D) surfaces (e.g. gel matrix scaffolds, hanging drops), cells change their 
shape, adhesive structures and migratory behaviour [252]. Cells are generally more 
elongated and follow more directional paths when in 3D matrices. Fibroblasts on 2D 
surfaces develop prominent and stable focal adhesions that associate with stress fibres 
over the broad lamellipodial region [253]. The existence of such focal adhesions in 3D 
environments is still unclear. Interestingly, cells plated on soft 2D surfaces show 
irregular and unstable focal adhesions [254], whereas adhesions similar in structure to 
those found in 2D can be detected in vivo in cells submitted to high tensile forces [255]. 
These findings indicate that cell adhesion is sensitive to physical properties of 
substrates such as tension and stiffness. Integrin mediated adhesion is required for 
leukocyte migration on 2D surfaces in vitro. However, murine dendritic cells that have 
been depleted of all integrin receptors are able to migrate in interstitial tissues in 3D 
[256]. Figure 1.8b summarises the differences between migration in 2D versus 3D 
environments. 
 
In addition to integrin signalling, the requirement for PI3K during neutrophil chemotaxis 
is context dependent in vitro. PI3Kγ is essential for murine neutrophil migration on 
fibrinogen-coated surfaces, but is dispensable for migration on glass [188]. Treatment 
of human neutrophils in vitro with PI3K inhibitors abolishes migration towards selected 
chemoattractants such as IL-8 and LTB4, but not towards others including fMLP or C5a 
[189]. 
 
In some situations, leukocytes use retrograde flow based mechanisms to drive 
locomotion. Activated neutrophils adhere to 2D surfaces and form a sheet-like 
protrusion that is spread out and rich in actin. Movement here is dependent on force 
coupling by integrins; interference with integrins inhibits 2D migration [256]. However, 
this changes when leukocytes are embedded into 3D environments. In 3D 
environments, leukocytes do not adapt to the ECM fibres, but change shape by 
deforming the cell body, even in suspension [257]. Leukocytes in 3D environments do 
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not form leading edge protrusions that align with ECM fibres but rather form rounded or 
cylindrical extensions that protrude between fibres [258]. This suggests that leukocytes 
do not need to adhere to their substrates in order to migrate. In vitro and in vivo studies 
have shown that integrins are unnecessary for 3D leukocyte motility [259]. In this case, 
frictional forces are generated by alternative force-coupling receptors, such as 
sydecans and CD44. Taken together, most reports suggest that cells migrating in 2D 
surfaces appear to form exaggerated versions of adhesive structures found in vivo, 
whereas less rigid 3D matrices favour more discrete adhesions that seem to resemble 
those most in vivo migrating cells. These studies highlight the importance of developing 




1.4 In vivo models of inflammation 
 
Given the complexity of the human immune system and the difficulty of modelling a 3D 
intact structure to study injury and cell damage, scientists rely on animal models to 
provide relevant platforms for their research. Model organisms, including Danio rerio 
and Drosophila melanogaster, have been used for decades for the study of diverse 
biological and genetic processes. Despite having simplistic immune systems and being 
clearly distant on an evolutionary scale, they are advantageous over mammalian 
models due to their low cost, avoidance of ethical considerations and the possibility of 
high throughput experimentation. Recent technological advances especially in genetics 
have made these model organisms more accessible to a wider research community. 
Two important models used in the study of inflammation and wound repair are 
described in more detail below. 
  
 
1.4.1 Zebrafish larvae tailfin wound model 
 
Zebrafish, Danio rerio, have emerged as a powerful model system to explore many 
aspects of cellular and molecular biology, including the wound repair process and 
inflammation. Recently zebrafish studies from various groups have greatly increased 
our understanding of leukocyte migration mechanisms. Additionally, zebrafish are 
gaining popularity as a model system to study human disease and drug screening. 
Support for conservation of innate immune functions can be found in the recapitulation 
of human immunodeficiency phenotypes in zebrafish models of WAS and LAD-like 
syndrome [260].  
 
Zebrafish are ideal for live imaging in vivo because their embryos develop externally 
and can be viewed and manipulated at all stages. Zebrafish are transparent during 
embryonic development and permit non-invasive observation of leukocyte behaviour 
and subcellular molecular events at a high resolution in vivo [261]. Transgenic 
zebrafish lines with fluorescently labelled neutrophils and macrophages have been 
developed in addition to reporter lines that label specific tissues including epithelium. 
This development has revolutionised our ability to study and track live events in real 
time.  
 
The immune system of the zebrafish and mammals is highly conserved on both the 
cellular and molecular level [262]. Zebrafish develop immune cells such as 
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lymphocytes, mast cells, dendritic cells, neutrophils and macrophages, and they 
produce chemokines and cytokines including TNF and IFN. Zebrafish utilize conserved 
molecules that are involved in pattern recognition, such as TLRs, NODs and Myd88 
[263]. The adaptive immune system does not appear until after the early larval period, 
so it is ideal to study innate immune system in isolation. Morpholino oligonucleotides 
(MOs) provide a powerful tool for globally suppressing gene expression. These are 
stable nucleic acid analogs that bind to pre-mRNA to prevent splicing or the initiation of 
translation [264].  
Modeling tissue damage in zebrafish larvae can be achieved by cutting the embryonic 
tailfin. Using zebrafish lines that express transgenes that encode fluorescently labeled 
proteins and are driven by the myeloperoxidase promoter to primarily label neutrophils, 
a robust and rapid recruitment of neutrophils to the site of tissue injury is observed 
following tail transection [265]. More recently, it has been shown that leukocytes can be 
recruited directly from the caudal hematopoietic tissue to sites of tissue injury, thereby 
bypassing the extravasation process [266]. Neutrophils subsequently migrated 
between the wound and the vasculature and finally resolve the inflammatory response 
through reverse migration back to the vasculature [266]. Recently, a population of 
inflammatory macrophages has also been reported to migrate towards wound sites and 
phagocytose melanocyte debris and apoptotic neutrophils in the zebrafish model. 
These macrophages display slower but more directional migration to tissue wounds 
compared with neutrophils, and dwell more persistently at the wound margin before 
wound resolution [267]. Characteristics of the zebrafish larval wound model are 
depicted in figure 1.10. 
 
 
1.4.2 Drosophila melanogaster embryonic wound model 
 
Fruit flies, Drosophila melanogaster, are an established invertebrate model for scientific 
research. Well characterised throughout both developmental and adult life cycles, the 
genetic tractability of Drosophila has supported the discovery of many basic principles 
of heredity, gene mapping and behaviour. Recent advances in labelling and imaging 
techniques have allowed Drosophila to become a robust invertebrate tool for studying 
cell behaviour and gene expression. In the last decade Drosophila have become 
recognised as a worthy model to study the genetics of tissue repair and inflammation. 




• Easy to culture • Stock keeping 
• High fecundity • Inability to freeze 
• Low cost maintenance • Mites 
• Non-pathogenic • Virgining 
• Well established knowledge base • Lack of adaptive immune system 
• Elegant genetics and tools • Lack of embryonic vasculature 
• Short generation time • Lack of embryonic fibrosis or scarring  
• Well annotated genomic databases • Lack of mammalian chemokine 
orthologues • Live imaging of embryonic events 
 
Table 1.4: Advantages and disadvantages of Drosophila melanogaster as a model 
organism. Fly stock keeping, virgining and general procedures are described in more detail in 
section 2.3. 
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Drosophila embryonic hemocytes are macrophage-like innate immune cells, and 
represent the main immune cell component of the innate response in the fly [268]. 
During embryonic development, hemocytes arise in the head mesoderm at 
developmental stage 10 and migrate along the ventral nerve cord before undergoing 
segmental, lateral migration (as illustrated in figure 1.9). At stage 15 hemocytes are 
arranged into three parallel lines extending along the full length of the embryo. During 
developmental migration, hemocytes are steered along gradients of growth factors 
PDGF/VEGF-like growth factor (PVF) 2 and 3 that are highly expressed in the 
developing nerve cord [269]. With actin rich protrusions and dynamic motility, the 
hemocyte’s primary function is to patrol the embryo and phagocytose cellular debris or 
cell corpses [268]. 
 
 
Figure 1.9: Developmental hemocyte migration in Drosophila. Hemocyte migration along 
the ventral nerve cord is directed by PVF signals. At stage 10, PVF3 is strongly expressed along 
the ventral midline. At stage 12, hemocytes migrate along the developing nerve cord from 
posterior and anterior ends, attracted by the expression of PVF3 and PVF2. These populations 
migrate until they form a continuous line along the ventral midline. At stage 14, PVF3 has 
disappeared and expression levels of PVF2 have increased. Hemocytes now rapidly migrate 
laterally leaving the midline and taking up three parallel lines extending along the whole length 
of the embryo. PVF= platelet-derived growth factor (PDGF) and vascular endothelial growth 
factor (VEGF)-related factor. 
 
 
Following laser induced epidermal damage, hemocytes at late developmental stage 14 
are rapidly recruited to the wound site. Hemocytes within close vicinity of the wound 
(20-30mm of a 40mm diameter wound) abandon their developmental migration position 
and migrate directly to the wound site [270]. This observation suggests that a local 
signal is generated at the wound site, and this damage signal can outcompete 
developmental migration signals. With this in mind, embryos at developmental stage 15 
are typically used for wounding studies. Migration of hemocytes to wounds depends on 
PI3K [269], and also requires GTPases Rho, Rac and Cdc42 [271]. Moreira et al 
(2010) discovered that the wound attractant acts transiently; within two hours post 
wounding, hemocytes migrate back to the ventral midline away from the wound. 
Following recruitment to the wound, hemocytes engulf damaged epidermal cells and 
bacteria if present. Characteristics of the Drosophila embryonic wound model are 
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1.4.3 H2O2 is a wound cue in in vivo models of inflammation 
 
The generation of ROS, specifically H2O2, at sites of tissue damage has been observed 
in phylogenetically diverse organisms, including plants, Drosophila, zebrafish and 
mammals [233], [270], [272]-[274]. Owing to their fast diffusion and versatile biological 
activities, ROS are interesting candidates for wound-to-leukocyte signalling. However, 
H2O2 is quickly degraded within cells so its effects are rapid and transient; a steep H2O2 
gradient must be maintained for prolonged effects to occur. 
 
The mechanism determining how H2O2 is generated is not well understood. Historically, 
most theories assumed H2O2 was released from ruptured cells after direct injury. New 
evidence has emerged to suggest ROS release is controlled by an immediate calcium 
signal triggered in the epithelium.  Recent findings in the Drosophila hemocyte wound 
model showed that wounding of the embryo epidermis results in an immediate calcium 
wave [220]. Reducing the calcium signal with chelators impairs the inflammatory 
response of hemocyte migration to a wound site. The study proposed that calcium 
activates NADPH oxidase Duox through its EF hand to direct H2O2 generation and 
attract hemocytes to wounds. Another group found that tissue mediated-ATP release 
activated purinergic receptors that modulate Duox activity through intracellular calcium 
signalling in vivo [275]. This Duox-derived H2O2 was also able to trigger the NFκB 
inflammatory signalling pathway. This report suggested the ATP-mediated Duox 
activity was able to modulate the early recruitment of leukocytes to the wound.   
 
The first studies investigating the action of wound-induced H2O2 were carried out in the 
zebrafish larvae tailfin wound model. Niethammer et al (2009) sought to investigate 
whether H2O2 could signal in a paracrine fashion. They first examined the role of H2O2 
during the early events of wound responses in zebrafish larvae expressing a 
genetically encoded H2O2 sensor, HyPer [233]. HyPer is highly selective for H2O2 over 
other ROS [276]. Niethammer’s study observed a sustained rise in H2O2 concentration 
at the wound edge, starting 3 minutes after wounding and peaking at 20 minutes, which 
extended 100–200mm into the tail-fin epithelium. They hypothesised that wound-
induced extracellular H2O2 may reach concentrations of ~0.5-50µM near the wound 
margin. Importantly H2O2 was reported to be required for rapid recruitment of 
leukocytes to the wound because neutrophils appeared at the scene approximately 17 
minutes after the initial injury. This recruitment was blocked in Duox-/- larvae, and 
following treatment with NADPH oxidase inhibitor diphenyleneiodonium (DPI). They 
conclude that the H2O2 gradient produced by Duox is required for rapid recruitment of 
leukocytes to a wound [233]. To explain their findings, Niethammer et al (2009) 
suggested that leukocytes could be expressing transmembrane receptors for H2O2. 
Alternatively, H2O2 may be directing migration by entering the cytoplasm and locally 
modifying intracellular mediators, such as redox-sensitive PTEN [277], considered to 
be an important regulator of chemotaxis. Leukocyte recruitment to a wound via a H2O2 
gradient has also been observed in the Drosophila embryonic hemocyte wound model. 
Moreira et al (2010) discovered that Drosophila hemocyte migration to a wound was 
impaired when DPI was inserted into the wound site via a bead [270].  
 
Many cellular and genetic responses occur in wounded tissue, including transcription of 
effector genes. Duox is required to activate wound reporters after epidermal wounding 
in Drosophila embryos [278]. Even injected H2O2 is sufficient to activate widespread 
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epidermal wound gene expression. This indicates the important of H2O2 not only in 
immune cell responses, but also in later epidermal repair.  
 
The molecular mechanisms responsible for H2O2 clearance have subsequently been 
investigated. Pase et al (2012) found that neutrophil delivered myeloperoxidase 
dampens the H2O2 burst after tissue wounding in zebrafish [279]. Neutrophils are rich 
in myeloperoxidase, an enzyme catalysing an H2O2-consuming reaction. Pase et al 
showed that neutrophil depleted zebrafish have an abnormally sustained wound H2O2 
burst, indicating that leukocytes themselves were required for H2O2 down regulation. 
Myeloperoxidase deficient zebrafish also had abnormally sustained high wound H2O2 
concentrations despite similar numbers of arriving neutrophils [279].  
 
As well as an increasingly more well defined role for H2O2 as a wound cue, studies in 
mammalian airway epithelium also suggest a regulatory role for enhanced H2O2 
production in the host innate immune response to sensing bacterial triggers [280]. 
Enhanced production of H2O2 might be a universal mechanism used by the host to 
sense the disruption of tissue homeostasis by various insults and to activate the 
appropriate innate immune response. Subsequent studies have reported that H2O2 is 
not required for neutrophil recruitment to sites of bacterial infection, indicating 
neutrophils can be sensitised by different chemical cues [281]. H2O2 has also been 
identified as a key factor that mediates leukocyte attraction to transformed cells in 
zebrafish [274], implicating H2O2-mediated migration in cancer. Further studies are still 
necessary to confirm the physiological relevance of H2O2 mediated leukocyte attraction 
to wounds in mammals.  
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Figure 1.10: Models of tissue damage in vivo. (A) Transection of the zebrafish larval tailfin 
triggers the recruitment of neutrophils. Migration occurs along a gradient of damage cue H2O2. 
H2O2 oxidises intracellular neutrophil Lyn kinase and activates a signalling cascade leading to 
cytoskeleton rearrangement and migration. (B) Laser ablation of Drosophila embryo epithelium 
similarly drives the recruitment of embryonic hemocytes to the wound margin. Tissue damage 
triggers a rapid and transient calcium wave in cells proximal to the wound edge, followed by an 




1.4.4 Lyn as a redox sensor 
 
Researchers have been keen to uncover the mechanisms that function downstream of 
epithelial ROS production following tissue damage. Recently, Lyn, an SFK member, 
was identified as a neutrophil sensor that directly responds to H2O2 in injured tissues.  
Yoo et al (2011) used a zebrafish larvae wounding model to reveal that Lyn mediates 
initial neutrophil recruitment to wounds and Lyn activation was dependent on wound-
derived H2O2 [282]. During this process, a single cysteine residue in Lyn, Cys466, 
appears to be the direct target of oxidation by H2O2. Mutation of Cys466 to alanine 
specifically abolishes H2O2-induced activation of Lyn. The direct physical implication of 
Cys466 oxidation on Lyn activation remains unclear. Oxidation may provoke a 
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bond that results in activation. Activation of Lyn leads to the activation of ERK 
signalling pathways, which are required for neutrophil wound attraction. Lyn can 
activate PI3K in vitro [283]. Therefore it is highly attractive to speculate that activation 
of Lyn by H2O2 can lead to asymmetric PI3K activation in leukocytes, which then drives 
cell polarisation and migration along a H2O2 gradient. Cys466 is highly conserved 
across species (e.g. in Drosophila Src42A and human Lyn). Therefore, oxidation-
dependent activation may be a general mechanism for all SFK members. It has not yet 
been established whether Drosophila Src42A can also act as a redox sensor in injured 
tissues. However, elegant genetic studies have indicated that Src42A is 
transcriptionally activated around a wound site, and is sufficient to inhibit wound-
induced transcription in epidermal cells [278].  
 
 
1.4.5 H2O2 may promote phagocytosis via SFKs 
 
Phagocytosis is a very important component of the inflammatory response. Defects in 
cell corpse clearance have been associated with autoimmune and inflammatory 
diseases [284]. An important driver of the phagocytic response in Drosophila is the 
engulfment receptor Draper, which recognizes cell corpses and guides the internal 
cellular machinery to promote phagocytosis. Various ligands for Draper have been 
proposed, including Pretaporter, an apoptotic cell ligand [285], and lipoteichoic acid, a 
bacterial cell ligand from S. aureus  [286].  
 
Ziegenfuss et al (2009) first proposed an association between Draper-dependent 
phagocytosis and the Drosophila SFK Src42A by studying the phagocytic activity of 
glial cells in adult fly brains [287]. Glial cells, the primary phagocyte in the brain, rapidly 
engulf neuronal cell corpses during development and during Wallerian degeneration in 
the adult brain. Wallerian degeneration occurs when axon injury destroys the parent 
cell body, and the proximal axon stump subsequently disintegrates [288]. Using a 
model of Wallerian degeneration in adult fly brains, Ziegenfuss et al revealed that 
ligand-dependent Draper activation initiates the Src42A-dependent phosphorylation of 
Draper, promoting glial phagocytic activity. Furthermore, Ziegenfuss et al also reported 
that following Src42A phosphorylation of Draper, Drosophila SH2 ankyrin repeat kinase 
(Shark), a non-receptor tyrosine kinase and homologue of mammalian Syk, binds to 
Draper via an intracellular immunoreceptor tyrosine-based activation motif (ITAM) 
[287]. Previously reported roles of Shark include embryonic dorsal closure [289], and 
maintenance of epithelial cell apicobasal polarity [290]. Shark activity at Draper is 
essential for downstream signalling events in vivo, including phagocytosis of axonal 
debris. Ziegenfuss et al concluded that both Shark and Src42A were crucial mediators 
in the activation of the Draper pathway.  
 
This association between Src42A, a potential redox sensor, and Draper, an engulfment 
receptor, suggests that Draper may also have a part to play in hemocyte migration to a 
wound and hemocyte phagocytosis at a wound. Both processes require the same 
functional outputs of internal signalling – actin remodeling aimed at polarisation of the 
cell towards a gradient. Therefore it is likely that the signalling pathways are 
overlapping and conserved together. 
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1.5 Damage cues in mammalian systems 
 
1.5.1 Reactive oxygen species 
 
ROS production and regulation 
 
ROS are considered to be not only the main mediator of pathological tissue injury but 
also important second messengers for a variety of cellular receptor signal transduction 
pathways. ROS are a heterogeneous group of molecules that include highly active free 
oxygen radicals (e.g. superoxide) and non-radical oxidants (e.g. H2O2). Given that 
superoxide is rapidly converted to H2O2 in the cell, H2O2 is often considered the 
principal ROS member. Following their generation, ROS can be further converted into 
other ROS species or they can be neutralised by enzymatic and non-enzymatic 
reactions inside and outside a cell [291]. Figure 1.11 illustrates ROS family members 
and their reactions. 
 
Figure 1.11: Reactive oxygen species and their reactions. HOCl, hypochlorous acid; 
HOSCN, hypothiocyanous acid; !NO, nitric oxide; !NO2 nitrogen dioxide; 1O2, singlet oxygen; 
!OH, hydroxyl radical; ONOO-, peroxynitrite; R-NHCl, chloramines; DUOX, dual oxidase. Figure 
modified from Sareila et al (2011) [292]. 
 
 
A number of intracellular mediators, including cyclooxygenases, cytochrome P450, 
lipoxygenases, xanthine oxidase and NADPH oxidases regulate the enzymatic 
production of ROS. Mitochondrial respiration is also a major source of ROS [291]. Free 
radicals can arise through chemical processes including oxidation of phenols, aromatic 
amines and hydrazine by heme proteins. ROS can also be produced by ionising and 
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autoxidation catalysed by transition metal ions. For example, metabolites of 
antimalarial drugs are oxidised by haemoglobin and can be accountable for drug 
toxicity [293]. 
 
The main source of extracellular ROS is likely to be NADPH oxidases. The NOX family 
of NADPH oxidases produces ROS as a result of electron transfer across membranes. 
The NOX family comprises NOX1-5 and DUOX1-2. NOX proteins are integral 
membrane proteins comprising six transmembrane domains that form a channel to 
allow successive transfer of electrons [292]. NADPH oxidases located in the plasma 
membrane generate ROS into the extracellular space. They can also be located on the 
membranes of intracellular vesicles and generate ROS in phagosomes. NOX can 
generate superoxide that can be dismutated into H2O2 by separate superoxide 
dismutase (SOD) enzymes; whereas Duox generates H2O2 without requiring a 
separate SOD [294].  
 
ROS are highly reactive and interact with several biological molecules including 
proteins, lipids, carbohydrates and nucleic acids. Owing to this high reactivity, ROS in 
high concentrations or at specific locations are likely to promote cellular damage and 
tissue destruction. H2O2 can cause oxidative damage at high concentrations and 
initiate cell death [295]. One possible mechanism for this is that H2O2 causes DNA 
strand breaks, leading to the activation of nuclear poly(ADP-ribose) polymerase, which 
critically depletes the cell of NAD, leading to eventual cell death. Another hypothesis 
proposes that H2O2 disrupts the cell membrane integrity in a non-specific manner 
through lipid peroxidation. H2O2 formed from superoxide is converted by neutrophil 
myeloperoxidase or eosinophil peroxidase to more reactive oxidants such as 
hypochlorous and hypobromous acids [292].  
 
ROS are rapidly produced and removed to avoid sustained signalling and oxidative 
damage. A complex assortment of antioxidant systems protects cells against ROS 
damage. These can be enzymatic (e.g. catalase, superoxide dismutase, and 
peroxiredoxin) or non-enzymatic (e.g. flavonoids, vitamin A, vitamin C) [296]. The 
activity of antioxidants is necessary to control fluctuations in cellular redox status and to 
avoid irreversible oxidation of cellular molecules leading to oxidative stress.  
 
 
ROS as signalling mediators 
 
ROS can have a wide array of different biological effects ranging from regulation of 
specific and fine tuned steps in cell signalling, to harmful nonspecific events such as 
lipid peroxidation. Damaging functions of ROS occur through uncontrolled excessive 
production, whereas ROS involved in signalling is tightly regulated and takes place in 
confined compartments. The known signalling roles of H2O2 in animals are primarily 
within the cytoplasm, where it regulates metabolism, phosphatase activity and gene 
transcription [297].  
 
H2O2 is a small, diffusible molecule that can be synthesised and destroyed rapidly, 
making it a useful intracellular messenger [298], [299]. Many cellular responses to 
growth factors, hormones and inflammatory cytokines involve redox signalling and 
H2O2 is likely to be a second messenger acting here [300]. Various studies have 
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suggested that H2O2 fulfils the role of messenger by modulating the extent of protein 
phosphorylation on either serine-threonine or tyrosine residues [301], [302]. Exogenous 
H2O2 mimics growth factors by inducing protein tyrosine phosphorylation and MAPK 
activation [303]. Given the simple structure of H2O2, it is unlikely to be recognised 
specifically by a protein, and so it is likely that modulation of protein phosphorylation by 
H2O2 is mediated by reversible binding of H2O2 to protein kinases or phosphatases.  
 
 
Redox regulation of proteins 
 
Proteins are the main targets for ROS within the cell and account for approximately 
69% of oxidation events mainly because of their abundance [304]. Oxidation of 
particular residues can influence the charge, size, hydrophobicity or polarity of amino 
acids in a polypeptide. This can affect the secondary and tertiary protein structure, 
which will dictate the stability and activity of the whole protein. Redox regulation of 
kinases for signalling purposes will impose a degree of structural re-configuration 
resulting in increased, altered or decreased enzyme activity [305]. Oxidation events 
that promote phosphorylation or dephosphorylation may increase or decrease the 
binding of substrates, as well as trigger dimerization or oligomerisation through 
disulfide bond formation. Additionally, it is possible that oxidative modifications may tag 
or cue a kinase for trafficking or sequestrations, thus indirectly affecting the activity of 
the kinase by removing it from the vicinity of its target and perhaps exposing it to novel 
binding partners [305]. 
 
Sulphur-containing cysteine and methionine are the most easily, and reversibly, 
oxidised amino acids [306]. Intracellular antioxidants can reverse or reduce this 
reaction [307]. Reversible cysteine modifications are the most physiologically relevant 
because hyper-oxidation occurs predominantly during conditions of oxidative stress, 
promoting enzyme inactivation and degradation [305]. A widely accepted hypothesis 
for how ROS modulate signalling pathways is that they reversibly inhibit protein 
tyrosine phosphatases (PTPs) through oxidation of redox-sensitive cysteine residues 
resulting in formation of intermediate sulphenic acid [308]. This is illustrated in figure 
1.12. Most cysteine residues contain a sulfhydryl group with a pKa of ~8.5 which is not 
prone to oxidation by H2O2, unlike the cysteine thiolate anion. Some protein cysteine 
residues do exist as thiolate anions at neutral pH because their pKa is lowered by 
charge interactions between the negatively charged thiolate and nearby positively 
charged amino acids. One example of this type of low pKa protein is PTPs [300]. All 
PTPs contain an essential cysteine residue that exists as a thiolate anion at neutral pH 
[309]. The active site cysteine is the target of specific oxidation by oxidants including 
H2O2. This modification can be reversed by incubation with thiol compounds such as 
dithiothreitol and reduced glutathione [310]-[312]. Together, this suggests that PTPs 
might undergo H2O2-dependent inactivation in cells, creating a window of 
phosphorylation that is un-interrupted by phosphatase activity, resulting in a shift in the 
equilibrium with protein tyrosine kinases towards protein phosphorylation.  
 




Figure 1.12: Redox-dependent signal transduction. (A) PTKs catalyse the transfer of 
phosphate groups from ATP to tyrosine hydroxyls of proteins. PTPs remove phosphate groups 
from phosphorylated Tyr residues. (B) PTKs can undergo oxidation/reduction at regulatory 
cysteines to modulate their function. (C) Oxidation of the active site cysteine residues in PTPs 
inactivates these enzymes, and can be reversed by reducing the oxidised residue back to its 
thiol form with RSH. PTP = protein tyrosine kinase; PTP = protein tyrosine phosphatase; RSH = 
reducing thiol; SOx = oxidised cysteine. Adapted from Truong et al (2013) [313]. 
 
 
The redox regulation of PTPs is an area that has been widely studied, however 
oxidation has also been implicated as a signalling device in the regulation of, amongst 
others, GTPases [314], and proteases [315]. Other kinases are also susceptible to 
redox-regulation, e.g. RTKs and Akt, which undergo direct oxidation [316]. cAMP-
dependent protein kinase is also regulated by redox activity. The formation of 
intramolecular disulfide bonds in oxidised cAMP-dependent protein kinase de-stabilises 
the enzyme and allows de-phosphorylation of its activation loop, resulting in decreased 
activity [317]. Redox regulation of the MAPK/ERK pathway has been implicated both 
by oxidative inactivation of regulatory phosphatases and associations with antioxidants 
[318], [319]. More recently, direct redox regulation of ERK2, JNK2 and p38 has been 
proposed to occur at different concentrations of H2O2. It was reported that low 
concentrations of H2O2 oxidised ERK2 and caused a conformational change that 
increased binding to MEK1/2 and leads the system towards proliferation. If the 
concentration of H2O2 reaches very high levels, the cysteine residues in ERK2 become 
redox-insensitive, while JNK2 and p38 are activated and stimulate a cell-cycle arrest 
programme [320].  
 
 
H2O2 in innate immunology 
 
ROS are a prominent feature of innate immunology in both health and disease. 
Generation of ROS by phagocytes is an essential process for host defence. Upon 
engulfment, phagocytes use intracellular ROS to destroy pathogens. ROS produced by 
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during cellular processes [296]. In phagocytic leukocytes, ROS and H2O2 are produced 
through NADPH oxidase mechanisms following activation of many cell surface 
receptors. Ligand stimulated receptors also provoke a H2O2 response in non-
phagocytic cells. Ligands that do this include PDGF, epidermal growth factor (EGF), 
fibroblast growth factor (FGF), insulin, GM-CSF, cytokines, IL-1, IL-3, IFNγ, TNFα, and 
agonists of GPCRs [321]. H2O2 release is triggered from cells stimulated by TNFα 
when they are plated on serum coated biological surfaces [17]. Several types of 
NADPH oxidase have been identified in non-phagocytic cells that have been shown to 
be responsible for receptor stimulated derived H2O2 production. Activated PI3K has 
been shown to be necessary for PDGF induced production of H2O2 [322].  
 
H2O2 has been reported to affect various processes associated with inflammation. It 
can increase phagocytosis in human neutrophils [323]. H2O2 increases ICAM-1 
expression and increased neutrophil adhesion to endothelial cells [324]. Experiments 
studying the directed locomotion of mouse peritoneal neutrophils show that at low 
micromolar concentrations H2O2 induces neutrophil chemotaxis [325]. This has been 
supported by studies showing human neutrophil chemotaxis to gradients of H2O2 in 
vitro [282]. Furthermore, overexpression of thioredoxin, a ROS decomposing protein 
thiol, suppresses leukocyte recruitment induced by MCP-1 [326]. Aquaporins (AQP) 
are a family of highly conserved transmembrane channels that transport water and 
small solutes. Recently, several AQPs, including AQP3 and AQP8, have been found to 
mediate membrane H2O2 uptake, which is used for intracellular signalling in 
mammalian cells [327]. T cell chemotaxis is dependent on AQP3-mediated H2O2 
uptake [327]. This H2O2 transport is essential for activation of Cdc42 and subsequent 
actin rearrangements driving cell migration [328]. 
 
 
Redox regulation of SFKs 
 
Cysteine residues in Src are necessary for the enzyme’s stability and transformative 
ability. Consistent with other examples of protein oxidation by ROS, Cys245 and 
Cys487 undergo intramolecular disulfide bridge linkage upon exposure to ROS, leading 
to Src activation. Oxidation of Src has been proposed to be crucial for a final ‘super-
activation’ state being achieved. This concept demonstrates that direct redox activation 
of Src is important in many systems [329]. In a disease environment where higher 
levels of ROS may be present, dysregulated Src activity could be contributing to 
pathogenesis. For example, in cancer, redox-regulated activation of Src could be an 
additional avenue for pro-tumorigenic activity (alongside oncogenic activation of Src 
through constitutive phosphorylation or overexpression).  
 
The first SFK proposed to be redox regulated was lymphocyte-specific Lck [305]. It 
wasn’t until later studies that detail of the oxidation-induced modifications to Lck by 
ROS was revealed, by examining the phosphotyrosine (pY) profile of T cells following 
oxidative stress. Lck was phosphorylated at its autophosphorylation site after exposure 
to an oxidant, and its activity was increased [330]. This study also showed that 
exposure of Lck to oxidant prompted the association of Lck with PI3K and implies that 
a conformational change to the enzyme occurs. Despite the presence of a number of 
cysteine residues in Lck, it is not yet established whether Lck is directly redox-
activated. More recently, Lyn in zebrafish was found to go undergo oxidation at Cys466 
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upon exposure to extracellular H2O2 [282]. This resulted in the autophosphorylation and 
activation of the kinase and selective stimulation of its downstream pathways, and was 
directly linked to driving the directional migration of neutrophils towards a wound.  
 
 
The effect of H2O2 in calcium mobilisation 
 
Recent reports have associated Duox activity and H2O2 release with calcium signalling. 
Duox possesses two canonical calcium-binding EF hands on an intracellular loop, 
which implicates cytosolic calcium as a potential regulator of H2O2 production [331]. 
Duox has been shown to act in concert with SFKs and calcium to drive epithelial 
aspects of the regenerative processes in zebrafish larvae [219]. There is good 
correlation between oxidative stress, induction of ROS, and an increase in intracellular 
calcium levels immediately preceding the final destructive events of cell death [224]. 
There are various theories as to how H2O2 mediates an increase in calcium, including: 
a) influx through voltage gated calcium channels, b) non specific changes in membrane 
permeability, c) alteration of Ca2+-Na2+ exchange, d) changes in calcium release from 
intracellular stores. 
 
Exogenous H2O2 can induce calcium mobilisation and signalling. Across a range of 
different cell types, H2O2-induced increase in intracellular calcium has been attributed 
to either mobilisation from intracellular stores [332], calcium influx across the plasma 
membrane [333], or both [334]. H2O2 causes a biphasic rise in intracellular calcium 
level in insulin-secreting cell line CRI-G1 [335]. These results indicated that the H2O2-
induced early increase in intracellular calcium level results predominantly from 
mobilisation of calcium from intracellular stores and that the second, late increase in 
intracellular calcium levels is a result of extracellular calcium influx.  Similarly, in rat 
parotid gland, H2O2 alone evokes a gradual and concentration dependent increase in 
intracellular calcium [336]. H2O2-evoked calcium release from intracellular stores may 
also be due to inhibition of SERCA [337]. Other studies have shown that extremely 
high concentrations of H2O2 (≥1mM) can cause severe oxidative stress in most cells, 
with the release of calcium from the mitochondrial and non-mitochondrial stores [338].  
 
 
ROS in disease 
 
Excessive and uncontrolled production of ROS leads to oxidative modification of 
cellular and molecular components in host tissues and has been identified in many 
different pathological settings. Excessive production of ROS has been causally related 
in the aetiology of inflammatory diseases, ageing and chronic degenerative diseases 
such as Parkinson’s disease, Huntington’s disease and Alzheimer’s disease [339]. The 
involvement of ROS and oxidation products is often suggested to be important for the 
progression of rheumatoid arthritis [340], as well as multiple sclerosis, type I diabetes 
and thyroiditis [341]-[343]. In light of new evidence placing H2O2 as an immune cell 
chemoattractant, excessive production could be a factor in diseases often marked by 
the elevation of white blood cell levels, e.g. in asthma, chronic obstructive pulmonary 
disease (COPD) and IBD. In asthma, the lung epithelia might be producing too much 
H2O2 because it is chronically irritated, which could explain inappropriate levels of white 
blood cells [344]. Cancerous cells have also been frequently associated with 
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overproduction of ROS, possibly due to elevated expression and activity of NOX 
enzymes downstream of constitutively active growth factor receptors. Elevated ROS 
production (oxidative stress) promotes genomic instability, and augments favourable 
growth mutations and chemoresistance [345]. Antioxidants including vitamin C, vitamin 
E and melatonin are often suggested to decrease inflammatory responses, however in 
vivo studies of antioxidants do not consistently support this [346]. 
 
Despite its known role in oxidative stress and cellular damage, topical H2O2 has been 
used for generations to sterilise wounds and promote faster healing [347]. Evidence to 
suggest that ROS can have a more regulatory role in particular disease settings has 
recently surfaced. Hyper-inflammatory responses in mice lacking functional NOX2 have 
been found in models of helicobacter gastritis [348], inflammation induced by UV [349], 
and lung inflammation induced by cigarette smoke [350]. These indicate a new picture 
of ROS being involved in the regulation and limitation of inflammatory responses.  
Further evidence for a regulatory role of ROS is seen in patients with chronic 
granulomatous disease (CGD). CGD patients have a genetic deficiency in the 
phagocyte NADPH oxidase NOX2 [351]. Phagocytes are unable to kill bacteria and 
fungi that they have ingested. The role of ROS as a pro-inflammatory mediator is 
questioned in CGD patients where a lack of ROS, in addition to recurrent bacterial and 
fungal infections, leads to aseptic inflammation. There is increasing evidence for hyper-
inflammatory, non-infectious complications in CGD, suggesting a role for ROS in 
dampening inflammatory responses. CGD patients suffer from increased frequency of 
bacterial infections and are more prone to developing other inflammatory diseases, 
such as granulomas and colitis [352]. 
 
 
Tools for ROS detection 
 
The development of methods for the detection of redox-modifications has been 
essential to the recent advances in the field of redox biology. This has included the 
development of fluorescent and affinity-labelled probes for the detection and isolation 
of cysteine residue modifications and the detection and quantification of PTP oxidation. 
Of note is the synthesis of DYn-2, a new chemo-selective probe for detecting 
sulphenated proteins in human cells [353], and the ox-PTP antibody, which can 
recognise sulfonic acid containing PTPs [354].  
 
Accurate localisation and quantification of H2O2 have previously been huge hurdles for 
researchers. The most common method of imaging biological ROS is through the use 
of fluorescent redox-sensitive dyes such as 2’,7’-dichlorofluorescein diacetate (DCFDA) 
or similar dyes MitoSox Red and Amplex Red. Disadvantages of these tools include 
uncertainties about specificity, cell uptake and subcellular diffusion [355]. Additionally, 
fluorescent probes such as hydrogen peroxide sensor (HyPer) incorporate redox-
sensitive cysteines, becoming fluorescent in the presence of particular ROS. HyPer is a 
genetically encoded ratiometric sensor that is highly selective for H2O2 over other ROS 
[276]. HyPer consists of the bacterial H2O2-sensitive transcription factor OxyR fused to 
a circularly permutated yellow fluorescent protein (YFP). Cysteine oxidation of the 
OxyR part induces a conformational change that increases emission excited at 500nm 
and decreases emission excited at 420nmm. This change is rapidly reversible within 
the reducing cytoplasmic environment, allowing dynamic monitoring of intracellular 
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H2O2 concentration. HyPer can be introduced into an organism by messenger RNA 
injection to induce global cytoplasmic expression [233]. These redox sensitive probes 
have high sensitivity and specificity, signal reversibility and easy modification to allow 
tissue specific expression [356]. The development of transgenic animals expressing 
redox-sensitive proteins has provided invaluable in vivo models to study ROS [233]. 
 
 
1.5.2 Nucleotides as damage signals 
 
Many other endogenous molecules can regulate the function of leukocytes and thereby 
modulate immune responses (e.g. following tissue damage). Intracellular localised 
substances can be released into the extracellular space and can therefore be a sign of 
tissue damage. For such molecules to be considered chemotaxins during an 
inflammatory event, they must be recognised by cells of the immune system that can 





Adenosine 5’triphosphate (ATP) is a naturally occurring nucleotide present in every 
living cell. ATP is often referred to as the molecular unit of currency in intracellular 
energy transfer for cell metabolism and can also function as an extracellular mediator 
[357]. ATP is produced by oxidation of glucose to carbon dioxide in a process known 
as cellular respiration. It is an unstable molecule with short half life, and is easily 
hydrolysed into adenosine diphosphate (ADP) and phosphate by the action of 
ubiquitous ecto-ATPases and ecto-nucleotidases [358]. ATP typically accumulates in 
lysosomes in the intracellular compartment, resulting in an intracellular concentration of 
1-10mM [359]. In the extracellular compartment, ATP contributes to the regulation of 
many processes, including cardiac function, neurotransmission, vasodilation and bone 
metabolism. Many reports suggest extracellular nucleotides such as ATP may function 
as endogenous signalling molecules that control inflammation and immune responses, 
and are therefore targets for anti-inflammatory and anti-tumour therapy [358]. 
 
ATP, ADP or adenosine are recognised by a large family of membrane bound 
purinergic receptors. P1 purinergic receptors are activated by adenosine and P2 
receptors are activated by ATP and other nucleotides (e.g. UTP). P2 receptors are 
further subdivided based on their signalling properties, and are described in table 1.5. 
Metabotropic P2Y receptors are G-protein coupled and ionotropic P2X receptors are 
nucleotide-gated ion channels and respond primarily to ATP [360]. Purinergic receptors 
are expressed on immune and non-immune cells. Receptor density may change during 
inflammatory conditions by the action of immunomediators. ATP can act in a feed 
forward loop possibly amplifying responses to it or other external cues which couple to 
ATP secretion, as described in epithelial cells [361]. Given its short half-life and high 
reactivity, ATP is likely to operate only transiently in the local microenvironment in an 
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 P2Y P2X 
Subtypes P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, 
P2Y12, P2Y13, P2Y14 
P2X1-7 
Receptor Type GPCR Ion channel 
Signalling pathway "IP3, "Ca2+, "DAG 
#cAMP 
Ca2+ >> Na+ > K+ 
Membrane depolarisation 
Ca2+-sensitive signalling 
Functional effect in 
immune cells 
Chemotaxis Cytokine production 
Agonists ATP, ADP, UTP ATP 
Antagonists Suramin, PPADS 
Immune cell 
expression 
Neutrophils, monocytes, macrophages, dendritic cells, T cells, B 
cells, natural killer cells 
 




ATP in innate cells and inflammation 
 
All immune and inflammatory cells express P2 receptors on the plasma membrane 
which are coupled to an array of different functional outputs such as chemotaxis, 
generation of nitric oxide or superoxide anion, secretion of lysosomal constituents, 
release of cytokines, cell differentiation, cytotoxicity and intracellular Ca2+ mobilisation 
[362]. Macrophage and monocyte P2R expression depends on maturation stage and 
state of activation. A lack of functional P2X7 has been found in monocytes, however the 
receptor appears during maturation of monocytes to macrophages [363]. Human 
monocytes secrete ATP in a constitutive manner, leading to activation of cell surface 
P2 receptors which elevate intracellular Ca2+ levels [364]. This ATP ‘halo’ appears to 
be important in regulating intracellular Ca2+ homeostasis following P2Y receptor 
activation.  
 
There exists overwhelming evidence to suggest that ATP and their purinergic receptors 
play a major role in immunity and inflammation. Following cell activation or direct injury, 
the extracellular ATP concentration is increased massively, especially in the pericellular 
space [365]. Mechanisms of extracellular ATP release are illustrated in figure 1.13. 
ATP can be released in an uncontrolled fashion, e.g. in necrosis, or in a more 
controlled manner through regulated transport. ATP can be released via 
transmembrane channels such as pannexins in apoptotic cells [366], and connexins 
[367]. Therefore, nucleotides can generate concentration gradients in tissues that can 
serve as chemotactic signals for different immune cells, causing migration. ATP 
breakdown may be delayed during early inflammatory processes due to the down-
regulation of hydrolyzing enzymes by pro-inflammatory cytokines (e.g. TNFα) [368]. 
This results in the accumulation of extracellular ATP at inflammatory sites.  
 
ATP acts as a pro-inflammatory mediator and constitutes a danger signal which 
triggers several pro-inflammatory effector functions of neutrophils, including the 
production of ROS and cytokines such as IL-1α, IL-1β, IL-6, IL-18 and TNFα [369]. 
Additionally, danger signals such as uric acid, complement factor C5a, TLR ligands and 
IL-8 are stimulated by an autocrine ATP-P2Y2R loop to modulate migration and 
cytokine production of neutrophils or eosinophils [368]. ATP function in early 
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inflammation is most likely to involve the P2X7 receptor, whose activation causes 
production of cytokines by residing immune cells. P2X7 receptors in monocytes and 
macrophages are down regulated by anti-inflammatory mediators IL-4 and IL-10, 
whereas they are upregulated by pro-inflammatory regulators TNFα, IFNγ and LPS 
[357]. Dying tumour cells release ATP, which activates P2X7Rs on dendritic cells, 
leading to priming of IFNγ-producing CD8+ T cells that kill cancer cells. But, P2X7R 
signalling and subsequent T cell priming to different T cell lineages can also lead to 
allergy, graft versus host disease and IBD [368]. Interestingly, ATP at low milimolar 
concentrations has been shown to upregulate E-selectin through P2X7 receptor 
mediated activation of NFκB [370]. Furthermore, reports suggests that extracellular 
ADP may increase surface expression of Mac-1 integrin on monocytes [371]. These 
findings propose a role for ATP in modulating the adhesive mechanisms behind 




Figure 1.13: Extracellular ATP release and signalling during inflammation. During 
inflammation, multiple cell types release ATP from their intracellular compartments into the 
extracellular space. ATP can be released by necrotic cells, apoptosing cells, or activated 
inflammatory cells. ATP signals via the activation of P2 receptors: metabotropic G-protein 
coupled P2YRs and ATP-gated ionotropic P2XRs. P2XRs bind to ATP in the milimolar range, 
and this induces ion transport and influx of extracellular Ca2+ leading to inflammasome assembly 
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The effects of extracellular ATP on neutrophil function during inflammation are 
ambiguous. At micromolar ATP concentrations, neutrophil chemotaxis and 
chemokinesis has been shown either to be unaffected [372], inhibited [373], or 
promoted via stimulation of P2Y2 receptors [374]. Neutrophils are capable of releasing 
ATP from their leading edge to amplify chemotactic signals and direct cell orientation 
by feedback signalling involving P2Y2R [375]. Thus, effector functions may be subject 
to autocrine and paracrine control by endogenous ATP. Additionally, promyeloid 
precursor HL60 cells respond to ATP by increasing intracellular Ca2+ concentration via 
a pertussis toxin-sensitive G-protein receptor that couples to the inositol phospholipid 
signalling system, suggesting involvement of P2Y subtypes [376]. ATP can also 
stimulate production of CXCL8 by eosinophils [377]. ATP stimulation of chemokine 
release by cells near sites of tissue damage may contribute to neutrophil recruitment 
towards these sites. Upon arriving at inflamed sites where ATP levels are the highest, 
neutrophil recruitment may be no longer affected, or even inhibited by ATP, allowing 
the neutrophils to exert their bactericidal functions.  
 
 
Targeting nucleotides for therapy 
 
Current therapeutic targets of nucleotides in inflammation and immune disease include 
agonist stimulated ATP release or purinergic receptor signalling. A wide array of 
different compound types is presently under investigation for targeting nucleotides 
during inflammation. Efforts have been made to develop highly selective antagonists of 
ATP-gated P2XRs. The P2X7R antagonist AZ9056 was tested in patients with RA, and 
initial studies were promising. However, phase IIb/III trials with different P2X7R 
antagonists failed to improve long-term clinical outcome [378]. There are on-going 
clinical trials with P2X7R and P2X3R antagonists in chronic pain and chronic cough 
[368]. Statins have both cholesterol lowering and anti-inflammatory functions. 
Interestingly, fluvastatin was shown to suppress native and recombinant human P2X4R 
function in monocytes through cholesterol depletion [379]. Suramin is a parasiticide 
and is also a non-specific inhibitor of P2YR and P2XR [380]. Suramin is commonly 
used as a pharmacological tool in the study of nucleotide biology. Only two types of 
P2YR specific compounds have been tested clinically: antithrombotic P2Y12R 
antagonists (e.g. clopidrogel) and P2Y2R agonist denufosol, which was examined for 
the treatment of cystic fibrosis but eventually failed in clinical trials [381]. The search for 
better therapeutics aimed at targeting nucleotides in inflammation will need to be more 
selective and specific, or involve specific combinations of antagonists to directly target 
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1.6 Project aims and objectives !
Inflammatory responses to tissue damage are highly coordinated and rely on efficient 
communication between cell types. Studies in model organisms have revealed that 
leukocytes are recruited to sites of tissue damage along gradients of soluble damage 
cues, including H2O2. In zebrafish, H2O2 can activate directed neutrophil migration to a 
wound via oxidation of the SFK, Lyn. The aims of this thesis are designed to examine 
how these processes transfer into other models: 
 
 
1. To study the role of SFK signalling in hemocyte migration to a wound 
using a Drosophila embryonic wound model. We hypothesise that SFKs 
containing the conserved Cys466 residue will be necessary for hemocyte 
directed migration to a wound, indicating conservation between zebrafish and 
Drosophila. The objectives to explore this are to: 
o Measure the recruitment of hemocytes to a wound site in Drosophila 
embryos and compare responses between wild type embryos and 
embryos lacking functional SFKs. 
o Analyse parameters of migratory responses, e.g. cell velocity and 
directionality, and compare responses between wild type embryos and 
embryos lacking functional SFKs. 
o Compare motility of SFK-mutant hemocytes in the presence and 
absence of a wound, to determine if the H2O2 gradient is necessary for 
SFK activity. 




2. To investigate the effect of damage-associated signals on human innate 
cell function in vitro. We hypothesise that H2O2 and ATP will act as 
chemoattractants in vitro, and activate immune cells in a fashion comparable to 
that induced by known chemoattractants. This aim is accompanied by the 
following objectives: 
o Identify whether H2O2 and/or ATP act as chemoattractants in vitro 
models of cell migration using human neutrophils and monocytes. 
o Analyse the effect of damage signals on ligand-mediated cellular 
responses, including chemotaxis, polarisation, phagocytosis, and ROS 
generation, in neutrophils and monocytes in vitro. 
o Interpret the responses of damage signals on intracellular signalling and 
receptor expression in monocytes and neutrophils in vitro. 
o Measure the effect of H2O2 on signal prioritisation in neutrophils placed 
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3. To examine the contribution of SFK and PI3K signalling in human innate 
cell function in vitro. We hypothesise that SFK and PI3K signalling are 
essential for monocyte and neutrophil cell function in vitro. We will address this 
aim with the following objectives: 
o Analyse the contribution of SFKs and Syk in models of monocyte and 
neutrophil chemotaxis and polarisation in vitro using pharmacological 
inhibitors of SFK and Syk kinase signalling components. 
o Use pan-isoform and isoform-selective PI3K pharmacological inhibitors 
to identify the contribution of PI3K isoforms to models of monocyte and 
neutrophil chemotaxis and polarisation in vitro. 
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2.1 Reagents and materials 
 
A full reagents and materials list containing product names, product numbers and 
supplier information can be found in table 2.5.1.  
 
2.2 Methods and materials for in vitro experiments with human cells 
 




Human THP-1 (monocytic) [382] and U937 (monocytic) [383] cell lines were maintained 
in RPMI 1640 cell culture medium supplemented with 10% fetal bovine serum (FBS), 
2mM L-glutamine, 100U/ml penicillin and 100µg/ml streptomycin. Human EA.hy926 
(endothelial) cells [384] were maintained in DMEM:F12 cell culture medium 
supplemented with 10% fetal bovine serum (FBS), 2mM L-glutamine, 100U/ml penicillin 
and 100µg/ml streptomycin. All cells were grown in a 37°C 95% air/5% CO2 incubator. 
Suspension cells were passaged every 2-3 days, maintained at a confluence of 0.1-
1x106 cells/ml and discarded after 3 months. Adherent cells that had reached 80% 
confluence were trypsinised with 0.25% Trypsin-EDTA and passaged at a subculture 
ratio of 1:6. Cell stocks were stored in liquid nitrogen at density of 1x106 cells/ml in 
cryopreservation media (complete medium + 5% DMSO v/v) until required. 
 
Differentiation of THP-1 monocytes 
 
THP-1 monocytes were differentiated as previously described [385]. Briefly, cells were 
cultured at density of 0.5x106 cells/ml in complete medium supplemented with 80nM 
PMA for 48 hours. Cells that had adhered to the culture flask were washed in complete 
media and cultured for a further 3-5 days in PMA free media to mature. The 
differentiation process was verified as described in section 4.11. 
 
Isolation of primary human neutrophils 
 
Neutrophil isolation was performed as originally described by Böyum (1968) [386] with 
several modifications. Peripheral heparinised whole blood from healthy human 
volunteers was mixed 1:1 with RPMI 1640, layered over LymphoprepTM density 
gradient medium and centrifuged at 300 g for 30 minutes at room temperature to 
separate differential layers of cell populations. Plasma, mononuclear cells and 
LymphoprepTM layers were discarded using a Pasteur pipette, and remaining 
granulocyte and red blood cell layers were resuspended in ice cold Ca2+-Mg2+-free 
HBSS and 6% dextran (Mr ~100,000) at 1:5 (dextran:HBSS). Sedimentation was 
allowed to occur at room temperature for 30-45 minutes, after which the top layer was 
removed and centrifuged at 300 g for 5 minutes. Pellets were resuspended in red blood 
cell lysis buffer (15.5mM NH4Cl, 1mM KHCO3, 0.01mM EDTA, pH 7.4) and rocked 
gently for 5 minutes before centrifugation at 300 g for 5 minutes. Supernatant 
containing lysed red blood cells was discarded, and remaining granulocyte pellet was 
resuspended in cold Ca2+-Mg2+-free HBSS before use.  Figure 2.1 illustrates the key 
steps in neutrophil isolation. This procedure yielded a cell viability of at least 95% by 
trypan blue stain exclusion. A neutrophil population was confirmed by morphology 
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using Wright-Giemsa (as described in section 2.2.4) and DAPI staining to show lobed 





Figure 2.1: Primary human neutrophil isolation from peripheral blood. Blood is mixed with 
RPMI and layered over Lymphoprep. Differential centrifugation yields separate layers of blood 
cell populations. Neutrophils are present in a band above the red blood cell (RBC) pellet. 
Plasma, mononuclear cells and remaining Lymphoprep are discarded and neutrophil/RBC 
layers resuspended in HBSS with 4% dextran. Sedimentation of RBCs occurs whilst tubes are 
allowed to stand at room temperature for 30 minutes. Finally, RBC pellet is discarded and 




2.2.2 MTT cell viability assay 
 
(4,5-dimethylthiazol-2-yl)-2,5-diphenyly tetrazolium bromide (MTT) can be used to 
assess the viability of cells. One inside a metabolically active, viable cell, MTT is 
converted to formazan by mitochondrial succinic dehydrogenase. Formazan can be 
dissolved by DMSO and releases an intense colour, which is proportional to cell 
viability and can be measured using a plate reader.  
 
Cells plated in a 96 well flat-bottomed plate were stimulated as described. Non-
adhesive cells were centrifuged in the plate at 500 g for 10 minutes, media removed 
and replaced with 100µl MTT media (1ml MTT (50mg/ml), 1ml FBS, 8ml plain RPMI 
1640). Plates were incubated at 37°C for 3-4 hours after which 100µl DMSO was 
added to each well. Absorbance was read using a FluoStar Optima plate reader at 
540nm wavelength. 
 




Calcein AM is a cell permeant dye that is used to determine cell viability and label cells. 
In live cells the non-fluorescent calcein AM is converted to a green-fluorescent calcein 
after acetoxymethylester hydrolysis by intracellular esterases. Fluorescence can be 












•  Lymphoprep  
Sedimentation 
•  4% Dextran 
Red cell lysis 
•  RBC lysis buffer 
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Cells were loaded with 10µM calcein-AM in DMSO for 30 minutes at 37°C before being 
washed in plain media twice. Fluorescence was read using flow cytometry on a 




Carboxyfluorescein succinimidyl ester (CFSE) is a cell tracing reagent that is used to 
label cells for lineage and proliferation studies [387]. CFSE readily diffuses into healthy 
viable cells and covalently binds to intracellular amines, resulting in a stable, well-
retained fluorescent signal. Excess unconjugated reagent passively diffuses out of the 
cells and can be quenched and washed away.  
 
Cells were loaded with 10µM Cell TraceTM CFSE in DMSO for 10 minutes at 37°C 
before being quenched with 5 volumes ice-cold plain media. Cells were incubated on 
ice for 5 minutes and then washed three times in plain media before use. Fluorescence 
was read using flow cytometry on a FACSAria with excitation/emission at 495/515nm, 
using FACSDiva software. 
 
 
2.2.4 Wright-Giemsa staining 
 
Wright-Giemsa stain is a histological Romanowsky stain that is used to perform 
differential cell counts and may also be used to facilitate diagnosis of diseases [388]. 
The stain contains components including eosin Y, which stains cytoplasm of cells 
pink/orange, and methylene blue and azure B, which stain nuclei varying shades of 
blue to purple. 
 
Whole blood, or blood containing only red cells and granulocytes was pipetted onto a 
clean microscope slide and a film smear created using a second slide. The slide was 
allowed to air dry and then submerged in methanol for 5 minutes to fix the cells. Slides 
were removed from methanol, allowed to air dry, and submerged in Wright-Giemsa 
stain for 5 minutes. After staining the slide was placed under running H2O for 2-3 
minutes. Slides were imaged immediately using a Zeiss LSM confocal microscope with 
a 40x oil objective.  
 
 
2.2.5 Measurement of intracellular ROS generation 
 
H2DCFDA (2'-7'dichlorofluorescein diacetate) is used as an indicator of ROS in cells 
[389]. CM-H2DCFDA passively diffuses into cells, where its acetate groups are cleaved 
by intracellular esterases and its thiol-reactive chloromethyl (CM) group reacts with 
intracellular glutathione and other thiols. Subsequent oxidation yields a fluorescent 
adduct that is trapped inside the cell and can be detected using a plate reader.  
 
Cells were washed twice in plain RPMI 1640, loaded with 10µM CM-H2DCFDA and 
incubated at 37°C for 30 minutes. Following incubation, cells were washed twice in 
PBS and density adjusted to 1x106 cells/ml. Cells were plated into black flat bottomed 
96 well plates at 100µl per well and allowed to rest at 37°C for at least 30 minutes. 
Cells were treated with compound or vehicle as described in figure legends. 
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Immediately after treatment fluorescence was read using a FluoStar Optima plate 
reader at excitation/emission 490/515nm.  
 
 
2.2.6 Measurement of intracellular calcium 
 
Fluo-4 is a cell permeant, labelled calcium indicator that exhibits an increase in 
fluorescence upon binding to calcium [390]. Fluo-4, AM (acetoxymethylester) is the 
ester derivative of the indicator that readily loads into cells because it is an uncharged 
molecule that can permeate cell membranes. Once inside the cell, the lipophilic 
blocking groups are cleaved by non-specific esterases, resulting in a charged form that 
is unable to breach the cell membrane. Changes in free intracellular ion concentration 
can be measured using a plate reader.   
 
Cells were washed twice in plain RPMI 1640 and loaded with 10µM Fluo-4,AM 
dissolved in DMSO and incubated at 37°C for 45 minutes. Following incubation, cells 
were washed twice in Ca2+-free HBSS and density adjusted to 1x106 cells/ml. 
Extracellular calcium concentration was adjusted to 1mM using CaCl2 solution. Cells 
were plated into black flat bottomed 96 well plates at 100µl per well and allowed to rest 
at 37°C for at least 30 minutes. The plate was loaded into FluoStar Optima plate reader 
and fluorescence read at excitation/emission 490/515nm over time at 37°C. 
Fluorescence at each well was read every 15 seconds. For compound additions, 
recording was temporarily paused, compounds were manually pipetted into appropriate 
wells and recording restarted.  
 
 
2.2.7 Cell surface receptor expression 
 
For experiments examining surface receptor expression of CCR2, CD14 or ICAM-1, 
cells were washed twice in plain RPMI 1640, density adjusted to 1x106 cells per 
sample, and treated as described in figure legends. Following treatment, cells were 
washed once in 300µl ice cold PBS and resuspended in ice-cold FACS buffer (5% BSA 
in PBS). Samples were incubated on ice on a rocker for 20 minutes before being 
pelleted and resuspended in 50µl PBS containing Alexa-Fluor 488- or phycoerythrin- 
conjugated primary antibody, or corresponding conjugated IgG control antibody. 
Samples were incubated at room temperature on a rocker for 30 minutes before being 
washed twice in ice cold PBS. Finally, the samples were resuspended in 500µl PBS 
and transferred to FACS tubes for flow cytometry on a FACSAria using FACSDiva 
software. Live cells were gated using forward and side scatter and mean fluorescence 







Cells were washed twice in plain RPMI 1640, density adjusted to 1x106 cells/ml and 
seeded onto coverslips coated with 10µg/ml fibronectin and allowed to adhere for 30 
minutes. Cells were treated as indicated in figure legends. After treatment, media was 
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removed and cells were fixed in 4% paraformaldehyde for 20 minutes at room 





Following permeablisation, samples were blocked with 2% BSA in PBS for 30 minutes 
and then incubated with primary antibody diluted in 2% BSA in PBS for 1 hour at room 
temperature, or overnight at 4°C. Following incubation, samples were washed in 2% 
BSA in PBS and then incubated with secondary antibody for 2 hours. Samples were 
then washed again and finally incubated in a 1µg/ml solution of 4’,6-diamidino-2-
pheylindole (DAPI) for 20 minutes to label the cell nuclei. Where indicated, cellular F-
actin was labelled by incubating the samples for a further 20 minutes with 1µM Alexa-
Fluor 488 Phalloidin dye for 30 minutes at room temperature. Excess DAPI or Alexa-
Fluor 488 was removed, samples washed in PBS and mounted with Mowiol mounting 
medium onto microscope slides. Samples were air dried overnight and stored at 4°C 
until imaging.  Fluorescent images were acquired using a Zeiss LSM 510 confocal 
microscope using a 40x oil objective, unless otherwise indicated. 
 
 




Cells were seeded at density of 0.5-1x106 cells/ml onto chambered coverglasses 
coated in 10µg/ml fibronectin and allowed to adhere for 30 minutes at 37°C.  
Coverglasses chambers were transferred to Zeiss LSM 510 confocal microscope with 
an external incubator heated to give air and stage temperature of 37°C. Coverglass 
chambers were allowed to equilibrate for at least 10 minutes before imaging began. 
Cells were imaged using a 40x oil objective, unless otherwise indicated. Time-lapse 
images were acquired using the brightfield channel. For live cell stimulations, recording 
was temporarily paused and compounds were pipetted manually into the chamber 
before recording recommenced.  
 
Time lapse movies corresponding to relevant figures are provided on a separate CD as 
.avi files. Movies legends are provided in Appendix 1.  
 
Images were analysed using ImageJ software as described below.  
 
 
2.2.10 Image analysis 
 
Image analysis using ImageJ 
 
Image J is a public domain Java image processing program [391]. Images recorded on 
Zeiss LSM 510 confocal microscope were opened as LSM files in ImageJ (version 
1.47b) using the LSM reader plugin. Background fluorescence was removed using the 
‘despeckle’ ImageJ function. For single slices with multiple channels, channels were 
overlayed using ‘merge channels’ tool. Images were saved as .tif files.  
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For time lapse migration recordings, the paths of individual cells were manually tracked 
using the ‘manual tracking’ plugin and data was analysed using the ‘chemotaxis tool’ 
plugin to calculate parameters such as cell velocity and directionality. For each time 
point, the center of the cell body tracked was manually highlighted, and through its 
coordinates mean velocity and directionality were calculated. The directionality of a 
migrating cell is calculated by comparing Euclidian and accumulated distance. It is a 
measure of directness of cell trajectories. A directionality of 1 means a straight-line 
migration from start to endpoint. For time lapse recordings, brightfield single channel 
images were saved as .avi files. 
 
 
Image analysis using CellProfiler 
 
CellProfiler is free open-source software designed to enable quantitative measurement 
of phenotypes from multiple images automatically [392]. Using CellProfiler version 
2.1.0, single slice images for analysis were split into pairs of separate channels – one 
for actin (phalloidin) staining and one for nucleic (DAPI) staining. Image pairs were 
uploaded and the following analysis pipeline applied: Identify primary objects; Identify 
secondary objects; Measure object size shape; Export to spreadsheet.  
 
‘Identify primary object’ module uses nucleic (DAPI) input image to identify nuclei of 
each cell in the image, restricted to diameter of 10-40 pixel units to remove outliers, 
groups of cells or overlapping cells. ‘Identify secondary object’ module uses actin 
(phalloidin) input image and nuclei (DAPI) input object to identify cells and pairs nuclei 
and actin from each individual cell. ‘Measure object size shape’ runs quantitative 
measurement of phenotypes, including ‘form factor’ and ‘area’. Figure 2.2 provides 
representative images of CellProfiler software. 
 
All quantitative measurements are exported to an Excel spreadsheet, and from this 
‘form factor’ measurements from every individual cell analysed can be obtained. ‘Form 
factor’ is a measurement of cell roundedness, given by the equation: 
4*π*Area/Perimeter2. A perfectly round cell is given a score of 1, and as the cell 
elongates and becomes more irregular, the score tends to 0. 
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Figure 2.2: Identifying individual cell phenotypes using CellProfiler software. Fluorescent 
images of THP-1 monocyte nuclei (DAPI) (A) and actin (phalloidin) (B) were uploaded into 
CellProfiler for analysis. (A) Using DAPI signal, the ‘identify primary objects’ module identifies 
and outlines the nuclei of all cells (bottom left panel) from the fluorescent image and generates 
a mask (right panel). (B) The paired phalloidin image is also analysed with ‘identify secondary 
object’ module outlining the cell based on the nuclei identified earlier (bottom left panel). From 
these identifiers, the software generates measurements of cell characteristics spanning shape 
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2.2.11 Migration assays 
 
Neuroprobe ChemoTx® migration assay 
 
Cells were washed and resuspended in chemotaxis medium (FBS- and phenol red-free 
RMPI 1640) at 3.2x106 cells/ml and rested for 1 hour. Chemoattractants were diluted in 
chemotaxis medium and 29µl placed in the lower wells of a 96-well ChemoTx® 
chemotaxis plate (Neuroprobe) (Fig 2.3). Polyvinyl-free polycarbonate membranes with 
5µm pores were placed over the chemoattractants to separate lower and upper wells of 
the plate. 25µl cell suspension was placed on top of the filter over each well. After 
incubation at 37°C for 3 hours in humidified air with 5% CO2, the cell suspension was 
removed from the top of the membrane with blotting paper. The plate was placed in a 
centrifuge at spun at 300 g for 10 minutes to collect cells that had migrated into the 
lower wells. Cells were removed from each well, transferred to 300µl PBS and counted 
using flow cytometry on FACSAria using FACSDiva software. Viable cells were gated 
using forward and side scatter. Each tube was counted for 30 seconds on high flow 
rate.  Results are expressed as chemotactic index, i.e. the ratio of migration between 






Figure 2.3: Apparatus for Neuroprobe ChemoTx transwell assay. (A) Neuroprobe 96 well 
ChemoTx plate showing (l-r) lower chamber base, filter membrane and lid. (B) Representative 
photograph showing droplet of cell suspension surrounded by hydrophobic ring on the surface 
of the filter membrane. (C) Schematic of a single well of Neuroprobe 96 well ChemoTx plate. A 
droplet of cell suspension is pipetted on the surface of the membrane, with chemoattractant 
placed in the lower chamber. Cells migrate through the membrane towards the chemoattractant 














Chapter 2 | Methods and Materials 
67 
Under-agarose cell migration assay 
 
The under-agarose cell migration assay was prepared as described by Heit and Kubes 
[393] with a few modifications. Key stages are illustrated in figure 2.4. 
 
Casting the gels 
 
0.48g ultrapure agarose was dissolved in 10ml H2O and boiled until all agarose had 
dissolved. This was mixed with a pre-warmed mixture of 10ml HBSS and 20ml 
RPMI+20% FBS to give a 1.2% agarose solution. 3ml agarose solution was carefully 
pipetted into each well of a 6 well tissue culture plate, covered and allowed to solidify 
slowly at room temperature. Slow cooling is vital here to allow serum proteins to coat 
the bottom of the tissue culture plate.  
 
Once gels were solidified, wells were punched using a hole punch. A hole punch was 
created using 3 identical plastic tubes each with diameter 3.5mm, configured in a 
straight line with a 2.2mm equal spacing between tubes. Tubes were mounted on a 
wooden holder to create a robust, reusable hole punch. Agarose was cleared from the 
holes using a sterile Pasteur pipette attached to an aspirator to suck the agar from the 
wells. Gels were equilibrated at 37°C for 1 hour in humidified air with 5% CO2. 
Following equilibration, any condensation formed in the wells was removed using an 
aspirator. Gels were inspected for uniform thickness, coloration and lack of bubbles, 
particles or fissures.  
 
Loading and running the gels 
 
Primary human neutrophils were isolated from peripheral human blood as described 
above. Cells were resuspended in Ca2+/Mg2+-free HBSS at a density of 1x106 cells/ml 
and rested at 37°C for at least 30 minutes. Cells were treated with inhibitors or 
stimulants for 30 minutes prior to being loaded in the gels, unless otherwise stated.  
 
Gels were first loaded with 10µl chemoattractant or HBSS control per well, followed by 
10µl cells per well, equating to 1x104 cells/well. For all experiments, cells were placed 
in the central well and chemoattractant was placed in either one or two of the outer 
wells, depending on whether the actions of opposing chemoattractant gradients were 
being studied. Gels were incubated at 37°C for 2 hours in humidified air with 5% CO2. 
Once incubation was complete, gels were placed in a refrigerator for 20-30 minutes to 
ease analysis by increasing contrast between cells and agar. 
 
Analysing the gels 
 
Gels were photographed using a Canon EOS 110D camera mounted on an Olympus 
CKX41 light microscope with a 4x objective. For each tissue culture plate well, the 
space between inner and outer wells was photographed. Images were viewed using 
ImageJ software. On each image, a rectangle with dimensions equating to 5mmx2mm 
was superimposed over the image to denote the target zone for cell counting. Cells that 
had migrated were counted in this target zone alone, and compared to the number of 
cells that had migrated in the other direction using the same rectangle template for 
target zone.  
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Figure 2.4: Under agarose cell migration assay. Agarose gel supplemented with RPMI 20% 
FBS was cast in a 6 well tissue culture plate (A) and allowed to solidify. 3 parallel holes were 
punched in the agar using hole punch (B). Cells were pipetted into the central well and 
chemoattractant or HBSS control was pipetted into the outer wells (C). Plates were incubated 
37°C for 2 hours in humidified air with 5% CO2 to allow migration to occur. Following incubation, 
gels were photographed (D) at the spaces in between wells. Using ImageJ software, a target 
zone of defined area was superimposed on the photograph and cells that had migrated into the 








For macrophage experiments, THP-1 monocytes were treated with 80nM PMA for 
differentiation into macrophages, as previously described. For neutrophil experiments, 
primary human neutrophils were isolated from peripheral human blood as previously 
described. All cells were washed in plain RPMI 1640, and rested for at least 1 hour at 






Cells Negative Control Chemokine 
1.2% Agarose + RMPI 20% FBS 
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IgG opsonisation of latex beads 
 
Carboxylate-modified polystyrene fluorescent red latex beads were washed in PBS and 
incubated with 10mg/ml human IgG for 1 hour on a rocker at room temperature. Beads 
were washed twice in PBS to remove excess IgG and stored at room temperature until 
use.  
 
Preparation of bacteria 
 
Overnight culture of E. coli was washed in warm PBS and loaded with 10µM CFSE in 
DMSO for 30 minutes at 37°C under agitation. Following incubation, bacterial cells 
were washed three times in PBS and rested.  
 
Phagocytosis procedure and analysis 
 
Phagocytes treated with compounds or vehicle as indicated in figure legends were 
mixed 5:1 (v/v) with latex beads or bacteria and incubated for 30 minutes at 37°C with 
constant gentle agitation to encourage mixing. Following incubation, samples were 
washed twice in PBS, transferred to flow cytometry tubes and analysed by flow 
cytometry on a FACSAria using FACSDiva software. Flow cytometry was performed to 
demonstrate that single live phagocytes were associated with IgG-coated fluorescent 
beads or bacteria.  
 
For each phagocyte population, viable cells were gated using forward and side scatter. 
Mean fluorescence signal of the phagocyte population was measured for 10,000 
individual viable cells. If a phagocyte had engulfed a particle, a fluorescent signal would 
be detected within the viable gate. Controls included phagocytes incubated with no 
fluorescent particle, which gave mean fluorescence signal of zero, and either latex 
beads or bacteria alone which, due to their smaller size as determined by side and 
forward scatter, did not appear in the phagocyte viable gate and obstruct the true signal 
value. Data analysis was performed using FACSDiva software. 
 
 




Following treatment as indicated in figure legends, cells were washed in ice cold PBS. 
Cells were then lysed by rotating at 4°C for 30-40 minutes in lysis buffer (50mM Tris-
HCl, 150mM NaCl, 1% Non-idet P40, 1mM sodium vanadate, 1mM sodium molybdate, 
10mM sodium fluoride, 40µg/ml PMSF, 0.7µg/ml pepstatin A, 10µg/ml aprotinin, 
10µg/ml leupeptin and 10µg/ml soybean trypsin inhibitor). Lysates were then 
centrifuged at 500 g at 4°C for 10 minutes to remove debris and the protein containing 
supernatant collected. Samples were diluted in sample buffer (60mM Tris-HCl pH 6.8, 
2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 0.01% bromophenol blue) and boiled 








Samples were loaded into a 10% SDS-page gel positioned in a gel tank containing 
running buffer (25mM Tris-Base, 192mM glycine, 0.1% SDS). Proteins were stacked at 
75V for 20 minutes and then resolved at 150V for approximately an hour or until the 
sample buffer had reached the base of the gel. Proteins were transferred onto 
nitrocellulose membrane at 40mA per membrane for 1 hour using semi-dry transfer 
buffer (48mM Tris-Base, 39mM glycine, 0.0375% SDS, 20% methanol). Following 
transfer, the membrane was blocked in 5% milk in TBS tween (20mM Tris-HCl, 150mM 
NaCl, 0.1% tween 20) for 1 hour at room temperature. Membranes were then 
incubated in primary antibody diluted in TBS tween containing 1% BSA and 0.01% 
sodium azide overnight at 4°C on a rocker. Following incubation, the membrane was 
washed in TBS tween for 15 minutes before being incubated in a species appropriate 
horseradish peroxidase conjugated secondary antibody for 1 hour at room 
temperature. Finally, the membrane was washed in TBS tween for 15 minutes and 
protein bands visualised using an EZ-ECL chemiluminescence detection kit and 




2.3 Methods and materials for Drosophila experiments 
 
2.3.1 Fly husbandry 
 
Unless otherwise stated, all fly stocks were maintained at 25°C in the Fly Room at the 
University of Bath. Flies were kept in plastic vials containing fly food (17g yeast, 39g 
malt extract, 60g cornmeal, 9g soya flour, 6g plant agar, 64g sugar, 1.5g in 15ml MeOH 
Nipagin, 5.3ml in 7.7ml H2O propionic acid, up to 1.2L H2O) and tipped on to new feed 
approximately every other day. Larger stocks of flies were maintained in bottles 
containing the same fly food. For phenotyping and collection, flies were anaesthetised 
using a CO2 emitting pad and viewed under a dissection microscope. For crosses, 
virgin females were collected every morning and afternoon and distinguished by a 
swollen pale abdomen with a visible meconium.  
 
 
2.3.2 Embryo collection 
 
To collect embryos, flies were transferred to a laying cage (Figure 2.5). Cages were 
constructed out of upturned 100ml plastic beakers with air holes punched into the base. 
An apple juice agar plate (Agar, Apple Juice, Sugar) was placed to seal the open end 
and secured with an elastic band. Agar plates were supplemented with a pea-sized 
amount of yeast paste. Cages were stored in a dark incubator at 23°C. 
 
Fresh apple juice agar plates were placed on cages in the late afternoon. Embryos 
were then collected from these plates the next morning. For collection, embryos were 
dislodged from the plate using water and a paintbrush, and sieved through a basket. 
Embryos were dechorionated in bleach for 1 minute and 45 seconds to allow the 
chorion to dissolve; this was checked using a dissection microscope. Embryos were 
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washed thoroughly in water and kept submerged in water to avoid dehydration before 
mounting for imaging. 
 
 
Figure 2.5: Drosophila embryo collection and mounting for confocal microscopy. (A) Fly 
stocks were maintained in plastic vials containing fly food. (B) To collect embryos, flies were 
transferred to a laying cage, comprising an upturned plastic beaker with apple juice agar plate 
placed to seal the open end. (C) Embryos were collected, dechorionated and mounted ventral 
side up onto double sided sticky tape attached to a microscope slide and covered in Voltalef oil. 
Two square coverslips were attached to both ends to form a bridge for a large coverslip to be 
placed over the embryos, and secured with nail varnish. 
 
 
2.3.3 Gal4-UAS system 
 
Unless otherwise stated, the Gal4-UAS system was used for fluorescent labelling of 
hemocytes (Figure 2.6). This two-component system contains a Gal4 driver fly line and 
an upstream activating sequence (UAS) effector fly line. The yeast transcription factor 
Gal4 contains a DNA binding domain alongside an activation domain, and will be 
expressed when driven by an upstream promoter. This is crossed to an effector line 
including an UAS containing CGG-N19-CCG motif, where N is equivalent to any base; 
Gal4 binds here. In these studies, unless otherwise stated, fly lines contained the 
hemocyte specific promoter croquemort upstream of Gal4 recombined to UAS 
upstream of green fluorescent protein (GFP) on chromosome three. This cytoplasmic 
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Figure 2.6: The GAL4/UAS system in Drosophila. When females carrying UAS-GFP are 
mated to males carrying the yeast transcriptional activator GAL4 under the control of tissue 
specific promoter croquemort, progeny containing both GAL4 and UAS are produced. The 
binding of GAL4 at UAS drives GFP expression in the hemocytes only. 
 
 
2.3.4 Stocks and crosses 
 
Fly stocks are described in table 2.5.3. A croquemort-Gal4,UAS-GFP line was used to 
visualise wild type (WT) hemocyte migration. Fly lines with mutations on chromosome 
II were crossed with a croquemort-Gal4,UAS-GFP line in order to visualise hemocyte 
migration. Mutations were kept over balancer CTG on chromosome II. Crosses were 
performed at 25°C on standard fly food medium supplemented with additional yeast 
paste in plastic vials. 
 
 




Dechorionated embryos were collected during stage 15 of development and mounted 
ventral side up using curved forceps onto double side adhesive tape attached to a 
microscope slide and covered in Voltalef oil. Two square no. 1 coverslips (22mm x 
22mm) were attached to both ends of the slide and a large coverslip (32mm x 24mm) 
was placed over the top using flat forceps. The top coverslip was secured in place 




For wounding, mounted embryos were subjected to laser ablation from a nitrogen 
laser-pumped dye laser connected to a microscope using the Micropoint system 
(Photonic Science, Robertsbridge, UK). Wounds were placed close to the ventral lines 
of hemocytes along the centre of the anterior/posterior axis.  
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Shark embryos and WT controls were wounded and imaged using a Zeiss LSM 510 
confocal microscope with 63x objective. Src42A embryos and WT controls were 
imaged using a Perkin Elmer spinning disc confocal at 40x objective with Volocity 
(Perkin Elmer) software.  
 
Unless otherwise stated, for time-lapse movies, images were collected at 2-minute 
intervals for one hour. Recording started immediately after wounding. Time-lapse 
movies were created from the confocal Z-stacks by using ImageJ software (NIH). 
Movies were made at room temperature. 
 
Time lapse movies corresponding to relevant figures are provided on a separate CD as 
.avi files. Movies legends are provided in Appendix 1.  
 
 




Embryos were collected and dechorionated as previously described. Unwounded 
embryos at stage 15 of development were fixed for 20 minutes in a 1.5ml plastic tube 
containing a 1:1 mix of heptane and 4% paraformaldehyde in PBS, on a roller at room 
temperature. The fixative phase was removed and replaced with methanol. To remove 
the vitelline membrane the embryos were shaken vigorously until embryos settled in 
the bottom of the plastic tube. Embryos were transferred to a fresh plastic tube using a 
glass Pasteur pipette and washed three times in methanol. Embryos were 
subsequently stored in 500µl methanol at -20°C.  
 
Wounded embryos were removed from the microscope slide using heptane to dissolve 
oil and adhesive tape, collected in a basket and transferred to a 1.5ml epindorf 
containing a 1:1 mix of heptane and 4% paraformaldehyde in PBS. Embryos were fixed 
for 20 minutes on the roller at room temperature. Fixed embryos were hand-
devitellinized in PBS using forceps, washed three times in methanol and transferred to 




Fixed embryos were transferred to a fresh 1.5ml plastic tube and rinsed three times 
with 300µl PBT before being washed in 300µl fresh PATx every 20 minutes for an hour, 
on the roller at room temperature. PATx and PBT are described in table 2.5.4. Embryos 
were incubated with 200µl primary antibody diluted in PATx overnight at 4°C on a 
roller. Antibodies and concentration used are listed in Table 2.5.2. Samples were then 
rinsed several times in PATx before longer washes of 20 minutes in fresh PATx for an 
hour. Embryos were collected in a fresh plastic tube and incubated in secondary 
antibody diluted in PATx for 2 hours at room temperature on the roller. Following 
incubation, secondary antibody was removed and embryos rinsed three times in PATx 
and then washed for 20 minutes three times in fresh PATx. Finally, PATx was removed 
and embryos were covered in 100µl DABCO mounting medium. Inversion of the plastic 
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tube allowed suspension and dispersal of the embryos throughout the DABCO. 
Samples were stored at 4°C until mounted on microscope slides for imaging. 
 
2.3.7 Image analysis 
 
Images recorded on Zeiss confocal and spinning disk confocal were opened as LSM 
files in ImageJ using the LSM reader plugin. Background fluorescence was removed 
using the ‘despeckle’ ImageJ function before stacking the z projections using 
Grouped_z_projector plugin. Images were saved as .tif files and movies as .avi files.  
 
Hemocyte recruitment to a wound  
 
Z stack images using the GFP fluorescent laser were taken of individual wounded 
embryos 60 minutes post wounding to visualise hemocytes. In addition, brightfield 
images of the embryo were recorded concurrently to reveal the wounded epithelium. 
Using ImageJ software, the size of the wound can be measured using freehand 
selections. From these images, the number of hemocytes at the wound were counted 
and normalised against the size of the wound.  
 
Individual cell tracking 
 
Cell tracking was performed using the ‘Manual Tracking’ ImageJ plugin on maximum 
projections of Z slices. For each time point, the centre of the cell body tracked was 
manually highlighted, and through its coordinates mean velocity and directionality was 
calculated. The directionality of a migrating cell is calculated by comparing Euclidian 
and accumulated distance. It is a measure of directness of cell trajectories. A 




Measurement of phosphotyrosine intensity following immunostaining was carried out 
using ImageJ measurement tool ‘Mean gray value’ on individual slices of images 
corresponding to phosphotyrosine channel.  
 
 
2.4 Statistical analysis 
  
Data were normalised as described above and in figure legends, statistical analysis 
was performed using GraphPad Prism 6 software. Graphical representations of data 
include mean values ± standard error of the mean (SEM) for experiments with n≥3.  
For normalised data either a one way-ANOVA followed by Tukey’s post test or two 
way-ANOVA followed by Dunnett’s post test was performed to analyse significance 
between treatment groups. A paired t-test was also used when only comparing 2 
groups. A p value of less than 0.05 was considered to be statistically significant. 
For all experiments the following annotations are used to indicate the levels of 
significance: *=p<0.05, **=p<0.01, ***=p<0.001, ****=p<0.0001. 
 




2.5.1 Table of reagents and materials 
 
Product Catalogue No. Supplier 
12-well tissue culture treated 
polystyrene plate with lid 
665180 Greiner Bio-One, Gloucester, UK 
13mm coverslips MNJ-500-010G Fisher Scientific, Loughborough, UK 
2-mercaptoethanol M6250 Sigma Aldrich, Dorset, UK 
30% Acrylamide/Bis Solution 161-0154 Bio-Rad, Hertfordshire, UK 
3AC 565835 Merck Millipore, Billerica, USA 
6 well tissue culture treated 
polystyrene plate with lid 
657160 Greiner Bio-One, Gloucester, UK 
A66 S2636 SelleckChem, Suffolk, UK 
Alexa-Fluor 488 Phalloidin dye A12379 Life Technologies, Paisley, UK 
Amersham Protran Supported 
0.45µm nitrocellulose 
15220033 Fisher Scientific, Loughborough, UK 
Ammonium persulfate  A3678 Sigma Aldrich, Dorset, UK 
Ampicillin A9518 Sigma Aldrich, Dorset, UK 
Annexin V A35111 Life Technologies, Paisley, UK 
Aprotinin A1152 Sigma Aldrich, Dorset, UK 
ATP A2383 Sigma Aldrich, Dorset, UK 
Bovine serum albumin A2153 Sigma Aldrich, Dorset, UK 
BpV (HOpic) 203-701 Merck Millipore, Billerica, USA 
Bromophenol blue B/P620/44 Fisher Scientific, Loughborough, UK 
Calcein C1359 Sigma Aldrich, Dorset, UK 
Catalase from bovine liver C1345 Sigma Aldrich, Dorset, UK 
Cell Scrapers 541070 Greiner Bio-One, Gloucester, UK 
CellTraceTM CFSE cell proliferation 
kit 
C34554 Life Technologies, Paisley, UK 
ChemoTx Migration plate 
(Neuroprobe) 
101-5 Receptor Technologies, Warwick, UK 
96 well tissue culture treated 
polystyrene plate, with lid, clear 
655180 Greiner Bio-One, Gloucester, UK 
CM-H2DCFDA C6827 Invitrogen, Paisley, UK 
DABCO (1,4-
diazabicyclo[2.2.2]octane) 
290734 Sigma Aldrich, Dorset, UK 
DAPI (4’,6’-Diamidino-2-
phenylindole dihydrochloride) 
D9542 Sigma Aldrich, Dorset, UK 
Dextran (Mr ~100,000) 09184 Sigma Aldrich, Dorset, UK 
Dimethyl sulfoxide D8418 Sigma Aldrich, Dorset, UK 
DPI (Diphenyleneiodonium chloride) D2926 Sigma Aldrich, Dorset, UK 
DMEM-F12 media 11330-057 Invitrogen, Paisley, UK 
EA.hy926 cells CRL-2922 ATCC, Virginia, USA 
EDTA (Ethylenediaminetetraacetic 
acid) 
BPE2482 Fisher Scientific, Loughborough, UK 
EZ-ECL Chemiluminescence 
Detection Kit for HRP  
K1-0170 Geneflow Ltd, Staffordshire, UK 
Flat bottomed 96 well plates 11997944 Fisher Scientific, Loughborough, UK 
Fluo-4 AM F14201 Life technologies, Paisley, UK 
Foetal bovine serum, heat 
inactivated 
7.01 Hi Source Bioscience, Nottingham, UK 
Glycerol G5516 Sigma Aldrich, Dorset, UK 
GSK2636771 S8002 SelleckChem, Suffolk, UK 
HBSS, no calcium, no magnesium 14185052 Invitrogen, Paisley, UK 
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Heparin sodium salt 84020 Sigma Aldrich, Dorset, UK 
Human Fibronectin 1918-FN R&D Systems, Minneapolis, USA 
Human M-CSF 130-093-963 Miltenyi Biotech, Cologne, Germany 
Human recombinant IL-8 (CXCL8) 200-08 Peprotech, New Jersey, USA 
Human recombinant MCP-1 (CCL2) 300-04 Peprotech, New Jersey, USA 
Hydrogen peroxide solution 216763 Sigma Aldrich, Dorset, UK 
IC87114 S1268 SelleckChem, Suffolk, UK 
Ionomycin calcium salt 1704 Tocris Bioscience, Bristol, UK 
L-glutamine 25030-081 Invitrogen, Paisley, UK 
LABTEK Chambered coverglass 8 
well 
10384221 Fisher Scientific, Loughborough, UK 
Latex beads carboxylate-modified 
polystyrene, fluorescent red 
L3030 Sigma Aldrich, Dorset, UK 
Leukotriene B4 2307 Tocris Bioscience, Bristol, UK 
Leupeptin BPE2662 Fisher Scientific, Loughborough, UK 
Lipopolysaccharide from E. coli 
(Serotype O111:B4) 
L2630 Sigma Aldrich, Dorset, UK 
LY294002 S1105 SelleckChem, Suffolk, UK 
Lymphoprep 1114547 Axis Shield, Dundee, UK 
Microscope Slides MNJ-700-010N Fisher Scientific, Loughborough, UK 
MnTBAP Chloride ab141496 Abcam Biochemicals, Cambridge, UK 
Mouse IgG Alexa Fluor 488 Isotype 
control 
IC0041G R&D Systems, Minneapolis, USA 
Mowiol 4-88 81381 Sigma Aldrich, Dorset, UK 
MTT formazan M2003 Sigma Aldrich, Dorset, UK 
N-formyl-Met-Leu-Phe (fMLP) F3506 Sigma Aldrich, Dorset, UK 
Nonidet P-40 56009 Sigma Aldrich, Dorset, UK 
PFA (Paraformaldehyde) P6148 Sigma Aldrich, Dorset, UK 
PBS (1mM KH2PO4, 155mM NaCl, 
3mM Na2HPO4-7H2O) 
10010023 Invitrogen, Paisley, UK 
Penicillin-Streptomycin 15140-122 Invitrogen, Paisley, UK 
Pepstatin A 10011413 Fisher Scientific, Loughborough, UK 
Pertussis Toxin 3097 R&D Systems, Minneapolis, USA 
PMA (Phorbol 12-myristrate 13-
acetate) 
P8139 Sigma Aldrich, Dorset, UK 
PMSF (Phenylmethanesulfonyl 
fluoride) 
P7626 Sigma Aldrich, Dorset, UK 
Piceatannol 1554 Tocris Bioscience, Bristol, UK 
PP2 1407 Tocris Bioscience, Bristol, UK 
Protein ladder, pre-stained 
recombinant for SDS PAGE gel 
11478503 Fisher Scientific, Loughborough, UK 
Protein Standard Marker 161-0375 Bio-Rad, Hertfordshire, UK 
RPMI 1640 Medium 11875-093 Invitrogen, Paisley, UK 
SDS (Sodium dodecyl sulphate) L3771  Sigma Aldrich, Dorset, UK 
STI (Soybean trypsin inhibitor) 17075-029 Life Technologies, Paisley, UK 
THP-1 Human monocytic leukaemia 
cell line 
88081201 ECACC, Porton Down, UK 
Triton-X100 X100 Sigma Aldrich, Dorset, UK 
Trypan blue solution, 0.4% 15250-061 Invitrogen, Paisley, UK 
Trypsin-EDTA (0.25%) 25200-056 Invitrogen, Paisley, UK 
Tween-20 P1379 Sigma Aldrich, Dorset, UK 
U937 cells CRL-1593.2 ATCC, Virginia, USA 
Ultra Pure Agarose 16500100 Invitrogen, Paisley, UK 
Wright-Giemsa stain WG128 Sigma Aldrich, Dorset, UK 
ZSTK474 S1072 SelleckChem, Suffolk, UK 
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2.5.2 Table of antibodies 
  
Antibody Species Manufacturer Product 
number 
Dilution 
Primary     
ERK1 Rabbit Santa Cruz Biotech, 
TX, USA 
SC-93 1:1000 (WB) 
ICAM-1 (H108) Rabbit Santa Cruz Biotech, 
TX, USA 
SC7891 1:1000 (WB) 
1:100 (IF) 
pAkt (S473) Rabbit Cell Signaling 
Technology, MA, 
USA 
4060S 1:1000 (WB) 
pERK (Y204) Rabbit Cell Signaling 
Technology, MA, 
USA 
4376S 1:1000 (WB) 
CCR2 (Alexa Fluor 488 
conjugated) 
Mouse R&D Systems, MN, 
USA 
FAB151G 1:10 (FC) 
CD14 (Fluorescein 
conjugated) 
Mouse R&D System, MN, 
USA 
FAB3832F 1:10 (FC) 
pTyrosine, clone 4G10 Mouse Merck Millipore, MA, 
USA 
05-321 1:100 (IF) 
     
Secondary     
HRP-conjugated anti Rabbit Goat DAKO, UK P0449 1:2000 (WB) 
Alexa Fluor 568-conjugated 
anti Rabbit 
Donkey Invitrogen, UK A10042 1:200 (IF) 
Alexa Fluor 568-conjugated 
anti Mouse 
Donkey Invitrogen, UK A10037 1:200 (IF) 
(WB= western blot; FC= flow cytometry; IF= immunofluorescence) 
 
 
2.5.3 Table of Drosophila stocks 
 
Fly line Supplier 
w;;crq-Gal4,UAS-GFP W Wood, University of Bath, UK 
w;shark/CTG;crq-Gal4,UAS-GFP I Evans, University of Bath, UK 
w;If/Cyo;crq-Gal4,UAS-GFP/TM6B W Wood, University of Bath, UK 
w;If/Cyo;MKRS/TM6B W Wood, University of Bath, UK 
w;src42aE1/Cyo Bloomington Stock Centre, Indiana, USA 
w;src42aK10108/Cyo Bloomington Stock Centre, Indiana, USA 
w;src42amyri/Cyo Bloomington Stock Centre, Indiana, USA 
w;shark1/Cyo Bloomington Stock Centre, Indiana, USA 
 
 
2.5.4 Table of buffers and solutions 
 
Buffer Contents 
Phosphate Buffered Saline with Triton X-100 (PBT) 0.1% Triton X-100 in 1X PBS 
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In vivo models of tissue damage have revealed that H2O2 is an early signal generated 
locally in response to wounding [233], [270]. Using a zebrafish larval model of tissue 
damage, it has recently been suggested that wound generated damage cue H2O2 can 
stimulate neutrophil recruitment to a wound by oxidising and activating an intracellular 
zebrafish kinase, Lyn [282]. Lyn has consequently been termed a ‘redox sensor’ in 
neutrophils. Lyn is a member of the SFK family, a conserved group of enzymes that 
drive many cellular signalling events. Zebrafish studies identified the critical residue 
that is oxidised by H2O2 as cysteine 466. Importantly, this residue is conserved in SFK 
members between species, including Drosophila Src42A, human Lyn, Src, Hck and 
Lck, and C. elegans Src-1 [282].  
 
The damage signal H2O2 is also important in driving immune cell recruitment to sites of 
tissue damage in Drosophila embryos. Whether this is via a SFK driven mechanism, 
akin to observations in zebrafish, has yet to be fully elucidated. Therefore, our first aim 
was to investigate whether Drosophila Src42A has a role in driving immune cell 
recruitment to sites of tissue damage. For this we can use a Drosophila embryonic 
wounding model with embryos lacking functional Src42A to analyse responses of 
immune cells to laser induced epithelial damage. This is a robust model that harnesses 
the tractability of Drosophila genetics with time-lapse confocal microscopy to measure 
cellular events in real time. 
 
Human Syk (Drosophila Shark) is a key signalling mediator and adaptor protein 
downstream of SFKs. SFK and Syk interactions have been characterised downstream 
of human immunoreceptors [126], and the Drosophila engulfment receptor Draper, as 
described in section 1.4.5. Shark is required for embryonic dorsal closure in 
Drosophila, a process which requires the synchronised movement of epithelial cell 
layers [289]. Additionally, a recent study in Drosophila highlighted a potential link 
between Src42A and Shark signalling downstream of the engulfment receptor Draper 
in glial cell phagocytosis of apoptotic corpses [287].  
 
The aim of this chapter is to examine the contribution of Src42A and Shark in 
hemocyte recruitment to a wound by examining individual cell behaviour in response to 
a wound event in embryos lacking functional Src42A or Shark.  
 
 
3.2 Src42A is required for hemocyte migration to a wound 
 
To investigate whether SFK redox sensitivity is conserved in Drosophila, SFK 
candidates containing the critical cysteine 466 residue were identified in a gene search 
using FlyBase. Drosophila Src42A was a positive hit. To determine whether Src42A 
was involved in the migration of hemocytes to wound, embryos with mutated Src42A 
were studied. Three mutant Src42A fly lines were used in the Drosophila embryonic 
wounding assay, as summarised in Table 3.1. 
 
To investigate the migratory response to a wound, developmental stage 15 Src42A 
mutant embryos expressing the fluorescent cytoplasmic marker GFP under the 
hemocyte specific driver croquemort were wounded close to the ventral midline and 
imaged using a spinning disc confocal microscope 60 minutes post wounding (Figure 
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3.1a). Hemocytes from Src42AE1 and Src42AK10108 embryos showed significant 
impairment in migration to the wound after 60 minutes (Figure 3.1b). Src42Amyri 
hemocytes migrated to the wound with greater variance and the mean hemocyte 
number was not significantly impaired compared to WT responses. Consistent with 
previous observations from our lab group, the number of WT hemocytes at the wound 
correlated linearly with the size of the wound (Figure 3.1c). However, for all three 
Src42A mutants linear regression analysis indicated this correlation was less linear 
than for WT embryos (Src42AE1 R2=0.049, Src42AK10108 R2=0.676, Src42Amyri R2=0.360, 
WT R2=0.709). Src42AE1 hemocyte number at the wound remained constant (<5 
hemocytes) regardless of the wound size.  
 
Time-lapse movies of hemocyte migration were captured using all three GFP-
expressing Src42A mutants and compared to WT embryos to gain a better insight into 
the migratory characteristics of Src42A mutant hemocytes. Images were captured 
every 2 minutes for one hour. Figure 3.2a contains representative images of embryos 
before wounding and up to 60 minutes post wounding, as well as individual cell tracks 
from which hemocyte velocity and directionality were calculated. Src42A mutant 
hemocyte directionality was significantly impaired in all three mutants compared to WT 
embryos (Figure 3.2b). This was also true of hemocyte velocity; all Src42A mutant 
hemocytes were significantly slower when migrating to a wound than WT controls 
(Figure 3.2b).  
 
We next sought to determine whether mutations in Src42A were affecting migratory 
responses in unwounded embryos. Embryos were mounted and imaged without 
wounding for up to 30 minutes. Individual cell tracking revealed that hemocyte random 
migration was not compromised by Src42A mutations. Interestingly, random migration 
velocity of Src42AE1 and Src42Amyri hemocytes was significantly higher than WT 
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Mutation Mutagen Feature Reference 
Src42Amyri EMS 
Membrane localisation defect – Point mutation in 
codon 2 results in amino acid substitution from 
Gly2 to Asp. Gly2 is conserved in all members of 
the Src family and must be myristoylated for 
localization of Src to the cellular membrane in 
mammals. 
[394] 
Src42AK10108 P-element Loss of kinase function – P{lacW}Src42A
K10108 
transgene insertion located on chromosome 2. [395] 
Src42AE1 EMS 
Loss of kinase function – Point mutation at codon 




Loss of kinase function – The Shark1 locus 
encodes a truncated form of Shark protein due to 
a C → T transition at nucleotide 685 that changes 






Table 3.1: Mutant Drosophila stocks used for the study of Src42A and Shark function in 








































Figure 3.1: Src42A drives hemocyte migration to a wound in Drosophila embryos. Stage 
15 embryos containing hemocyte specific GFP expression were mounted on a microscope slide 
ventral side up and wounded with a laser along the midline. Embryos were imaged using 
confocal microscopy with a 20x objective. (A) Images captured pre wound (0’) and 60 minutes 
post wounding (60’). Dashed yellow lines indicate embryo outline, red asterisk denotes site of 
wound. (B) Quantification of hemocytes at wound 60 minutes post wounding, normalised to WT. 
Statistical analysis by one way-ANOVA with Tukey’s post test, where *=p<0.05, **=p<0.01 and 
****=p<0.0001. (C) Correlation plot and linear regression analysis between wound size and 
number of hemocytes counted at wound 60 minutes post wounding. Data represents means 
(±SEM) from at least 3 separate experiments with at least 2 embryos per genotype measured 
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Figure 3.2: Src42A mutant embryos show reduced hemocyte directionality and velocity 
in Drosophila embryos. Stage 15 embryos containing hemocyte specific GFP expression were 
mounted on microscope slides ventral side up and wounded with a laser along the midline. 
Embryos were imaged using confocal microscopy with a 20x objective with image acquisition 
every 120 seconds. (A) Stills from time-lapse imaging representing pre-wound (0’) and 20, 40 
and 60 minutes post wound and manual tracking trajectories. Dashed yellow lines indicate 
embryo outline, red asterisk denotes site of wound, scale bar = 100µm. (B) Hemocytes were 
manually tracked and quantification of hemocyte directionality and velocity measured using 
ImageJ software with ‘Manual tracking’ plugin. Data represents velocity or directionality (± 
SEM), normalised to WT, from at least 25 hemocytes pooled from 3 embryos per genotype. 
Statistical analysis by one way-ANOVA with Tukey’s post test, where ***=p<0.001, 
****=p<0.0001. 
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Figure 3.3: Random migration of hemocytes is not compromised in Src42A mutant 
Drosophila embryos. Stage 15 embryos containing hemocyte specific GFP expression were 
mounted on microscope slides ventral side up. Embryos were imaged using confocal 
microscopy with a 20x objective and images acquired every 60 seconds. (A) Stills from time-
lapse imaging representing time points 0, 15 and 30 minutes and manual tracking trajectories. 
Dashed yellow lines indicate embryo outline. Scale bar = 100µm. (B) Hemocytes were manually 
tracked and quantification of hemocyte velocity measured using ImageJ software with ‘Manual 
tracking’ plugin. Data represents velocity (± SEM), normalised to WT, from at least 25 
hemocytes pooled from 3 embryos per genotype. Statistical analysis by one way-ANOVA with 
Tukey’s post test, where *=p<0.05, **=p<0.01 and ****=p<0.0001. 
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3.3 Shark is required for hemocyte migration to a wound 
 
Shark has been associated with the engulfment response seen in glial cells via the 
Draper receptor pathway and in coordinating actin remodelling [287]. There is potential 
for Shark to have a wider role in directing hemocyte migration in response to wounds. 
To investigate this, a Shark mutant fly line, Shark1 [289], was tested in the Drosophila 
embryonic wounding assay.  
 
To investigate the migratory response to a wound, developmental stage 15 Shark1 
mutant embryos expressing the fluorescent cytoplasmic marker GFP under the 
hemocyte specific driver croquemort were wounded close to the ventral midline and 
imaged using confocal microscopy 60 minutes post wounding. Shark1 mutant embryos 
showed significantly impaired hemocyte recruitment to the wound versus WT embryos 
(Figure 3.4a). We also observed weaker correlation between the number of hemocytes 
at the wound and the wound size: Shark1 mutant R2=0.02 when compared to WT 








Figure 3.4: Shark is involved in hemocyte migration to a wound in Drosophila embryos. 
Stage 15 embryos containing hemocyte specific GFP expression were mounted on microscope 
slides ventral side up and wounded with a laser along the midline. Embryos were imaged using 
confocal microscopy with a 20x objective. Confocal images were taken before wounding, and 
60 minutes post wounding. (A) Quantification of number of hemocytes at wound in Shark1 
mutant embryos normalised to WT. (B) Correlation plot and linear regression analysis between 
wound size and number of hemocytes counted at wound 60 minutes post wounding. Data 
represents means (± SEM) from at least 3 separate experiments with at least 2 embryos 

























































WT R2=0.3758 | Shark1 R2=0.01945
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3.4 Phosphotyrosine intensity is increased in activated hemocytes 
 
SFK activation leads to phosphorylation of various intracellular targets. In order to 
identify whether SFK activity is upregulated in hemocytes responding to a wound 
signal, WT embryos with GFP expressing hemocytes were wounded and fixed 30 
minutes post wounding. Embryos were stained for phosphotyrosine (pY) and imaged 
by confocal microscopy. Brightfield imaging revealed the location of the wound site in 
the epithelium. Microscopy revealed high pY expression throughout the embryo, 
particularly in epithelial tissue. pY intensity in individual hemocytes was measured and 
comparisons were made between activated hemocytes (those cells that had responded 
to wound cues and were present at the wound site), and quiescent hemocytes (non-
responders, distal to the wound site). Measurement of pY intensity indicated 
significantly enhanced pY expression in activated hemocytes at the wound site versus 




3.5 Exogenous H2O2 saturation impairs hemocyte random migration 
 
H2O2 has been identified as an early wound cue generated locally after tissue damage 
[287]. Immune cells respond to the H2O2 gradient and migrate towards its source. We 
examined the effects of saturated H2O2 environments upon random hemocyte motility 
to see if exploratory behaviour was influenced by stable concentrations of H2O2. WT 
embryos containing GFP expressing hemocytes were incubated with increasing 
concentrations of H2O2 for 10 minutes before hemocyte random migration was imaged 
using time-lapse microscopy for 5 minutes. Individual cell trajectories were tracked and 
cell velocity and accumulated distance measured. Embryos incubated in H2O2 had a 
significant and dose dependent impairment in random migration velocity and total 

























Figure 3.5: Phosphotyrosine (pY) intensity is increased in activated hemocytes at the 
wound site. WT Drosophila embryos at developmental stage 15 expressing crq-UAS,Gal4-GFP 
were wounded with a laser, fixed in PFA and immunostained to visualise pY. The embryo was 
imaged using confocal microscopy to locate the wounded epithelium. Representative images of 
(A) pY signal, (B) GFP hemocyte signal and (C) merged channel image. Yellow dashed lines 
indicates embryo outline. White dashed lines indicate areas sampled for quantification of (a) 
active hemocytes at the wound, or (q) quiescent hemocytes distal to the wound. (D) Brightfield 
image of embryo epithelium. Orange dashed line denotes wound site. (E) Quantification of pY 
signal intensity in hemocytes from an ‘active’ or ‘quiescent’ area of the embryo. Data collected 
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Figure 3.6: Exogenous H2O2 impairs hemocyte random migration in Drosophila embryos. 
WT Drosophila embryos at developmental stage 15 expressing crq-UAS,Gal4-GFP were 
dechorionated, permeabilised in methanol for 5 minutes, and incubated with increasing 
concentrations of H2O2 or PBS for 10 minutes. Following treatment, embryos were mounted and 
imaged over time using a light microscope with GFP filter. Images of each embryo were 
acquired every 30 seconds. (A) Stills from time-lapse imaging after 0 and 5 minutes, dashed 
yellow lines indicate embryo outline. (B) Hemocytes were manually tracked and quantification of 
hemocyte velocity and accumulated distance measured using ImageJ software with ‘Manual 
tracking’ plugin. Data represents velocity or distance (± SEM), from at least 25 hemocytes 
pooled from 3 embryos per genotype. Scale bar = 20µm. Statistical analysis by one way-
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3.6 Summary of results 
 
• Hemocyte accumulation at a wound was significantly impaired in Src42AE1 and 
Src42AK10108, but not Src42Amyri, mutant embryos compared to WT embryos.  
• Hemocytes migrated to a wound with significantly reduced velocity and 
directionality in Src42A mutant embryos compared to WT embryos.  
• Hemocyte random migration was not significantly impaired in Src42A mutant 
embryos compared to WT embryos.  
• Hemocyte accumulation at a wound was significantly impaired in Shark1 mutant 
embryos compared to WT embryos.  
• pY intensity was increased in ‘activated’ hemocytes that are present at the wound 
compared to hemocytes in distal regions of a wounded embryo.  
• Hemocyte random migration velocity was significantly impaired following embryo 




3.7 Chapter 3 Discussion 
 
 
Src42A and Shark kinases are required for immune cell migration to a wound 
 
In Drosophila embryos lacking functional Src42A, immune cell recruitment to a wound 
was impaired in comparison to responses in wild type embryos. The speed and 
directionality of immune cell migration was also compromised. However, migration and 
motility in the absence of a wound was unaffected by a Src42A mutation. This result 
agrees with the findings of Yoo et al (2011) that SFKs play a role in coordinating 
neutrophil migration following epithelial damage in zebrafish larvae [282]. Src42A has 
previously been found to inhibit wound-induced transcriptional events in epidermal cells 
[278], thus having an anti-inflammatory role in limiting epithelial responses to damage. 
However, other studies have found that Src42AE1 mutant embryos, which gave the 
strongest phenotype in our experiments, fail to heal and show delayed re-
epithelialisation after wounding [396]. The strongest phenotype in our experiments was 
found in Src42AE1 mutant embryos, where the Src42A kinase domain lacks a carboxyl-
terminal group. This implies that the kinase domain and ability of Src42A to 
phosphorylate other proteins is crucial in driving directed cell migration to a wound. The 
Src42Amyri mutant embryos showed the least severe phenotype in the wounding assay, 
with no significant difference in the number of hemocytes recruited to a wound versus 
WT embryos. The mutation in Src42Amyri embryos results in the protein being unable to 
localise to the plasma membrane. Our observations therefore suggest that this ability is 
not essential for detection of a wound cue and activation of Src42A. The Src42AK10108 
embryos showed an intermediate phenotype in response to wounds, indicating that the 
transgene insertion does not completely block its ability to function as a mediator 
downstream of tissue damage. Taken together, our findings show that in the immune 
cell compartment, at least, Src42A is likely to promote inflammation, while there may 
be diverging roles for SFKs in different tissues associated with the wound response. 
 
Similarly, immune cell recruitment to a wound in Drosophila embryos lacking functional 
Shark kinase was significantly impaired. This is complementary to other reports 
demonstrating the role of Shark in cell migration in the setting of embryonic dorsal 
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closure [289]. Shark tyrosine kinase may be activated directly or indirectly by wound-
associated H2O2. This cannot be concluded from our studies alone, however in other 
settings H2O2 has been reported to activate tyrosine kinase signalling and complex 
formation [397]-[399]. To study whether Src42A and Shark are interacting downstream, 
heterozygote mutants containing one allele of each mutation could be engineered and 
studied in the wound model. If the recruitment phenotype was exacerbated in 
heterozygote mutants, this would suggest that Src42A and Shark are signalling in 
distinct pathways. 
 
We found no linear correlation between wound size and the number of recruited 
immune cells in our Src42A or Shark mutant embryos. This suggests the total cell 
number in these embryos may be reduced and could account for the impaired 
recruitment we observe following wounding. Additionally, the mutations could affect the 
development and dispersal of hemocytes – a process that is normally tightly regulated 
by PVF gradients [270]. The mutant lines used here contained disrupted genes of 
interest. However, the mutant genes are not expressed specifically in hemocytes but in 
every cell of the embryo. Embryo wide genetic disruption is likely to have wide-reaching 
consequences given the infidelity of genes in multiple organ systems. However, our 
observations confirmed that random exploratory hemocyte velocity is unaffected by the 
loss of active Src42A. This indicated that while Src42A may be involved in detection of 
damage cues, it is unlikely to be a key signalling mediator in undirected motility.  
 
How Src42A ‘activation’ leads to directed cell migration still remains to be uncovered. 
From our studies alone we cannot identify the downstream targets of Src42A. Because 
SFKs lie upstream of many other signalling mediators we can predict that it is likely to 
be targeted by H2O2 directly, or indirectly via receptors that activate/recruit Src42A. 
Others have demonstrated that Src42A may serve as a negative regulator of receptor 
tyrosine kinases (RTKs). [400]. This has been suggested to be Ras-independent, 
indicating that Src42A works in a parallel pathway alongside Ras/Raf/MAPK signalling 
to inhibit RTK-mediated responses. Tateno et al (2000) suggest that Src42A may 
function in a synergistic manner with the tyrosine kinase Tec29 during dorsal closure 
and this pathway could be involved in migratory processes in hemocytes [394]. By 
localised expression of gain-of-function and dominant-negative forms of Src42A, it was 
demonstrated that Src42A may be involved in the regulation of cytoskeleton 
organisation and cell-cell contacts in the Drosophila eye [401].  
 
Given the complexity and indistinct functions of Src42A it will be pertinent to investigate 
the how embryos lacking functional Src42A-downstream mediators, particularly 
components of the MAPK pathway and Rac/Cdc42a pathway, respond to damage 
cues. In addition, it cannot be ruled out that other damage signals may also be 
produced following tissue injury in this model and could be acting in concert with H2O2 
to initiate migration. For example, extracellular ATP is considered a likely wound-
associated signal that can alert cells to damage [357]. However, when Drosophila 
embryos lacking functional Drosophila purinergic receptor were wounded, normal 
hemocyte recruitment responses were observed [270], suggesting additional factors 
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Kinase activity is upregulated at sites of tissue damage 
 
Our initial data indicate that kinase activity could be upregulated at the site of tissue 
damage. This is in agreement with previous reports showing phosphotyrosine up-
regulation in epidermal wounds [402] and activation of JNK signalling in wound healing 
[403]. Immunostaining wounded embryos offers the ability to reveal phosphorylation 
that may not otherwise be possible via genetically encoded reporters in vivo. While our 
results do indicate a higher phosphotyrosine signal in the vicinity of the wound 
compared to distal sites, we cannot conclude as to its tissue-specific location. The 
embryo used for this experiment contained GFP-expressing hemocytes and was 
immunostained for embryo-wide pY. When overlaid, the pY and GFP signals appear to 
co-localise particularly in the area where hemocytes have accumulated. However, 
kinase activity will be embryo wide and is likely to have important roles in many 
processes involved in the wound response. This approach cannot tell us for certain if 
the pY is upregulated in the wound hemocytes specifically. It is difficult to pinpoint 
specific pY expression in hemocytes, especially when images are taken from a fixed, 
uneven surface of an embryo. To confirm that Src42A is being activated during the 
wound response, or to identify kinase activity from other mediators, it may be more 
appropriate to dissect individual cells types and examine phosphorylation events ex 
vivo, or to use a genetic reporter in vivo, as live imaging will reveal a more dynamic 
response in actively migrating cells. 
 
 
Exogenous H2O2 slows hemocyte random exploratory migration 
 
The wound-generated H2O2 gradient has been shown to recruit neutrophils in a 
zebrafish larvae model of tissue injury [233]. To investigate the significance of an 
established H2O2 gradient, we were interested to study how exposure to exogenous, 
stable concentrations of H2O2 affected hemocyte motility. The effect of exogenous 
H2O2 in model organisms has been previously investigated in different settings. 
Exogenous H2O2 promotes growth of severed axons in zebrafish following tailfin 
transection [404]. It is likely that this process occurs in parallel with the neutrophil 
migratory response and that these are both in fact mediated by tissue damage-
generated H2O2. In adult Drosophila, feeding or injection of H2O2 causes increased 
adult fly locomotor activity and affects circadian rhythms [405]. Furthermore, in a 
mouse model of T cell migration, chemokine-dependent AQP3-mediated influx of 
extracellular H2O2 was crucial for the activation of Rho GTPase Cdc42 and subsequent 
actin remodelling, leading to T cell migration [328].  
 
When embryos were permeabilised and bathed in exogenous H2O2, hemocyte motility 
was slower and some cells were in fact stationary at the highest H2O2 concentrations. 
These results are unexpected and can be interpreted in several ways. Firstly, the 
stable, H2O2-saturated conditions created in this assay could reflect the environment at 
sites closest to tissue damage, where the H2O2 concentration is greatest. This 
represents the ‘target’ for migrating cells and could induce their arrest via inhibition of 
actin-mediated pathways in order to hold the cells at the damage site and allow them to 
carry out other processes such as phagocytosis. It may also suggest that the H2O2 
signal overrides any other embryonic guidance cues that may be regulating their 
embryonic dispersal at the time of wounding. This could explain why we have observed 
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a slowing of hemocyte migration when the H2O2 gradient is absent. Alternatively, the 
saturated H2O2 environment could be toxic to the cells and cause them to engage cell 
death mechanisms and stop migrating. To explore this further, studying functional 
processes such as phagocytosis in the presence of exogenous H2O2 could identify 
whether all the cell functions are halted. If the H2O2 is holding the cell at the site, we 
predict phagocytosis would be increased. 
 
 




Figure 3.7: Proposed models for hemocyte motility in the presence and absence of a 
H2O2 gradient. (A) In Drosophila embryos, the presence of a H2O2 gradient leads to Src42A 
activation and downstream signalling resulting in cytoskeletal reorganisation and directed cell 
migration. The adaptor kinase, Shark, may function downstream of Src-phosphorylated ITAM-
containing receptors via MAPK and Rac pathways to initiate directed cell migration in response 
to wounds. (B) When unwounded Drosophila embryos are bathed in exogenous, stable 
concentrations of H2O2, hemocyte random migration is reduced. This may be due to the action 
of H2O2 targeting protein kinase mediators of actin reorganisation, or by inducing cell death.  
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CHAPTER 4: THE EFFECT OF DAMAGE-ASSOCIATED 















































Innate immune cells are exposed to multiple signals throughout their lifetimes – during 
their development and maturation, their working lives as patrollers, engulfers and 
communicators, and finally during their end of life death mechanisms. In addition to 
homeostatic signals, innate cells can also encounter external foreign pathogenic 
signals and tissue damage-associated danger signals. The ability of innate cells to 
produce an integrated, signal specific response to all these signals is an essential 
driving force in inflammation. 
 
Zebrafish models have demonstrated that immune cells can migrate to areas of tissue 
damage and that H2O2 is an early wound signal involved in recruiting cells to promote 
healing [233]. In humans, the role of H2O2 as a signalling molecule at low 
concentrations has been associated with various processes. However, at higher 
concentrations it is a danger signal, involved in the respiratory burst and ROS 
signalling. Additional danger molecules, such as nucleotides, are also generated at 
high concentrations at sites of tissue damage and have auxiliary roles in mediating 
inflammatory responses [406]. In a setting of inflammation, damage signals are 
generated by the same cells as pro-inflammatory mediators such as chemokines. 
Therefore, interactions between chemokines and damage signals are likely to occur in 
vivo. It is important to ask whether damage signals could serve to amplify 
chemoattractant-induced changes in the immunological and inflammatory capacities of 
leukocytes and the endothelium. Various reports offer conflicting views on the 
responses of human innate cells to exogenous damage signals. It is important to 
establish whether the role of damage signals in immune cell recruitment to a wound 
can be recapitulated in human cells, as this offers a novel strategy for the management 
of many inflammatory and autoimmune pathologies.  
 
Two human innate immune cell types, neutrophils and monocytes, were employed to 
represent the innate immune system and to increase the range of known ligand-
receptor interactions for comparisons to damage signals. In order to model human 
physiological processes most representatively, primary human neutrophils have been 
isolated from healthy human blood. A limitation of working with primary neutrophils is 
their short life span after purification (6–8 hours), which makes it difficult to manipulate 
specific signalling pathways other than using inhibitor-based approaches. Due to the 
difficulties in obtaining large numbers of blood-derived neutrophils and monocytes, and 
the variations between donors, a monocytic cell line THP-1 was also used in most 
experiments in this study.  
 
The THP-1 cell line originates from a human child suffering from acute monocytic 
leukaemia. This pre-monocyte cell line possesses Fc and C3b receptors, as do 
monocytes [382]. THP-1 cells have a monocytic phenotype and can be differentiated 
into macrophage-like cells by various transforming factors such as phorbol esters and 
vitamin D3 [385]. In some cases, an alternative monocytic cell line, U937, was used 
alongside or in place of THP-1 cells. The U937 monoblastic cell line was originally 
established from a human patient with diffuse hystiocytic lymphoma and has been 
used extensively in studies of myeloid differentiation [383]. All cell types were 
employed in a range of in vitro assays covering many known immediate functional 
responses observed during inflammation. These include chemotaxis, motility, 
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polarisation, receptor expression, signal prioritisation, calcium signalling, protein 
phosphorylation, phagocytosis, adhesion molecule expression and viability. 
 
In summary, the aim of this chapter is to examine the effects of exogenous damage-
associated signals on human innate immune cells, particularly with regard to key 
cellular functions triggered during early inflammation, including chemotaxis, 
polarisation and cell activation. We aim to compare immediate functional responses of 
innate immune cells following exposure to damage cues against known 
chemoattractants, in order to dissect their comparative role in the inflammatory 
environment. This approach will distinguish whether there is conservation between 
human and model organism responses to tissue damage, and will potentially identify 
key therapeutic targets that could aid the management of clinical inflammatory events 
as well as chronic inflammatory disease.  
 
 
4.2 H2O2 does not act as a chemoattractant in the ChemoTx migration assay 
 
In vitro models of cell migration have been employed for many decades to reproducibly 
show migration across a membrane towards a source of chemoattractant. Here, the 
ChemoTx migration assay has been used to characterise chemotaxis of the monocytic 
cell line THP-1 and primary human neutrophils (Figure 4.1). In agreement with many 
historical reports, monocytes migrated towards MCP-1 and M-CSF1 with optimal 
chemotaxis occurring with 10nM and 0.1nM chemoattractant respectively (Figure 4.1a). 
Additionally, primary neutrophils migrated towards fMLP, IL-8, IFNγ and LTB4 with 
optimal concentrations of chemoattractant at 10nM, 10nM, 10ng/ml and 30nM 
respectively (Figure 4.1b). In all cases, chemotactic responses appeared to follow a 
bell-shaped response to increasing concentrations of chemoattractant.  
 
After validating the assay with known chemoattractants, H2O2 was tested to 
demonstrate if it was acting in a similar fashion. H2O2 was placed in the lower well of 
the chemotaxis plate and cells were plated on top of the filter. For both monocytes and 
neutrophils, migration across the filter membrane was inhibited when H2O2 was present 
in the chemoattractant compartment versus plain media (Figure 4.2). Whilst in 
monocytes this appears to be a concentration dependent effect, with significant 
inhibition at micromolar and milimolar concentrations of H2O2 (Figure 4.2a), in 
neutrophils the effect is sustained at approximately 50% basal migration across the 




4.3 Pre-incubation of cells with H2O2 inhibits monocyte and neutrophil 
chemotaxis in the ChemoTx migration assay 
 
Given the observation that exogenous H2O2 did not act as a chemoattractant alone in 
the ChemoTx migration assay, the next objective was to establish whether exogenous 
H2O2 had an effect upon chemoattractant-mediated migration. Cells were pre-exposed 
to increasing concentrations of H2O2 before being plated in the upper compartment and 
exposed to a chemoattractant in the bottom well of the ChemoTx assay.  
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Monocyte migration towards optimal concentrations of MCP-1 and M-CSF1 was 
inhibited following exposure to exogenous H2O2 (Figure 4.3a left panel). Significant 
inhibition was observed throughout the picomolar to milimolar concentration range of 
H2O2 tested. The degree of inhibition appeared to be stronger in cells migrating 
towards MCSF-1, where 10mM H2O2 led to almost no cells being detected in the lower 
chamber.  Similarly, neutrophil migration towards optimum concentrations of fMLP, IL-8 
and LTB4 was inhibited by approximately 50% following exposure to exogenous H2O2 
(Figure 4.3b left panel), although variation was higher in neutrophils compared to 
monocytes. The inhibition of neutrophil migration to all chemoattractants did not appear 
to occur in a concentration dependent manner.  
 
In both cell types basal migration was also inhibited by approximately 40-60% across 
the whole range of H2O2 concentrations tested compared to control cells, although this 
was not significant.  
 
Figure 4.3 (right panels) compares chemotactic indices as a percentage of the control 
cell response. From this analysis it is possible to compare the effect of H2O2 treatment 
on basal and chemoattractant-mediated migration in each experiment. In THP-1 
monocytes, basal migration was inhibited to a greater degree than MCP-1-mediated 
chemotaxis. However, M-CSF-1-mediated chemotaxis was inhibited more strongly by 
H2O2 than basal migrating cells, also in THP-1 monocytes. In neutrophils, the 
magnitude of inhibition of basal and chemoattractant-mediated migration was similar in 
















Figure 4.1: THP-1 monocytes and primary human neutrophils migrate towards a range of 
chemoattractants. (A) Chemotaxis of THP-1 monocytes towards increasing concentrations of 
MCP-1 and M-CSF1. (B) Chemotaxis of primary human neutrophils towards increasing 
concentrations of fMLP, IL-8, IFNγ and LTB4. Cells were washed in serum free media, 
resuspended to 3.2x106 cells/ml and plated on top of filter membrane above lower chambers 
containing chemoattractant or plain media. Chemotaxis across 5µm pore size membrane was 
determined after a 3 hour incubation at 37°C in 5% CO2 as previously described. Data 
presented represent means ± SEM from at least three separate experiments. Statistical 
analyses by one way-ANOVA versus untreated control with Dunnett’s multiple comparisons 
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Figure 4.2: H2O2 does not act as a chemoattractant in ChemoTx migration assay. 
Chemotaxis of (A) THP-1 monocytes or (B) primary human neutrophils towards increasing 
concentrations H2O2. Cells were washed in serum free media, resuspended to 3.2x106 cells/ml 
and plated on top of filter membrane above lower chambers containing H2O2 or plain media. 
Chemotaxis across 5µm pore size membrane was determined after a 3 hour incubation at 37°C 
in 5% CO2 as previously described. Data presented represent means ± SEM from at least three 
separate experiments. Statistical analyses by one way-ANOVA versus untreated control with 
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Figure 4.3: Exogenous H2O2 inhibits THP-1 monocyte and primary neutrophil chemotaxis. 
(A) Chemotaxis of THP-1 monocytes towards MCP-1 and M-CSF1 following pre-treatment with 
increasing concentrations of H2O2. (B) Chemotaxis of primary human neutrophils towards 10nM 
fMLP, IL-8 and LTB4 following pre-treatment with increasing concentrations of H2O2. Migration 
expressed as chemotactic index (left panels), and as a percentage of control cells (right panels). 
Cells were washed in serum free media, resuspended to 3.2x106 cells/ml and incubated with 
H2O2 for 30 minutes at 37°C before being plated on top of filter membrane above lower 
chambers containing attractant or plain media. Migration across 5µm pore size membrane was 
determined after a 3 hour incubation at 37°C in 5% CO2 as previously described. Data 
presented represents means (± SEM) from at least three separate experiments, with samples 
run in triplicate. Statistical analyses by two way-ANOVA versus untreated control with Dunnett’s 
multiple comparisons post hoc test. *=p<0.05, **=p<0.01, ***=p<0.001, ****=p<0.0001.  
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4.4 Inhibition of H2O2 production and signalling affects monocyte and neutrophil 
chemotaxis 
 
The use of pharmacological inhibitors offers alternative strategies for investigating the 
effects of H2O2 upon cell migration; in particular the cellular events involved in 
autocrine H2O2 control and signalling can be dissected. Here two approaches to target 
the action of H2O2 have been used: Diphenyleneiodonium (DPI), a potent NADPH 
oxidase inhibitor, to block H2O2 generation; and catalase, an enzyme that rapidly 
catalyses the decomposition of H2O2 to water and oxygen. O’Donnell et al (1993) 
demonstrated that the inhibition constant (Ki) for time-dependent inhibition by DPI of 
human neutrophil membrane NADPH oxidase was 5.6µM [407], in light of this we have 
tested DPI in the concentration range of 1-100µM. Similarly, catalase has activity at 
2000-5000 units/mg [Sigma Aldrich product information – enzymatic assay of catalase 
EC 1.11.1.6] therefore we have tested catalase in a concentration range of 0.1-1 
mg/ml.  
 
In the ChemoTx migration assay, cells were pre-treated with increasing concentrations 
of DPI or catalase before being exposed to optimal concentrations of chemoattractant. 
THP-1 monocyte chemotaxis to MCP-1 was significantly inhibited to approximately 30-
40% of the untreated control with DPI treatment (Figure 4.4a). Basal monocyte 
migration was also inhibited to 20-30% of the untreated control by DPI pre-treatment. 
Similarly, treatment with increasing concentrations of catalase significantly inhibited 
MCP-1-mediated monocyte migration. Basal migration was also inhibited to 20-40% of 
the untreated control, although this was not significant. Inhibition with catalase 
appeared to be concentration dependent in both cases.  
 
Primary neutrophil migration to IL-8 was inhibited to approximately 20% of the 
untreated control following treatment with increasing concentrations of DPI (Figure 
4.4b). Basal migration was also inhibited in a more variable albeit seemingly 
concentration dependent manner. Pre-treatment of neutrophils with catalase increased 
both basal and IL-8 mediated migration in a concentration dependent manner. 1mg/ml 
catalase increased neutrophil migration to IL-8 by approximately 2-fold. 
 
 




Figure 4.4: DPI inhibits THP-1 monocyte and primary neutrophil chemotaxis while 
catalase inhibits THP-1 monocytes but increases primary neutrophil chemotaxis. (A) 
Chemotaxis of THP-1 monocytes towards 10nM MCP-1 following pre-treatment with increasing 
concentrations of DPI or catalase. (B) Chemotaxis of primary human neutrophils towards 10nM 
IL-8 following pre-treatment with increasing concentrations of DPI or catalase. Migration 
expressed as chemotactic index (left panels), and as a percentage of control cells (right panels). 
Cells were washed in serum free media, resuspended to 3.2x106 cells/ml and incubated with 
DPI or catalase for 30 minutes at 37°C before being plated on top of filter membrane above 
lower chambers containing chemoattractant or plain media. Migration across 5µm pore size 
membrane was determined after a 3 hour incubation at 37°C in 5% CO2 as previously 
described. Data presented represents means (± SEM) from at least three separate experiments, 
with samples run in triplicate. Statistical analyses by two way-ANOVA versus untreated control 
with Dunnett’s multiple comparisons post hoc test. *=p<0.05, **=p<0.01, ***=p<0.001.  
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4.5 Neutrophils migrate under agarose towards IL-8, fMLP and H2O2 
 
The under agarose cell migration assay offers an alternative in vitro method for 
quantitative analysis of cell migration. The assay can be used for studying cell 
chemotaxis, as well as measuring cellular responses to multiple chemotactic gradients. 
The under agarose assay has been used to show that an intracellular signalling 
hierarchy determines chemotaxis in opposing gradients using known chemoattractants 
[189].  
 
Firstly, to examine the nature of neutrophil chemotaxis in the under agarose migration 
assay, primary human neutrophils were exposed to increasing concentrations of known 
intermediary or end-target chemoattractants, IL-8 (Figure 4.5a(i)) or fMLP (Figure 
4.5a(ii)), with plain buffer used as a control in the opposite well to measure basal 
migration. For both chemoattractants, neutrophils migrated in a concentration 
dependent manner towards the source of the chemoattractant, with 100nM IL-8 and 
10nM fMLP stimulating strong migration. Despite high variation of migration between 
human donors, the number of cells that migrated towards optimal concentrations of IL-
8 and fMLP was approximately 200-300 cells. 
 
This assay has previously been employed to show the migration of human neutrophils 
towards 10µM H2O2 [282]. Here it was used to examine whether this result was 
reproducible and whether chemotaxis induced by H2O2 was comparable to that induced 
by known chemoattractants. 10µM H2O2 induced a chemotactic response that was on 
average 2.3 times greater than to HBSS control alone. In the same experiment, 10nM 
IL-8 and 10nM fMLP stimulated a chemotactic response that was 5.7 and 5.1 times 
greater, respectively, than to HBSS buffer control alone (Figure 4.5b).  
 
In order to model a more physiologically relevant scenario, the next objective was to 
explore the effect of multiple chemoattractant signals on a single neutrophil population 
and determine whether the cells were showing a preference to one signal over another. 
When exposed to opposing gradients of 10nM IL-8 and 10nM fMLP, cells preferentially 
migrated towards fMLP (Figure 4.5c). The migratory response to fMLP was 
approximately 1.3 times greater than to IL-8. When exposed to opposing gradients of 
10nM IL-8 and 10µM H2O2, cells preferentially migrated towards IL-8, with 3.6 times 
greater migration over H2O2. Finally, when exposed to opposing gradients of 10nM 
fMLP and 10µM H2O2, cells preferentially migrated towards fMLP; migration towards 
fMLP was 9 times greater than towards H2O2. Interestingly, migration to fMLP was 
greatly reduced when the cells were co-exposed to H2O2 compared to when the cells 
were co-exposed to IL-8.  
 





Figure 4.5: Primary human neutrophils migrate under agarose towards IL-8, fMLP and 
H2O2. Neutrophils were isolated from human blood, resuspended in Ca2+-free HBSS at 1x106 
cells/ml and rested for 1 hour. 1x104 cells were placed in central wells and 10µl chemoattractant 
in outer wells of agarose plate prepared as described in Chapter 2. Cells were allowed to 
migrate for 2 hours at 37°C. Following incubation gels were photographed and the number of 
cells that had migrated towards the chemoattractant containing well was counted in a defined 
area. (A) Neutrophil migration towards increasing concentrations of (i) IL-8 or (ii) fMLP or HBSS 
control. (B) Neutrophil migration towards sub maximal concentrations of IL-8 (10nM) or fMLP 
(10nM) and 10µM H2O2. (C) Cells plated between pairs of chemoattractants in different 
combinations for prioritisation experiment between IL-8, fMLP and H2O2. Data represents 
means (±SEM) from at least three separate experiments, samples run in triplicate. Statistical 
analyses by one way-ANOVA versus PBS control with Dunnett’s multiple comparisons post hoc 
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4.6 Neutrophil chemotaxis under agarose is not affected by exogenous H2O2 
 
Using the ChemoTx migration assay, we demonstrated that exogenous H2O2 inhibited 
monocyte and neutrophil migration towards a range of chemoattractants. To 
investigate whether this observation was reproducible in the under agarose migration 
assay, neutrophils were pre-treated with increasing concentrations of H2O2 before 
being exposed to 10nM IL-8 or 10nM fMLP, with HBSS buffer control in the opposite 
well for the study of basal migration. Neutrophil migration towards IL-8 or fMLP was not 
affected when neutrophils were pre-treated with H2O2 (Figure 4.6a).  
 
The effect of H2O2 on chemoattractant preference was also studied using the under 
agarose migration assay. As before, neutrophils were pre-treated with increasing 
concentrations of H2O2 before being exposed to opposing gradients of 10nM IL-8 and 
10nM fMLP simultaneously. Neutrophils preferentially migrated towards fMLP. Pre-
treatment with H2O2 did not significantly compromise overall neutrophil migration, nor 
did it affect the cell’s preference to migrate to fMLP over IL-8 (Figure 4.6b).  
 
Having examined the effect of exogenous H2O2 directly on neutrophils in the under 
agarose assay, we next investigated whether H2O2 could influence migration if placed 
in the chemoattractant containing well, together with chemoattractant. Neutrophil 
migration towards 10nM IL-8 was not affected when cells were pre-treated with 10µM 
H2O2 or when H2O2 was added to the chemoattractant containing well together with IL-8 
(Figure 4.7a(i)). Similarly, migration towards 10nM fMLP was not affected if H2O2 was in 
the cell or chemoattractant compartment (Figure 4.7a(ii)). Finally, when neutrophils 
were exposed to both fMLP and IL-8 simultaneously, neither overall migration nor 
preference for fMLP was compromised when H2O2 was placed in the cell or 



















Figure 4.6: Neutrophil chemotaxis under agarose towards IL-8 or fMLP is not affected by 
exogenous H2O2. Neutrophils were isolated from human blood, resuspended in Ca2+-free 
HBSS at 1x106 cells/ml and rested for 1 hour at 37°C. Cells were treated with increasing 
concentrations of H2O2 for 30 minutes. 1x104 cells were placed in central wells and 10µl 
chemoattractant in outer wells of agarose plate prepared as described in Chapter 2. Cells were 
allowed to migrate for 2 hours at 37°C. Following incubation gels were photographed and the 
number of cells that had migrated towards chemoattractant containing well was counted in a 
defined area. (A) Neutrophil migration towards (i) 10nM IL-8 or (ii) 10nM fMLP or HBSS control 
following pre-treatment with H2O2 or PBS. (B) (i) Prioritisation experiment between 10nM IL-8 
and 10nM fMLP following pre-treatment with increasing concentrations of H2O2, (ii) Table 
showing ratios of IL-8 and fMLP migration responses in prioritisation experiments following pre-
treatment with H2O2. Data represents means (±SEM) from at least three separate experiments, 
samples run in triplicate. Statistical analyses by one way-ANOVA versus PBS control with 
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Figure 4.7: Neutrophil chemotaxis under agarose towards IL-8 or fMLP is not affected by 
exogenous H2O2 in either the cell or chemoattractant compartment. Neutrophils were 
isolated from human blood, resuspended in Ca2+-free HBSS at 1x106 cells/ml and rested for 1 
hour at 37°C. Cells were treated with 10µM H2O2 or PBS for 30 minutes. 1x104 cells were 
placed in central wells and 10µl chemoattractant in outer wells of agarose plate prepared as 
described in Chapter 2. Chemoattractant alone, or chemoattractant with 10µM H2O2 was added 
to outer wells. Cells were allowed to migrate for 2 hours at 37°C. Following incubation gels were 
photographed and the number of cells that had migrated towards chemoattractant containing 
well was counted in a defined area. (A) Neutrophil migration towards (i) 10nM IL-8 or IL-8 with 
10µM H2O2 or (ii) 10nM fMLP or fMLP with 10µM H2O2 or HBSS control following pre-treatment 
with 10µM H2O2 or PBS control. (B) Prioritisation experiment between 10nM IL-8 and 10nM 
fMLP, or IL-8 with 10µM H2O2 and fMLP with 10µM H2O2, or to IL-8 and fMLP following pre-
treatment with 10µM H2O2. Data represents means (±SEM) from at least three separate 
experiments, samples run in triplicate. Statistical analyses by one way-ANOVA versus PBS 
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4.7 H2O2 does not affect neutrophil chemokinetic velocity  
 
Our in vitro migration assays have suggested that H2O2 is not inducing a chemotactic 
phenotype in monocytes or neutrophils. To further explore the early migratory 
responses that occur upon cell stimulation, neutrophil migration on fibronectin coated 
chambered coverglasses was imaged over 30 minutes using time-lapse confocal 
microscopy. Migratory responses to different stimulants were recorded and analysed. 
Individual cell paths were tracked using ImageJ software that also calculates individual 
cell velocity.  
 
Under basal conditions, neutrophils followed random paths of migration with an 
average velocity of 36.31µm/min (Figure 4.8). During imaging, cells generally remained 
round although faster moving cells showed a slightly more elongated form. Cell 
tracking paths indicate heterogenic motility, with some cells moving across the field of 
view, while others remain in place throughout imaging.  
 
Stimulation of neutrophils with 10nM IL-8 immediately initiated a change in cell 
morphology from round and regular at resting to a much more elongated and irregular 
shape following stimulation. Cells appeared polarised, with a leading face in the 
direction of migration (Figure 4.8a). Cells were highly motile, with an average velocity 
of 82.63µm/min, significantly greater than PBS control treated cells (Figure 4.8b). 
Individual tracking paths indicate how neutrophils also explored a far greater area of 
the field of view than PBS control treated cells. However, imaging also revealed that 
approximately 20 minutes after the initial stimulation, the cells appear to return to a 
more regular rounded shape. Observations with fMLP mirror the responses to IL-8, 
with similarities in cell elongation and polarisation, exploratory behaviour and 
significantly increased velocity (89.91µm/min) versus PBS control (Figure 4.8). 
Neutrophils stimulated with fMLP remain elongated and irregularly shaped 30 minutes 
after the initial stimulation. 
 
Upon stimulation with 10µM H2O2, neutrophils did not alter their morphology from the 
regular, round form pre-stimulation. The cells did not adopt a polarised morphology nor 
did they exhibit a clear leading edge. H2O2 stimulated neutrophils showed a reduced 
exploratory phenotype, although a few cells did migrate some distance while others 
remained in place throughout imaging. H2O2 stimulated neutrophils had an average 
velocity of 31.91µm/min, which is slower, but not significantly so, compared to PBS 
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Figure 4.8: Neutrophil motility is increased by stimulation with IL-8 and fMLP but not with H2O2. Primary neutrophils were isolated from human blood, 
washed and rested. Cells were plated onto chambered coverglasses coated in 10µg/ml fibronectin and allowed to adhere for 20 minutes at 37°C. Cells were 
imaged using 40x oil objective on confocal microscope. (A) Images were acquired by time-lapse microscopy using the brightfield channel. Cells were stimulated 
with 10nM IL-8, 10nM fMLP, 10µM H2O2 or PBS and imaged for 30 minutes. Cell tracking was performed using ImageJ ‘Manual tracking’ plugin. Data shows 
representative images at time points (0 – 30 minutes) post stimulation, plus representative tracking showing individual cell paths. (B) Quantification of individual 
cell velocity per treatment group. Data represents means (±SEM) pooled from at least 3 separate experiments. Statistical analysis by one way-ANOVA with 
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4.8 Cell viability is not compromised by sub-milimolar exogenous H2O2, catalase 
or DPI 
 
It has been reported that H2O2 at high concentrations can be cytotoxic to cells [295]. It 
was therefore prudent to establish if the concentrations of H2O2 and its modulators 
selected for these studies were exhibiting such an effect on the cells.  Monocytic cell 
lines and primary human neutrophils were exposed to increasing concentrations of 
exogenous H2O2 for up to 4 hours and cell viability was analysed using the MTT assay. 
Metabolically active, viable cells are able to convert MTT to formazan, giving a colour 
change detectable by a plate reader. 
 
No significant change in enzymatic activity following up to 4 hours H2O2 stimulation was 
observed in THP-1 cells (Figure 4.9a). Enzymatic activity of the U937 monocytic cell 
line was unaffected by H2O2 up to 10µM. However, U937 cell viability was significantly 
decreased by 10mM H2O2 after 3 or 4 hours exposure compared to PBS treated control 
cells (Figure 4.9b). The viability of primary human neutrophils was also generally 
unaffected by increasing concentrations of H2O2, except 10mM H2O2 which significantly 
impaired neutrophil viability after 3 or 4 hours exposure, compared to PBS treated 
control cells (Figure 4.9c). Cell viability was also analysed in the presence of DPI and 
catalase. Primary human neutrophils were exposed to increasing concentrations of 
catalase or DPI for up to 4 hours before being used in the MTT assay. No change in 
cell viability was observed for all of the concentrations of either DPI or catalase tested 




























Figure 4.9: Monocyte and neutrophil viability is unaffected by sub-milimolar 
concentrations of H2O2. (A) THP-1 monocytes (B) U937 monocytes and (C) primary human 
neutrophils were exposed to increasing concentrations of H2O2 or PBS for up to 4 hours. 
Following culture, cells were assessed for viability using the MTT assay. Data presented 
represent means (± SEM) minus plate background and normalized to untreated control from at 
least three independent experiments measured in triplicate, n=3. Statistical analysis by two 
way-ANOVA with Tukey’s multiple comparisons post hoc test where *=p<0.05, **=p<0.01, 
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Figure 4.10: Neutrophil viability is unaffected following exposure to catalase or DPI. 
Primary human neutrophils were exposed to increasing concentrations of (A) catalase or (B) 
DPI or PBS vehicle control for up to 4 hours. Following culture, cells were assessed for viability 
using MTT assay. Data presented represent means (± SEM) minus plate background and 
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4.9 H2O2 does not induce changes in monocyte actin organisation 
 
Clear changes in cell morphology and motility in response to chemoattractant have so 
far been demonstrated, however little effect in response to H2O2 has been observed. 
To further investigate the effect of exogenous H2O2, DPI and catalase on cell 
morphology, THP-1 monocytes were seeded onto fibronectin-coated coverslips. 
Following treatment, cells were fixed and stained to visualise cellular F-actin by 
confocal microscopy. Quantitative analysis was carried out using CellProfiler software 
that calculates the degree of roundness of each individual cell, to give a circularity 
score that indicates the extent of cell polarisation, where 1 is a perfect circle. This 
analysis technique also measures the cell surface area. 
 
THP-1 monocytes were treated with increasing concentrations of exogenous H2O2 for 
30 minutes, followed by a 5 minute stimulation with 10nM MCP-1 or PBS. Visualisation 
of cellular actin revealed that MCP-1 initiates a change in monocyte shape to a more 
elongated morphology and the cells appear ‘polarised’ compared to basal cells (Figure 
4.11a). H2O2 alone does not induce a similar phenotype to MCP-1 – cells appear more 
rounded and mirror the morphology of basal cells. Quantitative analysis indicated that 5 
minute MCP-1 stimulation induced significant elongation compared to basal cells 
(mean circularity: 0.643 versus 0.836), but did not significantly increase cell spreading 
(Figure 4.11b). The mean circularity scores of cells treated with all concentrations of 
exogenous H2O2 did not differ from untreated cells, and were significantly higher than 
MCP-1-stimulated cells. H2O2 treatment significantly attenuated MCP-1-induced 
elongation with all tested concentrations. Furthermore, 10mM H2O2 alone, and 10nM 
H2O2 in combination with MCP-1 stimulation, induced a significant decrease in cell 
surface area compared to both basal and MCP-1-stimulated cells.  
 
As an alternative approach to studying the action of H2O2, this assay was repeated 
using inhibitors of H2O2 production and signalling. THP-1 monocytes were treated with 
1mg/ml catalase or 10µM DPI for 30 minutes before being stimulated with MCP-1 or 
PBS for 5 minutes, and fixed and stained to visualise F-actin.  
 
Catalase treated monocytes had an elongated, polarised morphology with long, 
extended protrusions compared to untreated cells (Figure 4.12a), reminiscent of those 
observed after treatment with MCP-1. Quantitative analysis revealed that catalase 
alone significantly decreased circularity (mean circularity: 0.703 versus 0.924) and 
increased surface area (mean area: 249.9µm2 versus 143.1µm2). Catalase treatment 
did not significantly alter MCP-1-mediated elongation, although MCP-1-mediated 
increase in cell surface area was significantly decreased (mean area: 356.0µm2 versus 
298.0µm2). Monocytes treated with DPI alone were significantly more elongated than 
control cells (mean circularity: 0.796 versus 0.924), although this was to a lesser extent 
than MCP-1 alone (Figure 4.12a+c). DPI alone had no effect on cell area compared to 
basal cells. DPI treatment significantly attenuated MCP-1-mediated elongations (mean 
circularity: 0.834 versus 0.7034), and significantly reduced the MCP-1-mediated 
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Figure 4.11: H2O2 does not induce changes in THP-1 monocyte actin organisation. THP-1 
monocytes were washed in serum free media, rested and plated on coverslips coated with 
10µg/ml fibronectin and allowed to adhere for 30 minutes. Cells were treated with increasing 
concentrations of H2O2 for 30 minutes, followed by either 10nM MCP-1 or PBS for 5 minutes. 
Following incubation, cells were fixed in 4% PFA, permeabilised with 0.1% Triton-X and stained 
with Alexa-Fluor 488 dye (for actin) and DAPI (for nuclei). Samples were imaged using confocal 
microscopy with 40x oil objective. (A) Representative images showing actin staining, scale bar = 
20µm. (B) Circularity score (left) and area (right) were calculated using CellProfiler software, 
with at least 100 individual cells analysed per sample, from at least 4 pooled experiments. Data 
presented represents mean (± SEM) with statistical analysis by one way-ANOVA with Tukey’s 
multiple comparisons post hoc test where ****=p<0.0001 versus basal control and 
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Figure 4.12: Catalase and DPI induce actin reorganisation in THP-1 monocytes. THP-1 
monocytes were washed, rested and plated on coverslips coated with 10µg/ml fibronectin and 
allowed to adhere for 30 minutes. Cells were treated with either 1mg/ml catalase or 10µM DPI 
for 30 minutes, followed by either 10nM MCP-1 or PBS for 5 minutes. Following incubation, 
cells were fixed in 4% PFA, permeabilised with 0.1% Triton-X and stained with Alexa-Fluor 488 
(for actin) and DAPI (for nuclei). Samples were imaged using confocal microscopy with 40x oil 
objective. (A) Representative images showing actin staining, scale bar = 20µm. (B) Circularity 
score (i) and area (ii) for catalase treated cells and (C) Circularity score (i) and area (ii) for DPI 
treated cells were calculated using CellProfiler software, with at least 100 individual cells 
analysed per sample, from at least 4 pooled experiments. Data presented represents mean (± 
SEM) with statistical analysis by one way-ANOVA with Tukey’s multiple comparisons post hoc 
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4.10 H2O2 does not affect monocyte receptor expression 
 
Our observations so far have suggested that H2O2 is negatively affecting chemotaxis 
and polarisation. These processes are driven by signal detection via receptors 
expressed on the cell surface. With this in mind, the next approach was to investigate 
whether H2O2 could affect monocyte chemokine receptor CCR2 expression, the ligand 
for which is MCP-1.  
 
THP-1 monocytes were treated with increasing concentrations of H2O2 for 5 or 30 
minutes before being incubated with anti-CCR2 antibody conjugated to fluorophore. 
CCR2 expression was analysed by flow cytometry. Across all concentrations and times 
tested, H2O2 did not significantly affect monocyte CCR2 expression (Figure 4.13a). To 
extend the investigation, monocytes were treated with increasing concentrations of 
H2O2 inhibitors DPI and catalase before CCR2 expression was analysed. Only 30µM 
DPI significantly inhibited CCR2 expression, while catalase had no significant effect 
(Figure 4.13b). This suggests that the inhibitory effects of H2O2, DPI and catalase on 
monocyte migration are not mediated by altered CCR2 surface expression. 
 
It has been previously reported that MCP-1 stimulation initiates a down regulation of 
CCR2 expression [408]. However, when monocytes were treated with 10nM MCP-1 for 










Figure 4.13: THP-1 monocyte CCR2 surface expression is not affected by H2O2. THP-1 
monocytes were washed twice in serum free media, rested and treated with (A) increasing 
concentrations of H2O2 for 5 or 30 minutes, (B) increasing concentrations of DPI or catalase for 
30 minutes, or (C) 10nM MCP-1 for 1, 5 or 10 minutes. Cells were washed twice in ice cold 
PBS, incubated with Alexa-Fluor 488-conjugated CCR2 antibody or IgG control antibody at 
room temperature for 30 minutes and washed again in ice cold PBS. Mean fluorescence 
intensity per 10,000 cells was measured using flow cytometry after gating on live viable 
population via side and forward scatter. Data presented represents means (± SEM) minus IgG 
control signal, normalised to untreated control from three separate experiments, with samples 
run in duplicate. Statistical analysis by one way-ANOVA with Dunnett’s post hoc test where 
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4.11 Characterisation of THP-1 derived macrophages and primary human 
neutrophils 
 
Macrophages are considered the ‘big eaters’ in innate immunology and their ability to 
engulf debris and microbes is a fundamental process within inflammation. With this in 
mind, it was important to use macrophages when studying phagocytosis in vitro. THP-1 
monocyte differentiation has been previously described by Daigneault and colleagues 
[385]. Briefly, THP-1 monocytes were treated with 80nM PMA for 48 hours in normal 
culture conditions (i.e. complete RPMI 1640 media). During PMA treatment cells 
become adherent to the culture flask. Cells are then ‘rested’ in complete media (minus 
PMA) for 3-5 days. During the rest period cells become more macrophage-like and 
present a mature phenotype with a larger surface area and visible cytoplasmic 
granules.  
 
Figure 4.14a illustrates analysis of monocyte differentiation during the differentiation 
period. Light phase photographs show rounded monocytes in suspension pre-
treatment (Figure 4.14a(i)). Following 48 hours PMA (PMA48) cells are adhesive and 
flattened on the tissue culture flask surface. Following 5 days rest (PMAr), macrophage 
like cells appear larger, more irregularly shaped and visible granules can be identified 
within the cell body.  
 
Generation of intracellular granules is a key physical attribute of macrophages. To 
examine this more closely, cells were analysed using flow cytometry. In a given viable 
cell population, forward scatter can be used to measure the cell size, while side scatter 
measures the cell granularity. Figure 4.14a(ii) shows an increase in side scatter in 
PMA48 treated cells, which further increases following the 5 day rest period, indicating 
increased granularity.  
 
Another marker of monocyte differentiation is CD14 expression. CD14 is lost upon 
monocyte differentiation into macrophages [385]. Using flow cytometry to quantify 
CD14 expression, PMA48 and PMAr cells have significantly lower CD14 expression 
than untreated THP-1 monocytes (Figure 4.14a(iii)). 
 
Together these results confirm that the differentiation protocol generates a clear 
population of macrophages with increased surface area, granularity, and decreased 
CD14 expression.  
 
In addition to characterising monocyte differentiation, imaging techniques were used to 
demonstrate that the neutrophil isolation protocol was yielding a neutrophil population. 
Wright-Giemsa staining highlights the distinctive lobed neutrophilic nucleus, 
recognisably unique compared to other leukocytes within the blood smear (Figure 
4.14b). This observation is further supported by nuclear staining using DAPI and 
visualisation using confocal microscopy (Figure 4.14b).  
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Figure 4.14: Characterisation and identification of PMA-differentiated macrophages and 
primary human neutrophils. (A) THP-1 monocytes were treated with 80nM PMA for 48 hours 
in culture to induce differentiation into macrophages, scale bar = 10µm. Following treatment, 
cells were cultured for a further 5 days in PMA-free media (known as rest period). PMA48 
denotes cells following 48 hours PMA, prior to rest; PMAr denotes cells that were rested for 5 
days following PMA treatment. (i) Photographs showing changes in cell morphology during 
differentiation period. (ii) Flow cytometry analysis showing forward and side scatter of cells 
during differentiation. (iii) CD14 expression during differentiation quantified by flow cytometry. 
(B) Isolation of primary human neutrophils, scale bar = 10µm. (i) Wright-Giemsa staining of 
whole human blood before neutrophil isolation, (N, neutrophil; M, monocyte; L, Lymphocyte), (i) 
Wright-Giemsa staining after isolation of neutrophils and before red cell lysis, arrowheads 
indicate neutrophil, (iii) Lobed neutrophil nuclei as indicated by DAPI staining (blue). Statistical 
analysis by one way-ANOVA with Dunnett’s post test, ***=p<0.001. 
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4.12 Phagocytosis of latex beads and bacteria is inhibited by H2O2 
 
Clearance of foreign pathogens and dying cells by phagocytes makes a critical 
contribution to the innate immune response. Similar to previous aspects of innate cell 
function so far investigated in this thesis, phagocytosis relies on rearrangement of 
structural components including the actin cytoskeleton. Given the observation that both 
migration and polarisation are inhibited by H2O2, we next examined the effects of 
exogenous H2O2 on phagocytosis.  
 
In vitro studies of phagocytosis have previously been carried out using a variety of 
experimental particles as targets for engulfment. Here IgG-opsonised latex beads and 
E. coli bacterial cells were to be engulfed by phagocytes. Firstly, primary human 
neutrophils were treated with chemoattractants, increasing concentrations of H2O2, or 
H2O2 inhibitors catalase and DPI for 30 minutes before being co-incubated with either 
fluorescent IgG-conjugated latex beads or fluorescently labelled bacteria to allow 
phagocytosis to occur.  
 
Neutrophils seeded onto fibronectin-coated coverslips were stimulated with 
chemoattractant or H2O2, co-incubated with fluorescent latex beads, washed and fixed. 
Cells were stained to visualise cytoplasm and nuclei. Confocal microscopy was used to 
visualise the location of beads that were associated with cells. Figure 4.15a provides 
representative images of a single neutrophil containing a latex bead. Orthogonal 
projections of stacked image slices indicate that the bead is inside the cell as red 
fluorescence can be seen throughout the cell body. Neutrophil phagocytosis was 
inhibited by pre-treatment with increasing concentrations of H2O2 (Figure 4.15b). The 
number of cells that contained at least one bead (percent phagocytosis) was 
significantly inhibited with all H2O2 concentrations and incubation time points tested. To 
give an indication of the rate of phagocytosis, the number of phagocytosed latex beads 
per cell was also measured. Treatment with 10µM H2O2 for 5 minutes resulted in a 
significantly reduced number of latex beads per cell.  
 
Furthermore, both percent phagocytosis and the number of beads phagocytosed per 
cell were not affected by pre-treatment with 10nM IL-8 (Figure 4.15c).  
 
As an alternative approach for quantitatively assessing phagocytosis, flow cytometry 
was used to analyse the fluorescent signal associated with the viable cell population 
after phagocytosis had occurred. Neutrophil phagocytosis of latex beads was not 
affected by pre-treatment with either 10nM IL-8 or 10nM fMLP (Figure 4.16a). Pre-
treatment with increasing concentrations of H2O2 inhibited phagocytosis of beads in a 
concentration dependent manner, with 10mM H2O2 significantly inhibiting phagocytosis 
versus control-treated cells. Neutrophils pre-treated with 10µM DPI showed significant 
reduction in phagocytosis of latex beads versus control cells. No difference in 
phagocytosis of latex beads was seen when neutrophils were pre-treated with 1mg/ml 
catalase (Figure 4.16a). 
 
Neutrophil phagocytosis of bacterial cells was not affected by pre-treatment with 10nM 
IL-8, however significant inhibition was observed when cells were pre-treated with 
10nM fMLP versus control cells (Figure 4.16b). Pre-treatment with increasing 
concentrations of H2O2 inhibited phagocytosis of bacteria in a concentration dependent 
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manner, with 10mM H2O2 significantly inhibiting phagocytosis versus control-treated 
cells. Phagocytosis of bacterial cells was not affected when neutrophils were pre-
treated with either 10µM DPI or 1mg/ml catalase (Figure 4.16b).  
 
Macrophages are highly phagocytic leukocytes so PMA-differentiated THP-1 
monocytes were employed to study macrophage phagocytosis of IgG-conjugated latex 
beads. Macrophages were pre-treated with either H2O2 or MCP-1 before being co-
incubated with fluorescent beads to allow phagocytosis to occur.  Using flow cytometry 
to measure latex beads fluorescence associated with viable macrophages, we found 
that H2O2 inhibited bead uptake in a concentration dependent manner (Figure 4.17a). 
Significant inhibition was observed with 10µM and 10mM H2O2.  
 
In addition to flow cytometry analysis, macrophage phagocytosis of latex beads was 
also assessed using confocal microscopy and manual counting of the number of cells 
associated with latex beads. In agreement with flow cytometry results, H2O2 
concentration dependently inhibited macrophage phagocytosis of latex beads (Figure 
4.17b). The number of macrophages imaged in the field of view that contained at least 
one bead (percent phagocytosis) was significantly inhibited with all H2O2 concentrations 
tested after 30 minutes pre-treatment versus control cells. Additionally, the number of 
phagocytosed beads per cell was slightly less than untreated controls, although this 
was not statistically significant.  
 
These results show that macrophage and neutrophil phagocytosis of beads and 
bacteria is inhibited by pre-treatment with H2O2.  






Figure 4.15: Neutrophil phagocytosis of latex beads is inhibited by H2O2. Peripheral 
human neutrophils were isolated from human blood, loaded with 10µM CFSE, rested and plated 
on fibronectin (10ng/ml) coated coverglass chambers. (A) Representative images indicating 
intracellular location of latex bead (red), confirmed by orthogonal projection images. Cells were 
incubated with (B) increasing concentrations of H2O2 for 5 or 30 minutes or (C) 10nM IL-8 for 30 
minutes at 37°C. Cells were washed in warm HBSS and mixed with IgG-opsonised fluorescent 
latex beads. Cells were incubated at 37°C for 30 minutes to allow phagocytosis to occur. Cells 
were fixed in 4% PFA before being stained with DAPI. Samples were immediately imaged using 
confocal microscopy with 40x oil objective. Images were manually scored for neutrophils 
containing beads, confirmed by orthogonal projection imaging. Percent phagocytosis is 
percentage of total cells imaged containing at least one bead. Data presented represents 
means (± SEM) from at least three separate experiments. Scale bar = 20µm. Statistical 
analyses (A) by two way-ANOVA versus control with Tukey’s multiple comparisons post hoc 









































































































Figure 4.16: Neutrophil phagocytosis of latex beads and bacteria is inhibited by H2O2. 
Peripheral human neutrophils were isolated from human blood, rested and incubated with 
100nM IL-8, 10nM fMLP, 10µM DPI, 1mg/ml catalase, or increasing concentrations of H2O2 for 
30 minutes at 37°C. Cells were washed in warm HBSS and mixed with (A) IgG-opsonised 
fluorescent latex beads or (B) CFSE (10µM) loaded E. coli bacteria. Cells were incubated at 
37°C for 30 minutes to allow phagocytosis to occur. Cells were washed 3 times in PBS before 
fluorescence intensity in viable neutrophil population was measured using flow cytometry. Data 
represents mean (±SEM) fluorescent signal per 10,000 cells normalised to basal or untreated 
fluorescence, from at least three separate experiments. Statistical analyses by one way-ANOVA 
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Figure 4.17: Macrophage phagocytosis of latex beads and bacteria is inhibited by H2O2. 
PMA differentiated THP-1 monocytes were incubated with increasing concentrations of H2O2 or 
10nM MCP-1 for 30 minutes at 37°C. (A) Cells were washed in warm PBS and mixed with 
CFSE (10µM) loaded E. coli bacteria. Cells were incubated at 37°C for 30 minutes to allow 
phagocytosis to occur. Cells were washed 3 times in PBS before fluorescence intensity in viable 
neutrophil population was measured using flow cytometry. Data represents mean (±SEM) 
fluorescent signal per 10,000 cells normalised to basal or untreated fluorescence, from at least 
three separate experiments. Statistical analyses by one way-ANOVA versus control with 
Dunnett’s multiple comparisons post hoc test. **=p<0.01, ***=p<0.001. (B) Cells were washed in 
warm HBSS and mixed with IgG-opsonised fluorescent latex beads. Cells were incubated at 
37°C for 30 minutes to allow phagocytosis to occur. Cells were fixed in 4% PFA before being 
stained with DAPI. Samples were immediately imaged using confocal microscopy with 40x oil 
objective. Images were manually scored for neutrophils containing beads, confirmed by 
orthogonal projection imaging. Percent phagocytosis is percentage of total cells imaged 
containing at least one bead. Data presented represents means ± SEM from at least three 
separate experiments. Statistical analyses (A) by two way-ANOVA versus control with Tukey’s 
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A Macrophage phagocytosis of bacteria (flow cytometry) 
B Macrophage phagocytosis of latex beads (microscopy) 
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4.13 Monocyte and neutrophil stimulation induces transient elevation of 
intracellular calcium  
 
Our results demonstrate that H2O2 inhibits monocyte and neutrophil motility. It was 
therefore prudent to investigate whether H2O2 was targeting the intracellular signalling 
pathways that drive motility. Elevation of intracellular Ca2+ concentration triggered by 
ligand stimulation is a well-characterised observation in leukocytes and provides an 
assessment of signalling potential. As a quantitative measurement of intracellular Ca2+, 
Fluo-4 was loaded into cells prior to stimulation. Fluo-4 produces a fluorescent signal 
upon detection of Ca2+ that can be measured over time using a plate reader.  
 
Exposure of cells to increasing concentrations of ligands induced a concentration 
dependent transient elevation of intracellular calcium ([Ca2+]i) (Figures 4.18+4.19). The 
responses observed with all ligands were immediate and short lived, typically returning 
to baseline within 5 minutes. In the THP-1 monocytic cell line, 1-100nM MCP-1 or LTB4 
elevated [Ca2+]i in a concentration dependent manner (Figure 4.18a). A second 
monocytic cell line, U937, displayed a similar response to LTB4 (Figure 4.18b). For 
both cell types, stimulation of purinergic receptors with ATP was used as a positive 
control and indeed prompted a significant increase in detectable [Ca2+]i.  
 
Ligand-stimulated Ca2+ mobilisation was also examined in primary human neutrophils 
with increasing concentrations of chemoattractants IL-8, fMLP and LTB4. All ligands 
stimulated transient, concentration dependent elevations of [Ca2+]i that were 
significantly higher than baseline (Figure 4.19). As a positive control, 1mM ATP elicited 
a significantly detectable elevation of [Ca2+]i. Furthermore, neutrophils were stimulated 
with 1µM ionomycin after the chemoattractant-induced response had plateaued. 
Ionomycin is an ionophore and acts as a mobile ion carrier to transport Ca2+ across the 
plasma membrane. Here it was used as a positive control to indicate maximal potential 
[Ca2+]i influx.  
 
To investigate the potential source of Ca2+ responsible for the responses observed, 
monocytic cell lines and primary human neutrophils were stimulated with agonists in 
the presence of high (1mM) and low extracellular Ca2+. MCP-1-mediated Ca2+ 
responses in THP-1 monocytes were attenuated in low extracellular Ca2+, although this 
was not statistically significant. Ionomycin-induced Ca2+ influx was significantly 
attenuated in low extracellular Ca2+ in these cells (Figure 4.20a). LTB4- and ionomycin-
mediated Ca2+ influx in U937 monocytes was significantly attenuated in low 
extracellular Ca2+ (Figure 4.20b). Furthermore, fMLP- and ionomycin-mediated Ca2+ 
influx was significantly attenuated in primary human neutrophils in low extracellular 
Ca2+ (Figure 4.20c). In all three cell types examined, chemoattractant- and ionomycin-
mediated Ca2+ responses were not completely abolished in low extracellular Ca2+, 








Figure 4.18: MCP-1, LTB4 and ATP increase intracellular calcium mobilisation in 
monocytic cell lines. (A) THP-1 monocytes and (B) U937 monocytes were loaded with 10µM 
Fluo-4 before being washed in Ca2+-free HBSS, resuspended in HBSS and extracellular calcium 
adjusted to 1mM. Cells were plated in black 96 well plates. Fluorescence was measured over 
time at 37°C using a plate reader (upper panels). Increasing concentrations of MCP-1, LTB4 or 
ATP were added after baseline established. Peak change in fluorescence signal is plotted 
against vehicle control (lower panels). Data presented show representative traces from a single 
experiment and peak change graphs represent mean (± SEM) from three separate experiments, 
samples run in duplicate. Statistical analysis by one way-ANOVA with Dunnett’s post test where 
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Figure 4.19: IL-8, fMLP, LTB4 and ATP increase intracellular calcium mobilisation in 
primary human neutrophils. Primary human neutrophils were isolated from peripheral human 
blood and loaded with 10µM Fluo-4 before being washed in Ca2+-free HBSS, resuspended in 
HBSS and extracellular calcium adjusted to 1mM. Cells were plated in black 96 well plates. 
Fluorescence was measured over time at 37°C using a plate reader (upper panels). Increasing 
concentrations of (A) IL-8, (B) fMLP, (C) LTB4 or (D) ATP were added after baseline 
established. 1µM ionomycin was added once response had returned to baseline. Peak change 
in fluorescence signal plotted against vehicle control (lower panels). Data presented show 
representative traces from a single experiment and peak change graphs represent mean (± 
SEM) from three separate experiments, samples run in duplicate. Statistical analysis by one 






































































































































































































Figure 4.20: Ligand induced intracellular calcium mobilisation in monocytes and 
neutrophils is reduced in low extracellular calcium. (A) THP-1 monocytes, (B) U937 
monocytes and (C) Primary human neutrophils were loaded with 10µM Fluo-4 before being 
washed in Ca2+-free HBSS, resuspended in HBSS. Half the populations had extracellular 
calcium adjusted to 1mM, the other half remained in Ca2+-free HBSS. Cells were plated in black 
96 well plates. Fluorescence was measured over time at 37°C using a plate reader (i). 10nM 
MCP-1, 10nM LTB4 or 10nM fMLP were added after baseline established. Finally, 1µM 
ionomycin was added to all samples. Peak change in ligand- and ionomycin-induced 
fluorescence signal is plotted against vehicle control in the presence and absence of 
extracellular Ca2+ (ii). Data presented show representative traces from a single experiment and 
peak change graphs represent mean (± SEM) from three separate experiments, samples run in 
duplicate. Statistical analyses by two way-ANOVA with Sidak’s multiple comparisons post hoc 
test where *=p<0.05, **=p<0.01, ***=p<0.001, ****=p<0.0001. 
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After validating the assay with known chemoattractants, the next step aimed to 
examine whether H2O2 could induce a similar elevation of [Ca2+]i. THP-1 and U937 
monocytes, and primary human neutrophils were stimulated with increasing 
concentrations of H2O2 and changes in [Ca2+]i measured over time. In THP-1 cells, 
H2O2 had no significant effect upon [Ca2+]i although a decrease in Ca2+ signal was 
observed with 10mM H2O2 (Figure 4.21a). THP-1 cells were still able to respond to 
ionomycin following H2O2 stimulation. H2O2 did not cause a transient response in U937 
monocytes (Figure 4.21b). Interestingly, only 10mM H2O2 provoked a gradual and 
steep rise in [Ca2+]i in U937 cells that did not plateau over time, although ionomycin 
was still able to further increase the response. Out of all the concentrations tested, only 
10mM H2O2 provoked an increase in [Ca2+]i in primary human neutrophils (Figure 
4.21c). Whilst transient, this response was longer-lived that those observed with 
neutrophil chemoattractants, however the response had returned to baseline within 5 
minutes. Ionomycin triggered a large and rapid increase in detectable [Ca2+]i in 
neutrophils, regardless of any previous treatment.  
 
It has previously been reported that H2O2 can provoke a biphasic elevation of [Ca2+]i in 
rat pancreatic cells [335]. To see if this response could be replicated in primary human 
neutrophils, cells were stimulated with 10mM H2O2 for 30 minutes and [Ca2+]i levels 
continuously detected using a Fluo-4 probe (Figure 4.22a). Indeed, an initial, short, 
transient peak that returned to baseline after approximately 5 minutes was observed, 
followed by a gradual, sustained increase in [Ca2+]i that plateaued during the 30 minute 
incubation. Addition of ionomycin after H2O2 further increased the Ca2+ elevation. To 
elucidate the possible mechanisms of Ca2+ influx responsible for the biphasic response 
seen with H2O2 stimulation, the experiment was repeated in low extracellular Ca2+. 
10mM H2O2 elicited an initial increase in [Ca2+]i signal, which peaked approximately 5 
minutes after stimulation at which point it plateaued (Figure 4.22b). Over the next 25 
minutes the elevated signal did not return to baseline, nor did it increase further. 
Responses to ionomycin were attenuated in cells in the absence of extracellular Ca2+. 
 




Figure 4.21: The effect of exogenous H2O2 upon intracellular calcium mobilisation in 
human monocytes and neutrophil. THP-1 monocytes, U937 monocytes or primary human 
neutrophils were loaded with 10µM Fluo-4 before being washed in Ca2+-free HBSS, 
resuspended in HBSS and extracellular calcium adjusted to 1mM. Cells were plated in black 96 
well plates. Fluorescence was measured over time at 37°C using a plate reader (left panels). 
Increasing concentrations of H2O2 were added after baseline established. 1µM ionomycin was 
added once response had returned to baseline. Peak change in fluorescence signal plotted 
against vehicle control (right panels). Data presented show representative traces from a single 
experiment and peak change graphs represent mean (± SEM) from three separate experiments, 
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Figure 4.22: H2O2 induces a biphasic increase in intracellular calcium in primary human 
neutrophils. Primary human neutrophils were isolated from peripheral human blood and loaded 
with 10µM Fluo-4 before being washed in Ca2+-free HBSS, resuspended in HBSS and 
extracellular calcium adjusted to (A) 1mM, or (B) left calcium free. Cells were plated in black 96 
well plates. Fluorescence was measured over time at 37°C using a plate reader. 10µM H2O2 
was added after baseline established and fluorescence signal captured for 30 minutes before 
1µM ionomycin was added. Peak change in fluorescence signal plotted against vehicle. Data 
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4.14 H2O2 does not affect ligand-stimulated calcium mobilisation in monocytes or 
neutrophils 
 
To test whether H2O2 could influence the immediate Ca2+ signal observed in ligand-
stimulated cells, monocytic cell lines and primary human neutrophils were pre-treated 
with 10µM H2O2 for 10 minutes before stimulation with a known chemoattractant, and 
levels of  [Ca2+]i analysed using Fluo-4 loaded cells and a plate reader.  
 
THP-1 monocyte stimulation with increasing concentrations of MCP-1 induced a 
concentration dependent increase in [Ca2+]i. This was not affected when cells were pre-
treated with H2O2 (Figure 4.23a). Similarly, U937 monocyte stimulation with increasing 
concentrations of LTB4 induced a concentration dependent increase in [Ca2+]i signal. 
Again, pre-treatment with H2O2 did not alter the chemoattractant-induced response 
(Figure 4.23b).  
 
Furthermore, primary human neutrophil Ca2+ mobilisation with a range of known 
chemoattractants was investigated. 10nM IL-8, 10nM fMLP and 10nM LTB4 increase 
[Ca2+]i influx compared to PBS control. The chemoattractant-mediated rise in [Ca2+]i 
was not affected when neutrophils were pre-treated with H2O2 prior to stimulation with 
chemoattractant (Figure 4.24).  
 
 




Figure 4.23: H2O2 does not affect chemoattractant-induced intracellular calcium 
mobilisation in monocytic cell lines. (A) THP-1 monocytes and (B) U937 monocytes were 
loaded with 10µM Fluo-4 before being washed in Ca2+-free HBSS, resuspended in HBSS and 
extracellular calcium adjusted to 1mM. Cells were plated in black 96 well plates. Fluorescence 
was measured over time at 37°C using a plate reader (upper panels). Cells were treated with 
either 10µM H2O2 or vehicle for 10 minutes before increasing concentrations of MCP-1 or LTB4 
were added. Finally, 1µM ionomycin was added to each well. Peak change in fluorescence 
signal is plotted against vehicle control (lower panels). Data presented show representative 
traces from a single experiment and peak change graphs represent mean (± SEM) from three 
separate experiments, samples run in duplicate. Statistical analyses by two way-ANOVA with 
Sidak’s multiple comparisons post hoc test where ns=no significant difference. 
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Figure 4.24: Ligand induced intracellular calcium mobilisation in neutrophils is not 
affected by pre-treatment with H2O2. Primary human neutrophils were isolated from peripheral 
human blood, loaded with 10µM Fluo-4, washed in Ca2+-free HBSS, resuspended and 
extracellular calcium adjusted to 1mM. Cells were plated in black 96 well plates. Fluorescence 
was measured over time at 37°C using a plate reader (upper panels). 10µM H2O2 or vehicle 
was added after baseline established and fluorescence signal captured for 10 minutes before 
10nM IL-8, 10nM fMLP or 10nM LTB4 was added. Once responses had returned to baseline, 
1µM ionomycin was added to each well. Peak change in fluorescence signal is plotted against 
vehicle control (lower panels). Data presented show representative traces from a single 
experiment and peak change graphs with mean (± SEM) from three separate experiments, 
samples run in duplicate. Statistical analyses by two way-ANOVA with Sidak’s multiple 
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4.15 H2O2 activates PI3K and MAPK signalling pathways in monocytes 
 
There are many reports implying H2O2 as an important signalling component in many 
signalling pathways, including PI3K and SFK signalling cascades, as reviewed by 
Truong and Carroll (2013) [313]. Given our observations that H2O2 appears to inhibit 
cell chemotaxis and polarisation, but does not affect receptor expression or calcium 
mobilisation, we next sought to examine whether H2O2 could activate other signalling 
pathways. The monocytic cell line U937 was employed for these experiments due to its 
robustness and sensitivity.  
 
U937 monocytic cells were stimulated with increasing concentrations of fMLP or H2O2 
before being lysed and protein extracted. Lysates were run on SDS-PAGE gels to 
separate proteins by electrophoresis, transferred to membranes and probed for 
pAkt(S473) as an indicator of PI3K activation, and pERK(Y204) as an indicator of 
MAPK signalling. Membranes were also probed for total ERK as a loading control. 
 
Stimulation with increasing concentrations of fMLP increased pAkt levels in a 
concentration dependent manner. fMLP also increased pERK compared to untreated 
samples, which peaked with 10nM fMLP (Figure 4.25a). Stimulation with increasing 
concentrations of H2O2 increased pAkt above basal levels. H2O2 did prompt a small 
increase in pERK versus untreated controls, although this did not appear to be 
concentration dependent and fluctuated over the concentration range tested (Figure 
4.25a).  
 
To investigate the combined effect of H2O2 and fMLP and to examine whether H2O2 
was able to affect fMLP mediated increases in pAkt and pERK, U937 cells were treated 
with 10µM H2O2 for 30 minutes either alone or followed by 5 minutes with 10nM fMLP. 
While both fMLP and H2O2 alone increased pAkt levels, the extent of this increase was 
not affected when H2O2 and fMLP stimulation was combined (Figure 4.25b). 
Interestingly, while fMLP alone increased pERK, H2O2 alone had only a very modest 
effect on pERK levels. Pre-treating cells with H2O2 before fMLP stimulation appeared to 











Figure 4.25: fMLP and H2O2 induce activation of PI3K and ERK signalling pathways in 
monocytes.  Western blot analysis of pAKT, pERK and ERK expression in U937 cells cultured 
(A) for 5 minutes with increasing concentrations of fMLP or for 30 minutes with increasing 
concentrations of H2O2 or (B) for 5 minutes with 10nM fMLP alone, for 30 minutes with10µM 
H2O2 alone, or fMLP and H2O2 in combination (upper panels). Band intensity was quantified 
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4.16 H2O2 does not affect ICAM-1 expression in endothelial cells 
 
Following tissue damage or infection, inflammatory mediators stimulate the expression 
of adhesion molecules on the vasculature in the affected tissue. Circulating leukocytes 
interact with these adhesion molecules and this leads to their extravasation from 
vessels into tissue. TNFα is a pro-inflammatory mediator that is known to upregulate 
ICAM-1 expression on endothelial cells [409]. H2O2 has previously been reported to 
increase adhesion of neutrophils to human endothelial cells [324]. In order to examine 
the effect of H2O2 on vasculature adhesiveness, the next objective sought to 
investigate whether H2O2 could influence adhesion molecule expression on the 
endothelial surface.  
 
Firstly, to create pro-inflammatory conditions, monolayers of EA.hy926 endothelial cells 
were stimulated with 10ng/ml TNFα for up to 6 hours to induce ICAM-1 expression. 
Confocal microscopy (Figure 4.26a(i)) and Western blot analysis (Figure 4.26(ii,iii)) 
show an increase in ICAM-1 expression following 6 hours TNFα stimulation. (Positive 
control for ICAM-1 expression is presented in Appendix 1). ICAM-1 protein expression 
indicates this occurs in a time dependent manner.  
 
To investigate the effects of H2O2 on TNFα stimulated endothelial cells, confluent 
monolayers were treated with 10µM H2O2 for up to 6 hours before cells were lysed and 
assayed for ICAM-1 expression, and total ERK, as a loading control. Western blot 
analysis indicated that H2O2 alone only induced very modest expression of ICAM-1 
compared to TNFα treated cells (Figure 4.26b(i)). Furthermore, H2O2 did not affect 









Figure 4.26: H2O2 alone does not induce ICAM-1 expression or affect TNFα induced 
ICAM-1 expression in endothelial monolayers. (A) Confluent monolayers of EA.hy926 
endothelial cells were treated with 10ng/ml TNFα for up to 6 hours. ICAM-1 expression was 
assessed by (i) confocal microscopy, scale bar = 50µm, or (i,ii) Western blot. (B(i)) ICAM-1 and 
ERK expression in endothelial monolayers following 6 hours 10ng/ml TNFα or up to 6 hours 
10µM H2O2 alone. (B(ii)) ICAM-1 and ERK expression following 6 hours 10ng/ml TNFα or up to 
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4.17 fMLP and exogenous H2O2 increase intracellular ROS in primary human 
neutrophils 
 
Phagocytes produce ROS following activation, either as part of respiratory burst or 
inside a phagolysosome. Using an intracellular ROS detector, DCFDA, the effect of 
chemoattractant stimulation upon intracellular ROS formation was measured. 
Moreover, to validate the use of DPI in other experimental settings, we tested whether 
DPI could reduce intracellular ROS concentrations. It must be noted that DCFDA is a 
general ROS detector and therefore it cannot be assumed that it specifically reflects 
true H2O2 levels. A cell permeable SOD mimetic, MnTBAP, was also employed to 
generate intracellular H2O2. Here, MnTBAP acted as a validation tool to confirm that 
DCFDA was functioning correctly. 
 
Firstly, primary human neutrophils were loaded with 10µM DCFDA and treated with 
increasing concentrations of DPI for 30 minutes. Following incubation we observed 
significantly lower intracellular ROS in cells treated with 10µM DCFDA versus 
untreated controls (Figure 4.27a). To further validate the ROS detector, neutrophils 
were treated with SOD mimetic MnTBAP for 30 minutes. Following incubation, 
MnTBAP-treated cells showed a modest increase in intracellular ROS versus untreated 
cells, although this was not significant (Figure 4.27a). Next, neutrophils were treated 
with 10nM fMLP, a concentration determined to be optimal in chemotaxis assays. 
Intracellular ROS was sampled at time points over 30 minutes and a gradual increase 
in intracellular ROS following initial stimulation with fMLP was observed (Figure 4.27b). 
This was significantly higher than untreated cells after 15 minutes fMLP exposure. 
Finally, neutrophils were treated with increasing concentrations of exogenous H2O2 and 
intracellular ROS was detected after 5 or 30 minutes. A significant concentration 
dependent increase in intracellular ROS was seen after just 5 minutes with H2O2 
concentrations greater than 10µM. This response was further amplified following the 
same trend after 30 minutes (Figure 4.27c).  
 
Analysis of intracellular ROS was also carried out in monocytic cell lines. In both THP-1 
and U937 cells (Figure 4.28), DPI evoked a concentration dependent reduction in 
intracellular ROS. SOD mimetic MnTBAP induced no increase in intracellular ROS in 
THP-1 monocytes and only a modest increase in U937 cells. Interestingly, in both 
monocytic cell lines, chemoattractant stimulation over 5 or 30 minutes (MCP-1 and 
LTB4) did not provoke any observable change in intracellular ROS. Finally, exogenous 
H2O2 significantly increased detectable ROS in both monocytic cell lines.  





Figure 4.27: Intracellular ROS detection in primary human neutrophils. Neutrophils were 
isolated from peripheral human blood, rested in Ca2+ free HBSS and loaded with 10µM DCFDA 
for 30 minutes. Cells were washed in HBSS and treated with (A) increasing concentrations of 
DPI (NADPH oxidase inhibitor) or 1µM MnTBAP (SOD mimetic) for 30 minutes, (B) 10nM fMLP 
for 5 to 30 minutes, or (C) increasing concentrations of H2O2 for 5 or 30 minutes. Fluorescence 
was analysed immediately using a FluoStar Optima plate reader. Data presented represent 
mean (±SEM) fluorescence minus plate background, normalized to untreated control from at 
least three separate experiments. Statistical analysis via one way-ANOVA with Dunnett’s post 
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Figure 4.28: Intracellular ROS detection in monocytic cell lines. THP-1 monocytes (A) or 
U937 monocytes (B) were washed twice in plain media and loaded with 10µM DCFDA for 30 
minutes. Cells were washed again and treated with increasing concentrations of DPI (NADPH 
oxidase inhibitor), 1µM MnTBAP (SOD mimetic) for 30 minutes, or increasing concentrations of 
MCP-1 or LTB4 or H2O2 for 5 or 30 minutes. Fluorescence was analysed immediately using a 
FluoStar Optima plate reader. Data presented represent mean (±SEM) fluorescence minus 
plate background, normalized to untreated control from at least three separate experiments. 
Statistical analysis via one way-ANOVA with Dunnett’s post hoc test where *=p<0.05, 
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4.18 ATP induces migration of monocytes and neutrophils 
 
As well as its known function in signalling and energy transfer, at high concentrations 
ATP acts as a damage-associated molecular signal. ATP is released by activated cells 
at sites of inflammation and therefore has key autocrine and paracrine signalling 
functions. The effect of exogenous ATP on innate cell chemotaxis, polarisation and 
morphology was investigated to complement the analysis of damage-associated signal 
H2O2 in innate cell function. 
 
In the ChemoTx migration assay, THP-1 monocytes and primary human neutrophils 
migrated in a concentration dependent manner towards sub-milimolar concentrations 
of ATP (Figure 4.29a+b). This migration response showed a characteristic bell shaped 
trend, as seen previously with known chemoattractants in Figure 4.1. In order to 
investigate whether ATP-mediated migration was acting via G-protein related 
mechanisms, THP-1 monocytes were incubated with pertussis toxin (PTX) for 16 
hours, before being plated in the ChemoTx assay above ATP. 1-100ng/ml PTX 
inhibited monocyte migration towards all concentrations of ATP (Figure 4.29a(ii)). 
 
To test whether ATP was stimulating chemokinesis, or whether exogenous ATP could 
affect chemotaxis to known chemoattractants, cells were treated with increasing 
concentrations of exogenous ATP before being plated in the ChemoTx migration assay 
above 10nM MCP-1 (monocytes) or 10nM IL-8 (neutrophils), or plain media. ATP pre-
treatment increased both MCP-1-mediated and basal migration of THP-1 monocytes to 
a comparable extent (Figure 4.30a(i)). However, the lowest ATP concentration tested 
(0.01mM) potentiated MCP-1-mediated chemotaxis but did not affect basal migration. 
Pre-treatment of neutrophils with increasing concentrations of ATP inhibited IL-8 
mediated chemotaxis, to a significant extent with 1mM ATP (Figure 4.30b(i)). Basal 
migration appeared to be increased by ATP pre-treatment, in a bell shaped 
concentration dependent manner.  
 
We have previously demonstrated that treatment with exogenous H2O2 inhibits both 
monocyte and neutrophil chemotaxis to known chemoattractants. The next approach 
tested whether this was also the case with ATP-stimulated chemotaxis. Both monocyte 
and neutrophil chemotaxis to 0.1mM ATP was significantly and concentration 
dependently inhibited by exogenous H2O2. Basal migration was also inhibited, but to a 
lesser extent (Figure 4.29a+b(ii)).  
 




Figure 4.29: ATP induces migration of monocytes and neutrophils. (A) THP-1 monocytes 
or (B) primary human neutrophils were washed in serum free media, resuspended to 3.2x106 
cells/ml and rested. (i) Cells were plated on top of filter membranes above lower chambers 
containing increasing concentrations of ATP. (ii) Cells were stimulated with increasing 
concentrations of pertussis toxin (PTX) or vehicle for 16 hours at 37°C before being plated on 
top of filter membrane above lower chambers containing increasing concentrations of ATP or 
plain media. Chemotaxis across 5µm pore size membrane was determined after a 3 hour 
incubation at 37°C in 5% CO2 as previously described. Data presented represents means ± 
SEM from at least three separate experiments. Statistical analyses (i) by one way-ANOVA 
versus untreated control with Dunnett’s post and (ii) by two way-ANOVA versus untreated 
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Figure 4.30: ATP-mediated chemotaxis is inhibited by exogenous H2O2. (A) THP-1 
monocytes or (B) primary human neutrophils were washed in serum free media, resuspended to 
3.2x106 cells/ml and rested. (i) Cells were stimulated with increasing concentrations of ATP for 
5 minutes at 37°C before being plated on top of filter membrane above lower chambers 
containing (A) 10nM MCP-1 or (B) 10nM IL-8 or plain media. (ii) Cells were stimulated with 
increasing concentrations of H2O2 for 30 minutes at 37°C before being plated on top of filter 
membrane above lower chambers containing 0.1mM ATP or plain media. Chemotaxis across 
5µm pore size membrane was determined after a 3 hour incubation at 37°C in 5% CO2 as 
previously described. Data presented represents means ± SEM from at least three separate 
experiments. Statistical analyses by two way-ANOVA versus untreated control with Tukey’s 
multiple comparisons post hoc test. *=p<0.05, **=p<0.01, ***=p<0.001. 
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4.19 ATP stimulates actin reorganisation and spreading of THP-1 monocytes 
 
We have seen that ATP induces a strong migratory effect in monocytes. To further 
explore the effect of ATP upon monocyte morphology in vitro, cell roundness and area 
in ATP treated cells was compared to untreated control cells. THP-1 monocytes were 
allowed to adhere to fibronectin-coated coverslips, treated with increasing 
concentrations of ATP for 5 minutes, fixed and stained to reveal F-actin. Confocal 
microscopy images reveal an elongated, irregular morphology of ATP treated 
monocytes compared to untreated cells (Figure 4.31a). Quantitative analysis revealed 
that ATP induced a significant concentration dependent reduction in cell circularity and 
increase in cell area compared to untreated cells (Figure 4.31b). 
 
Studying immediate morphological responses to ligands can give us an insight into 
dynamic cell activation and the nature of their next actions, i.e. if they will migrate. 
THP-1 monocytes seeded onto fibronectin-coated coverglasses, stimulated with MCP-
1, ATP or H2O2 and their immediate responses were imaged using phase contrast 
time-lapse microscopy. Following stimulation with 10nM MCP-1, cells appeared 
irregularly shaped and after 3 minutes they were elongated with a leading protrusive 
‘arm’ (Figure 4.32a). Stimulation with 0.3mM ATP provoked a rapid change in 
monocyte morphology: many large protrusions around the cells extending into the 
surrounding space appeared within two minutes, which appeared to have collapsed 
and moved closer to the cell body by three minutes post stimulation (Figure 4.32b). 
10µM H2O2 did not elicit any marked changes in monocyte morphology within 6 
minutes post stimulation (Figure 4.32c). To provide a quantitative assessment of 
morphology, cell circularity was analysed over time and reveals a prominent shape 
change in ATP treated cells, with very little variation of morphology in H2O2-treated 
cells (Figure 4.32d). 
 
 
4.20 ATP does not affect cell viability 
 
As ATP is a known marker of damage and a strong damaging molecule, the effect of 
ATP on cell viability was assessed. Using the MTT viability assay, increasing 
concentrations of exogenous ATP did not have any significant effect on neutrophil 












Figure 4.31: ATP increases THP-1 actin reorganisation and spreading. THP-1 monocytes 
washed, rested and plated on coverslips coated with 10µg/ml fibronectin and allowed to adhere 
for 30 minutes. Cells were treated with increasing concentrations of ATP for 5 minutes. 
Following incubation, cells were fixed in 4% PFA, permeabilised with 0.1% Triton-X and stained 
with Alexa-Fluor 488 conjugated Phalloidin and DAPI. (A) Representative images showing actin 
staining, scale bar = 20µm. (B) Circularity score (left) and area (right) were calculated using 
CellProfiler software, with at least 100 individual cells analysed per sample, from at least 4 
pooled experiments. Data presented represents mean (± SEM) with statistical analysis by one 
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Figure 4.32: Time lapse imaging of THP-1 monocytes seeded on fibronectin reveals 
changes in shape following stimulation with different agonists. 106 cells/ml were seeded 
on a chambered coverglass coated with 10µg/ml fibronectin and allowed to adhere for 30 
minutes. Time-lapse recording began before cells were stimulated with (A) 10nM MCP-1, (B) 
0.3mM ATP or (C) 10µM H2O2. Cells were imaged using confocal microscope with 63x oil 
objective under brightfield light. White arrows indicate membrane protrusions. Scale bar = 
10µm. (D) Quantification of circularity over time as analysed by CellProfiler software with the 



























































Figure 4.33: Neutrophil viability is unaffected following exposure to ATP. Primary human 
neutrophils were exposed to increasing concentrations of ATP or PBS vehicle control for up to 4 
hours. Following culture, cells were assessed for viability using MTT assay. Data presented 
represent means (± SEM) minus plate background and normalized to untreated control from at 
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4.21 Chapter 4 – Summary of Results 
 
Exogenous H2O2: 
• Inhibits basal and chemoattractant-mediated migration in neutrophils and 
monocytes in the ChemoTx migration model. 
• Does not affect neutrophil chemotaxis to IL-8 or fMLP in the under agarose 
migration assay, nor does it affect neutrophil prioritisation in opposing gradients 
of IL-8 and fMLP. 
• Does not induce monocyte actin reorganisation on fibronectin, nor does it affect 
chemokinesis or exploratory motility. 
• Does not affect monocyte CCR2 expression or endothelial cell ICAM-1 
expression. 
• Inhibits macrophage and neutrophil phagocytosis of latex beads and bacteria. 
• Induces a transient, biphasic rise in intracellular calcium in neutrophils but does 
not affect ligand-stimulated transient elevation of intracellular calcium in 
monocytes or neutrophils. 
• Activates PI3K and MAPK signalling pathways in monocytes. 
• Has no effect on neutrophil or monocyte viability at concentrations below 
10mM. 
• Increases intracellular ROS in monocytes and neutrophils. 
 
DPI: 
• Reduces intracellular ROS formation and inhibits monocyte and neutrophil 
chemotaxis, polarisation and spreading on fibronectin. 
• Does not affect monocyte CCR2 expression 
 
Catalase: 
• Inhibits neutrophil chemotaxis, but enhances monocyte chemotaxis, 
polarisation and spreading in response to MCP-1. 
• Does not affect monocyte CCR2 expression 
 
ATP: 
• Stimulates chemokinesis in monocytes and neutrophils, polarisation and 
spreading of monocytes on fibronectin, and does not affect viability. 
• ATP-mediated monocyte migration is sensitive to pertussis toxin. 
• Potentiates monocyte chemotaxis to MCP-1 but inhibits neutrophil chemotaxis 
to IL-8. 
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4.22 Chapter 4 – Discussion 
 
H2O2 does not act as a chemoattractant for human innate immune cells in vitro 
 
In the ChemoTx migration assay, monocytes and neutrophils did not migrate towards 
H2O2. In fact, increasing concentrations of H2O2 inhibited basal migration. These results 
were unexpected given that H2O2 triggers immune cell recruitment to sites of injury in 
model organisms [233], [270]. To assess whether our results were consistent in vitro, 
an additional, alternative model of migration was used. In the under agarose migration 
assay, neutrophil migration towards a source of H2O2 was greater than migration 
towards an opposing gradient of plain control media. This has been demonstrated by 
other groups using zebrafish [282] and mouse neutrophils [325]. However, the extent of 
chemotaxis observed was considerably smaller than similar reported results. 
Furthermore, when compared to chemotaxis induced by IL-8 or fMLP, chemotaxis to 
H2O2 was noticeably smaller. Our observations suggest that H2O2 is not acting as a 
chemoattractant for human innate immune cells on a comparable level to known 
chemoattractants in an in vitro setting. The H2O2 concentration in these assays was not 
monitored over time, and therefore it cannot be assumed that a stable gradient of H2O2 
was formed. In the ChemoTx migration assay, where the liquid-phase compartments 
are less likely to maintain a gradient of H2O2 for very long, cells in the top compartment 
are unlikely to sense a gradient of H2O2, and therefore may not migrate. This could be 




Exogenous H2O2 does not induce human innate cell migration and polarisation  
 
At a site of tissue damage, activation of inflammatory cells will lead to the generation of 
multiple signals in addition to wound-generated cues. We sought to investigate whether 
H2O2 could influence the ability of known chemoattractants to stimulate migration. Cells 
were treated with exogenous H2O2 before being placed in either in vitro migration 
assay. In the ChemoTx migration assay, both monocyte and neutrophil migration to a 
range of chemoattractants was inhibited in H2O2-treated cells compared to untreated 
cells. In the under agarose migration assay, neutrophil migration to either IL-8 or fMLP 
was not affected by exogenous H2O2. This result highlights the differences in our in 
vitro assays, and suggests that exposure to short-lived gradients and subsequent 
saturated concentrations of H2O2 in the ChemoTx migration model is sufficient to 
induce arrest of motility. This response is less pronounced in the under agarose 
migration assay, possibly because gradients of H2O2 are longer lived.  
 
Interestingly, another group have demonstrated that incubation of isolated human 
neutrophils with 10mM H2O2 caused a significant decrease in both chemotaxis and 
random migration of cells in agarose gel [410]. This was suggested to be due to a loss 
of deformability following exposure to H2O2. Exogenous H2O2 also inhibits induced 
pluripotent stem cell migration through fibronectin-coated porous filters and 
transendothelial migration [411]. Other groups have demonstrated that inflammatory 
mediators LPS and TNFα inhibit monocyte chemotaxis. This has been suggested to be 
due to transcription of MAPK phosphatase 1 (MKP1) which arrests MAPK-mediated 
chemotaxis [412]. Since phosphorylation of MAPK is required for monocyte and 
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macrophage chemotaxis towards MCP-1, H2O2 may be acting in a similar manner to 
inflammatory mediators to inhibit chemotaxis.  
 
The effect of exogenous H2O2 on neutrophil random exploratory motility on fibronectin 
was also examined. This experiment mirrored the exogenous H2O2 experiment carried 
out in Drosophila embryos, where exogenous H2O2 reduced immune cell velocity in 
vivo. In vitro, when placed in exogenous H2O2, neutrophils did not polarise, move or 
explore the sample area to the same extent as when they were activated with IL-8 or 
fMLP, indicating that these defects could account for loss of migration. To investigate 
this further, monocytes were stimulated and fixed on fibronectin coated coverslips. 
Actin fibres were visualised to indicate cytoskeletal organisation in response to H2O2 or 
MCP-1. We found that monocytes adopt an irregular, ‘polarised’ morphology and 
increased area in response to stable concentrations of MCP-1, indicative of an 
activated adhesive cell that is ready to migrate. H2O2-treated cells remained round and 
regular in shape. Furthermore, H2O2 inhibited MCP-1-mediated changes in morphology 
when monocytes were first treated with H2O2. These data suggest that H2O2 may be 
modulating adhesive responses, and that H2O2 may be a negative regulator that limits 
lamellipodia formation. 
 
We hypothesised that loss of surface expression or inactivation of the monocyte 
chemokine receptor CCR2 could account for the inhibition of monocyte chemotactic 
migration by H2O2. Certain inflammatory signals (e.g. LPS and TNFα) rapidly inhibit 
chemokine-receptor expression by targeting transcript stability. In a study of human 
monocytes, CCR2 mRNA was down-regulated 4 hours after the addition of LPS, 
although migration was inhibited before this [413]. Others have found that LPS induced 
a marked reduction in CCR2 cell surface protein levels within 2 hours [414]. However, 
studies using cultured human monocytes have shown that mRNA expression levels of 
the major chemokine receptors, CCR2, CCR5, and CXCR4 are upregulated by 
treatment with H2O2, and are downregulated by treatment with antioxidant reagents 
[415]. In contrast to these reports, we found no change in monocyte surface CCR2 by 
flow cytometry after 30 minutes exposure to exogenous H2O2. However, a significant 
loss of CCR2 following treatment with 30µM DPI was demonstrated, indicating that 
CCR2 expression may be redox sensitive. The detection method in our study could 
account for these contrasting results. It is possible that CCR2 mRNA, intracellular 
localisation and degradation could each be influenced by redox stimulation, but is 
unlikely that changes in transcription would occur within the 30 minute stimulation 
period. Therefore it is more likely that early changes in receptor expression may be due 
to receptor trafficking, which cannot be determined by flow cytometry alone. 
 
 
Alternative approaches to modulate ROS signalling 
 
Innate immune cells continuously produce ROS, even more so during activation 
following detection of inflammation [416]. NOX-generated H2O2 is produced at the 
plasma membrane, moves into the extracellular space and feeds back into cells to 
drive many important processes. For example, H2O2 influx via aquaporins is essential 
for T cell migration in response to a chemoattractant [327]. In light of this, we chose to 
investigate the effect of blocking the intracellular or extracellular compartments of H2O2 
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in order to dissect the contribution of intrinsic H2O2 generation and feedback upon 
immune cell processes in vitro.  
 
Catalase is a naturally produced catalyst of H2O2 breakdown and was used to remove 
extracellular H2O2. Catalase inhibited monocyte migration towards MCP-1 in the 
ChemoTx migration assay, suggesting that ROS generation and subsequent autocrine 
or paracrine signalling in monocytes is an important regulatory mechanism in migration 
towards MCP-1. Interestingly, the opposite effect was observed in neutrophils; catalase 
induced a potentiation of IL-8-mediated migration. This observation suggests that H2O2 
feedback may be important in promoting controlled migratory responses or 
immunosuppression. Monocytes plated on fibronectin and stimulated with catalase 
adopted an irregular, flattened morphology, and excessive lamellipodia. This indicates 
that extracellular H2O2 and feedback into monocytes is involved in regulating cell shape 
and substrate-integrin interactions and signalling. The morphology of catalase-treated 
monocytes is indicative of a cell with reduced motility, as lamellipodia are not focussed 
in one particular direction. 
 
The effect of inhibiting NADPH oxidase with DPI to block ROS generation was also 
investigated. DPI-treated monocytes and neutrophils both displayed significantly 
reduced migration to chemoattractants. In the presence of DPI, monocyte morphology 
is more irregular than untreated cells, but not to the same extent as with MCP-1 alone. 
When co-treated with DPI and MCP-1, cells are more round and have fewer 
lamellipodia than with MCP-1 alone. These results suggest that intracellular NADPH 
oxidase signalling is vital in regulating cell migration and polarisation and is consistent 
with previously published reports. NOX4, an NADPH oxidase in monocytes and 
macrophages, has been shown to localise to focal adhesions and the actin 
cytoskeleton, and was associated with phospho-FAK, paxillin and actin, implicating it in 
the regulation of human monocyte adhesion and migration [417].  
 
 
The influence of H2O2 in opposing chemoattractant gradients 
 
During an inflammatory event, leukocytes must follow endogenous and bacterial 
chemoattractant cues, as well as wound-generated cues if present. When faced with 
multiple cues, leukocytes must be able to distinguish and prioritise end target signals 
emanating from the source of damage or infection over intermediary chemoattractants 
encountered en route. Heit et al (2002) have reported that an intracellular signalling 
hierarchy determines the direction of neutrophil migration in opposing chemotactic 
gradients of end-target fMLP and intermediary IL-8, using the under agarose migration 
assay [189]. Other in vitro experiments have studied how neutrophils respond to 
stepwise and competing gradients of IL-8 and LTB4, and have highlighted the ability of 
neutrophils to carry out serial responses to agonists presented in a defined spatial 
array [23]. We were interested to investigate whether H2O2 could be placed within this 
hierarchy, and to discover if H2O2 could be influencing signal prioritisation at sites of 
tissue damage.  
In the under agarose migration assay, neutrophils migrated preferentially towards fMLP 
over IL-8, and this response was not affected by exogenous H2O2 in the cell or 
chemoattractant compartments. Neutrophils placed in opposing gradients of H2O2 and 
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IL-8 or fMLP, preferentially migrated towards IL-8 or fMLP over H2O2. Our results 
indicate that in the under agarose migration assay, H2O2 does not disrupt the ability of 
neutrophils to detect and distinguish competing cues. Exogenous H2O2 does not impair 
migration to IL-8 or fMLP alone or in opposing gradients, and is therefore is not 
prioritised over either intermediary or end-target cues. 
 
ChemoTx versus under agarose migration assays 
 
Our in vitro migration assays have revealed considerable differences in responses of 
innate cells to H2O2. The nature of these models could influence experimental 
outcomes and could be responsible for discrepancies observed between the models. 
Several important differences are summarised in table 4.1.  
 
 
ChemoTx migration assay Under agarose migration assay 
• Vertical migration – influence of gravity • Horizontal migration 
• Liquid phase • Agarose is semi-solid 
• Fast diffusion rate • Slower diffusion rate 
• Uncoated polycarbonate filter • Plates coated with FBS-enriched media 
• Movement restricted by 5µm pores • Un-restricted movement in all directions 
• Only one gradient at a time • Multiple gradients possible 
• High throughput • Low throughput 
 
Table 4.1: Differences between in vitro migration assays. 
 
 
The most prominent experimental difference we have noticed between the models is 
that in the ChemoTx model, basal and chemoattractant-mediated cell migration is 
inhibited by H2O2, whereas in the under agarose model chemoattractant-mediated 
migration is not affected by H2O2. While the ChemoTx migration assay is a simplistic, 
high-throughput model of migration, it lacks physiological characteristics such as a 
substrate or forces exerted onto cells that the under agarose assay provides. 
Neutrophils migrating under agar will do so along serum coated plastic and will 
therefore engage adhesion receptors that will influence intracellular signalling. 
Neutrophils migrating through a vertical porous filter with no substrate are unlikely to be 
engaging the same adhesive processes. Additionally, the rate of diffusion between 
each molecule will vary greatly. The liquid-phase ChemoTx assay will facilitate very 
fast diffusion rates and sharp, short-lived gradients. In the under agarose model, the 
agar is likely to slow the rate of diffusion, but also provides a medium with which H2O2 
can interact and breakdown. It is likely that all of these factors will influence 
experimental outcome and this highlights the limitations of simplistic in vitro models. In 
light of this, the pipette-tip chemotaxis assay [418], whereby a continuous source of 
H2O2 is perfused into an environment, may provide a better model for the gradients of 
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The effect of H2O2 on particle engulfment 
 
Our results demonstrate that H2O2 inhibits actin reorganisation and actin-mediated 
motility. We were therefore interested to see if this was also the case for phagocytosis, 
another actin-driven process. H2O2 is a secreted mediator during phagocytosis and 
contributes to bactericidal activity [419], so it was possible that H2O2 may have a 
regulatory role in this process. The effect of exogenous H2O2 on phagocyte engulfment 
of IgG-coated latex beads and bacteria was studied. One mechanism triggering 
phagocytosis is recognition of the Fc portion of immunoglobulins. Engagement of 
FcγRs by IgG-coated particles leads to the induction of signalling events involving actin 
reorganisation and membrane restructuring [420]. Alternatively, phagocytosis may be 
stimulated by activation of pathogen recognition receptors by bacteria [25]. Two 
phagocytes were used, macrophages and neutrophils, to study the engulfment of both 
IgG-coated beads and bacteria. Our results indicated that phagocytosis of both 
particles was significantly inhibited when phagocytes were pre-exposed to exogenous 
H2O2. This was an interesting result because it confirmed that another actin-regulated 
process was inhibited by exogenous H2O2 and suggests that H2O2 is indeed important 
in regulating phagocytosis. Our data was also in contrast to similar reports showing 
that high micromolar concentrations of H2O2 increased phagocytic function of human 
neutrophils [323]. In this case, H2O2-mediated calcium mobilisation was proposed as a 
mechanism for inducing subsequent phagocytosis of beads, and was reduced in the 
presence of catalase. No significant effect of catalase on neutrophil engulfment of 
beads or bacteria was observed, although we did find slight but significant inhibition of 
neutrophil phagocytosis of beads in the presence of DPI. 
 
It is likely that a global effect of H2O2 is to account for the reduced phagocytosis, as we 
observed the same trends regardless of the particle type being engulfed and 
subsequent signalling pathways that would be activated.  
 
During phagocytosis, phagocytes release H2O2 into the phagosomes and into the 
extracellular space. Because H2O2 can diffuse back into phagocytes, the intracellular 
environment is protected against peroxidation by catalase. Studies have shown that 
human phagocytes are damaged by extracellularly-generated H2O2 when intracellular 
catalase is inhibited [421]. When H2O2, generated during phagocytosis or adherence, is 
scavenged with catalase, the phagocytosis and chemotactic responsiveness of 
neutrophils is enhanced [422]. Furthermore, incubation of human neutrophils with H2O2 
resulted in impairment of these functions [422]. This mechanism could also be 
accounting for the observation we have made – intracellular peroxidation by high 
concentrations of exogenous H2O2 may promote cell damage. 
 
 
Redox regulation of intracellular signalling – calcium 
 
Our results demonstrate that monocyte and neutrophil ligand-stimulated activation 
results in a rapid and transient rise in intracellular calcium. This signal was only 
partially reduced in the absence of extracellular calcium, indicating that the responses 
were, in part, due to mobilisation of intracellular stores. These results are in line with 
published reports investigating agonist-mediated calcium mobilisation in innate cells 
[423]. In both monocytic cell lines and primary neutrophils tested, ATP induced a very 
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strong rise in intracellular calcium, consistent with other reported studies [360]. Our 
previous observations of immune cell function have revealed that in our hands many 
processes are impaired in the presence of exogenous H2O2. It was important to next 
investigate whether intracellular signalling pathways were also being inhibited by H2O2. 
Many published reports have suggested that H2O2 can induce mobilisation of 
intracellular calcium. However, the mechanism of how this occurs remains an issue of 
conflict, as discussed below.  
 
Whilst H2O2 did not appear to induce transient calcium mobilisation in either of our 
monocytic cell lines, in THP-1 monocytes calcium levels decreased slightly and stably. 
In U937 monocytic cells, however, 10mM H2O2 induced a steady and linear rise in 
cytosolic calcium. These abnormal responses indicate that these concentrations of 
H2O2 could negatively affect the integrity of cell membranes. In primary neutrophils, 
however, 10mM H2O2 induced a transient and relatively short-lived increase in cytosolic 
calcium, although the kinetics appeared to be slower than responses induced by fMLP 
or IL-8 in these cells. Previous studies utilising neutrophils have observed a biphasic 
response to H2O2 in smooth muscle cells and cell lines [323], [333] so we were 
interested to see if this occurred in human neutrophils. 10mM H2O2 induced an initial 
transient and short-lived peak that returned to baseline. When recording was continued 
for a further 25 minutes, the initial peak was followed by a slower, sustained rise in 
cytosolic calcium that plateaued after approximately 10 minutes.  
 
To dissect the possible mechanism driving this response, the experiment was repeated 
in the absence of extracellular calcium. Here, we observed an initial peak that was 
considerably smaller in intensity to that observed in the presence of extracellular 
calcium. This response plateaued and did not return to baseline and the response did 
not appear to be biphasic. Our results suggest that the initial transient increase in 
calcium could be due, in part, to mobilisation from intracellular stores because it was 
still apparent in the absence of extracellular calcium. However, the reuptake, or 
descending phase, of the initial transient response was lost following H2O2 stimulation 
in the absence of extracellular calcium. This suggests that reuptake of calcium into 
internal stores following stimulation by H2O2 is dependent upon the extracellular 
calcium concentration. This is distinct from our responses to other agonists, where 
reuptake appeared to occur in the absence of extracellular calcium.  
 
Many reports have attempted to establish the mechanism of H2O2-evoked calcium 
responses, but these vary widely between cell types. Most relevantly, Korzets et al 
(1999) used PBMCs to show that the H2O2-induced rise in intracellular calcium was 
mostly due to influx via RTK-mediated mechanisms because of sensitivity to the 
tyrosine kinase inhibitor genistein. However, part of the response was due to the 
translocation from internal stores [334]. An alternative and less commonly discussed 
source of intracellular calcium mobilisation can occur through the membrane 
dissociation and cytoplasmic mobilisation of the phospholipid and calcium bound 
protein annexin VI. This potential source of oxidant-induced calcium flux has been 
characterised by Cuscheiri et al (2005). Using THP-1 monocytic cells, they identified 
that exposure to H2O2 results in lipid raft-regulated changes in annexin VI that results in 
cytosolic calcium flux, caMKII activation, and the formation of focal adhesion-like 
complexes [424]. Additionally, ROS-induced calcium influx could be via regulation of 
neutrophil death. After phagocytosis, where vast amounts of H2O2 are produced, 
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neutrophils eventually undergo apoptosis to prevent excessive inflammation. In a 
monocytic cell line H2O2 treatment of cells expressing the calcium channel TRPM2 
resulted in calcium influx and onset of apoptosis [425]. What is noticeable in our 
calcium experiments is the very high H2O2 concentration (milimolar) required to initiate 
a response. The high threshold of H2O2 activation might serve to hold off activation in 
circulating neutrophils that, after transmigration and degranulation in the site of 
infection, would activate the calcium influx to reinforce the neutrophil activity. 
Alternatively, the calcium influx could be an apoptotic signal when ambient oxidant 
levels reach a level dangerous for the surrounding cells.  
 
In light of a response being induced by H2O2 in neutrophils, we briefly explored the 
possibility of H2O2 being able to influence calcium signalling driven by other 
chemoattractants. Pre-exposure of cells to H2O2 before stimulation by 
chemoattractants did not affect calcium mobilisation, suggesting that the H2O2-
mediated inhibition of leukocyte migration and polarisation is probably not due to H2O2 
disrupting calcium signalling.   
 
 
Redox regulation of intracellular signalling – protein kinases 
 
The direct targeting of protein kinases by H2O2 is considered to be a likely mechanism 
by which H2O2 modulates intracellular signalling as redox regulation of protein kinases 
contributes to their activity in a number of settings [305]. The effect of exogenous H2O2 
on kinase phosphorylation in a monocytic cell line was briefly investigated. U937 
monocytic cell lysates were probed for levels of pAkt and pERK following stimulation 
with H2O2 and compared to responses induced by fMLP, which increases PI3K and 
MAPK signalling in leukocytes [426]. H2O2-mediated ERK activation has been 
previously reported in human monocytes [427]. 
 
Our initial data indicate that micromolar concentrations of exogenous H2O2 can 
increase pAkt and pERK levels in a monocytic cell line compared to untreated control 
cells. However, this was not a concentration dependent response although levels were 
similar to those induced by fMLP. This suggests that PI3K/Akt and MAPK signalling 
pathways are being activated by the presence of exogenous H2O2. When treated in 
combination with H2O2 and fMLP, pAkt levels did not alter from fMLP-alone treated 
cells, while pERK levels increased almost 1.5 fold from fMLP-alone. Taken together, 
these preliminary results suggest that both bacterial and wound-derived cues can 
activate PI3K/Akt and MAPK signalling pathways. However, increased pAkt and pERK 
could be indicative of general cell stress or damage. 
 
 
Redox regulation of intracellular signalling - ROS generation 
 
Dichlorofluorescein was used to detect intracellular ROS and show that fMLP 
stimulated an increase in intracellular ROS in neutrophils, but this was not apparent in 
MCP-1- or LTB4-stimulated monocytic cells, even with concentrations optimal for 
migration. This indicates that production of ROS and feedback into cells may be more 
tightly controlled in monocytes than in neutrophils. It has previously been reported that 
THP-1 cells undergo mild redox remodelling in response to PAMPs, a process that is 
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absent in primary monocytes. Upon challenge with several TLR ligands, including pro-
inflammatory mediator LPS, intracellular ROS did not change in THP-1 cells [428]. This 
was found to be because THP-1 cells have upregulated antioxidant systems that buffer 
the oxidative hit provided by TLR triggering and suppress the consequent redox 
response. Only very high (5mM) concentrations of H2O2 overcame the high antioxidant 
capacity of THP-1 cells to restore a redox response [428]. It is likely that a similar 
process is occurring upon exposure of THP-1 monocytes to chemoattractants such as 
MCP-1.  
 
Exogenous H2O2 lead to significant increases in intracellular ROS most notably in 
neutrophils with micromolar concentrations, although monocytic cell lines required 
higher concentrations to have similar effects. This does not, however, indicate whether 
the exogenous H2O2 is entering the cells, possibly via aquaporins, or whether 
stimulation with H2O2 leads to upregulated NOX activity. Either way it confirms that in 
our experiments exogenous H2O2 gives rise to an oxidative intracellular environment. 
Treatment of unstimulated cells with DPI resulted in reduced detectable levels of ROS, 
and indicates the ROS generation occurs in the absence of cell activation. This 
observation concurs with many reports on the mechanism of action of DPI [429].  
 
 
Redox regulation of adhesion receptor expression 
 
Endothelial activation by inflammatory mediators, including TNFα, is associated with 
specific increases in surface expression of leukocyte receptors including ICAM-1. 
Using the EA.hy926 endothelial cell line, we were able to recapitulate TNFα-induced 
ICAM-1 expression, as confirmed by microscopy and analysis of protein expression. 
The human umbilical vein cell line, EA.hy926, was established by fusing primary 
human umbilical vein cells with a permanent human cell line A549 [384]. At a site of 
tissue damage, there is potential for wound-generated signals to diffuse into an area of 
tissue containing vasculature. Like other inflammatory mediators, several studies have 
indicated that H2O2 can affect endothelial cell properties including permeability [430], 
and adhesiveness [431]. H2O2-induced increases in neutrophil adhesion are inhibited in 
vivo by antibodies against ICAM-1 and CD18 [432], highlighting the relevance of H2O2 
in regulating adhesion molecules. We next sought to determine whether H2O2 could 
influence endothelial cell ICAM-1 expression in a similar manner to that induced by 
TNFα.  
 
Our results demonstrate that 10µM H2O2 alone does not induce ICAM-1 expression to 
levels similar to those induced by TNFα over a six hour time period. Furthermore, co-
treatment with H2O2 did not affect TNFα-mediated ICAM-1 expression. These results 
are in direct contrast to those of a group that studied the action of H2O2 in human 
umbilical endothelial cells. Bradley et al (1993) used ‘subinjurious’ concentrations of 
H2O2 to modulate ICAM-1 expression. Here, 50-100µM H2O2 selectively increased 
surface expression of ICAM-1 after 24 hours [433]. They also found increased ICAM-1 
mRNA after 4 hours. Interestingly, co-treatment with H2O2 inhibited TNF-induced gene 
expression at 4 hours – they attribute this to reversible inhibition of TNF binding to 
endothelial surface receptors. A key difference between our study and that of Bradley 
et al is the timing of measurement. The 6 hour time frame in this investigation may 
have been too early to allow for any transcriptional changes in ICAM-1 to be measured. 
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However, another group have observed changes at earlier time points. In a study of the 
effect of H2O2 on endothelial cell adhesiveness, expression of steady state ICAM-1 
mRNA and protein was determined in human umbilical cord vein endothelial cells 
[324]. It was reported that adhesion of human leukocytes to the endothelium, ICAM-1 
protein and ICAM-1 mRNA were all increased following stimulation with H2O2 within two 
hours. Furthermore, the addition of catalase inhibited H2O2-induced adhesion. 
Differences between our investigations and those of others could arise due to factors 
such as use of a hybrid cell line instead of primary endothelial cells; the timing of 
measurement to allow for transcription, trafficking, or degradation; and the stability of 
the initial H2O2 signal and how long it is maintained for. In a similar manner to 
experiments analysing CCR2 expression, protein levels alone do not provide a 
dynamic assessment of ICAM-1 localisation, trafficking or activation, which are likely to 




H2O2 and cell viability 
 
The MTT cell viability assay was employed to assess the toxicity of H2O2 in our cell 
populations. Our results indicate that sub-milimolar concentrations of exogenous H2O2, 
catalase or DPI, did not affect mitochondrial enzymatic activity. In experimental models 
exploring the physiological functions and toxic effects of H2O2, cultured cells are often 
exposed to H2O2 added as a bolus into the culture medium, as was the case in our 
experiments. In these settings, considerable variations in the concentrations of H2O2 
determined to be cytotoxic can be found ranging from less than 10µM to 1000µM [434]. 
In a study of mammalian cell viability, Nakamura et al (2003) reported that micromolar 
concentrations of H2O2 induce oxidative DNA lesions more efficiently than milimolar 
concentrations [435]. Because of the variability and inconsistency between reported 
effects of H2O2, Gulden et al (2010) demonstrated that experimental conditions such as 




Extracellular ATP promotes chemokinesis 
 
Extracellular ATP is a damage-associated signal, which, like H2O2, can have distinct 
effects at different concentrations. Elevated and sustained concentrations of ATP 
cause cell death through P2X7R signalling [363] while lower concentrations have been 
linked with regulatory processes such as cell proliferation [436]. We were interested to 
investigate the effects of sub-toxic concentrations of ATP on immune cell function in 
vitro. Importantly, no loss of cell viability was observed with any of the ATP 
concentrations used in these studies.  
 
In the ChemoTx migration assay, monocytes and neutrophils migrated towards 
increasing sub-milimolar concentrations of ATP with a bell shaped response curve. 
These observations were similar to published studies showing migration of human 
blood-derived monocytes and macrophages to ATP in the ChemoTx migration assay 
[437]. ATP-mediated chemotaxis of THP-1 monocytes was pertussis toxin sensitive, 
indicating that migratory processes are likely to be activated by the action of G 
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proteins, possibly downstream of the ATP-sensitive P2Y receptors. Indeed, Chen et al 
(2006) report that ATP release by human neutrophils at their leading edge directly 
feeds back through P2Y2Rs to amplify chemotactic signals and direct cell orientation 
[438]. 
 
To determine whether the ATP-induced migration of monocytes and neutrophils was 
dependent on gradient formation, studies were conducted in which ATP was added to 
the upper compartment of the chemotaxis chamber, together with the cell population. 
Migration of cells with ATP in the cell compartment was increased in the absence of an 
additional chemoattractant cue in the bottom chamber, indicating ATP was stimulating 
chemokinesis. This result echoes previous observations by Lambert et al (2010), 
where ATP-mediated migration of microglia was found to be due to ATP-mediated 
chemokinesis [437].  
 
When monocytes were plated with ATP in the upper compartment, migration to MCP-1 
was also considerably increased, even at lower concentrations of ATP. This suggests 
that the chemokinetic effect of ATP was potentiating MCP-1/CCR2-mediated migration. 
However, when neutrophils were plated with ATP in the upper compartment, their 
migration to IL-8 was inhibited, while migration to plain media was increased. This 
result is conflicting with other reports that show ATP synergises with IL-8 to activate 
neutrophil migration [439]. However, it is important to consider that IL-8-induced 
neutrophil chemotaxis requires concurrent activation of P2Y2R by ATP [439], and this 
may be gradient sensitive. Additionally, cell activation by IL-8 is likely to induce ATP 
release [440], which, together with exogenously added ATP, may push the extracellular 
concentration towards excessive levels and thus inhibit migration, as observed with our 
earlier bell-shaped concentration response curve.  
 
Our results indicate that ATP might regulate distinct responses in monocytes and 
neutrophils. It was therefore important to test whether H2O2 could also influence ATP-
mediated chemokinesis. Consistent with earlier results, plating monocytes or 
neutrophils with H2O2 in the top compartment of the chemotaxis chamber resulted in 
the inhibition of migration towards ATP. This suggests that H2O2 may be inhibiting ATP-
induced chemokinesis and provides additional evidence to support the hypothesis that 
H2O2 is acting to inhibit global motility and not directed chemotaxis in the ChemoTx 
migration assay.  
 
To further explore the effect of ATP on cell activation, we also studied the ability of ATP 
to induce cell polarisation and spreading on fibronectin. Staining of F-actin in fixed 
ATP-treated THP-1 monocytes revealed a concentration dependent decrease in 
circularity, and a concurrent increase in cell area, indicative of an activated phenotype. 
This response is in agreement with early studies that revealed extracellular ATP 
promotes the formation of microglial processes that are characteristic of the 
surveillance state [441]. To extend this investigation we compared the immediate 
morphological responses of monocytes to bolus additions of ATP, H2O2 or MCP-1 
using time-lapse imaging. Within seconds of ATP stimulation, membrane extensions 
are visible on all sides of the cell and are indicative of rapid activation capable of 
driving motility. This was not observed with H2O2, where only small and broader 
lamellipodial extensions were formed more slowly, although not in one particular 
direction or with any comparable intensity to ATP. In contrast to both damage 
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associated cues, MCP-1 induced the formation of what appeared to be one leading 
broad projection, promoting its role as a chemoattractant even in the absence of a 
gradient. Taken together, these morphological studies support the idea that H2O2 and 








Figure 4.34: Proposed model for redox and ATP-mediated control of cell polarisation and 
phagocytosis. Bacterial and intermediate chemoattractant cues activate GPCRs, which in turn 
activate NOX enzymes to generate H2O2. Extracellular H2O2 can feedback into cells and 
activates signalling pathways including MAPK and PI3K cascades. H2O2 may be acting on 
downstream signalling mediators to inhibit actin-driven processes such as migration and 
phagocytosis. Chemokine receptor activation also leads to production of ATP, which feedback 
through P2YRs to engage similar pathways involved in actin reorganisation. Addition of 
exogenous H2O2 or ATP exacerbates the signalling pathways shown. Catalase can break down 
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CHAPTER 5: SFK AND PI3K SIGNALLING AND FUNCTION IN 














































Src family kinases (SFKs) are a conserved group of enzymes known for their 
widespread cellular functions across many signalling pathways in multiple species. In 
human cells, multiple SFK family members play overlapping roles, particularly during 
activation of the immune system. They signal downstream of various receptor types by 
phosphorylating tyrosine residues and enable recruitment of key adaptor molecules, 
including Syk kinase. Importantly, SFKs have been shown to act as redox sensors in 
vivo and are involved in driving immune cell recruitment to a wound [282]. 
 
Earlier in this thesis, using an embryonic Drosophila model of tissue damage, we have 
observed a significant role of SFK member Src42A in hemocyte recruitment to a 
wound. Furthermore, we have detected compromised motility and directed migration of 
hemocytes in flies lacking functional Src42A. These results agree with external reports 
suggesting a role for zebrafish Src42A homologue Lyn in neutrophil recruitment in a 
similar tissue damage model [282]. We have also shown that the adaptor molecule Syk 
(Drosophila Shark) is also involved in mediating immune cell migration to a wound in 
Drosophila (see section 3.3). In light of these findings, a natural progression for this 
study is to next examine the role of SFKs and Syk in human innate immune cell 
function, to identify possible conservation or divergence in responses between species. 
To achieve this, pharmacological modulators of SFK and Syk can be used in in vitro 
models of innate cell activation and function.  
 
Hanke et al (1996) first reported of PP1, a pyrazolopyrimidine, and its close relative 
PP2, both discovered in tyrosine kinase inhibitor screens [442]. PP1 and PP2 display 
considerable selectivity for SFKs, although they do not discriminate between family 
members. Hanke’s group used an in vitro kinase assay with human peripheral blood 
lymphocytes to indicate PP2 IC50 values against Lck (4nM), Hck (5nM), Fyn (5nM), 
JAK2 (>50µM), and EGF-R (480nM) [442]. In a later, more comprehensive screen, PP1 
and PP2 inhibited Src and Lck with IC50 values of 50nM, whereas Csk, p38a MAPK 
and CK1d were inhibited with 3-10 fold lower potency. Interestingly, RIP2 was inhibited 
more potently than either Src or Lck [443]. A recent kinome profile using a panel of 
over 200 kinases deemed PP2 to be non-selective [444].  
 
One report has questioned the mechanism of action of PP2 as a competitor for the 
ATP binding pocket of SFKs. Karni et al (2003) report that PP1 and PP2 are not ATP 
competitors and are ‘mixed-competitive’ regarding the substrate [445]. The relative 
selectivity of PP1/PP2 towards active Src may be accounted for by their binding to a 
unique domain close to the substrate site but removed from the ATP binding domain. 
The sequences of Src, Lck and Hck at domains adjacent to the ATP binding site show 
significant differences. PP2 may therefore bind to the ATP-adjacent domain, and this 
would account for the significant differences in the IC50 values for PP2 for Hck, Lck, 
Fyn and Src demonstrated by Hanke et al (1996) [445].  
 
The small molecule protein kinase inhibitor piceatannol can be used to study the 
contribution of Syk in the responses of monocytes and neutrophils to chemoattractants. 
Piceatannol is a resveratrol analogue that exhibits anti-proliferative and anti-
inflammatory effects. It inhibits protein tyrosine kinases by competing for the tyrosine-
containing substrate binding site [446]. In a cell-free kinase activity assay, piceatannol 
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was shown to inhibit p40 kinase, a proteolytic fragment of Syk, with Ki = 15µM. This 
concentration was lower than that required in inhibit Lck [446]. Another study showed 
that piceatannol is also more selective for Syk (IC50 = 10µM, cell-free kinase assay) 
than another SFK, Lyn (IC50 = 100µM) [447].  
 
The role of PI3K enzymes in leukocyte biology has been extensively studied and it is 
clear that PI3K signalling contributes to many cellular processes, especially those 
involved in immune responses. PI3K signalling has been reported to regulate 
neutrophil protrusion and polarity in an in vivo zebrafish model by activation of Rac in a 
spatial manner within cells [190]. Additionally, PI3K has been shown to be essential for 
hemocyte chemotaxis towards a wound in a Drosophila embryonic wound model [269]. 
To complement our investigations into SFK signalling in innate cells, we also sought to 
examine the role of PI3K in models of human innate immune cell chemotaxis using 
pharmacological tools.  
 
Pan-isoform inhibitors such as LY294002 and ZSTK474 have been well studied and 
widely used to elucidate the function of PI3K. LY294002 is a first generation, non-
selective and reversible inhibitor of PI3K [448], with some activity against mTOR 
signalling at concentrations above 5µM [196]. ZSTK474 is an ATP-competitive inhibitor 
of class I PI3K isoforms with weak activity against mTOR even at high micromolar 
concentrations [197]. In vivo models have revealed that ZSTK474 inhibits the growth of 
solid tumours in mice xenograft models [449], and is currently in Phase I clinical trials 
in patients with solid tumours. ZSTK474 also has anti-inflammatory effects. A recent 
study demonstrated that ZSTK474 protected mice from collagen-induced arthritis [450], 
and another showed that ZSTK474 ameliorates the progression of adjuvant-induced 
arthritis in rats [451]. 
 
As PI3K family members are involved in many different processes, therapeutic 
targeting of PI3K with pan-isoform inhibitors is likely to provoke strong side effects. 
Therefore, endogenous and leukocyte-specific negative regulators of PI3K have 
emerged as potential therapeutic candidates through which PI3K signalling can be 
modulated. SHIP-1 and PTEN control local spatial localisation of PI(3,4,5)P3 and thus 
regulate cell polarisation, as described in section 1.2.2.  
 
SHIP-1 dephosphorylates the PI3K product PI(3,4,5)P3, yielding PI(3,4)P2. SHIP-1 
activators should therefore mimic the actions of PI3K inhibitors and provide an 
alternative way of targeting the PI3K pathway. Aquinox pharmaceuticals have 
developed SHIP-1 activating compounds for application in inflammatory disorders. 
AQX-1 (AQX-1125) is the most advanced and displayed positive effects in a recent 
Phase I clinical trial for asthma [452]. AQX-1 directly binds to SHIP-1 and requires an 
intact SHIP-1 C2 domain to function [201]. 260nM AQX-1 was demonstrated to inhibit 
monocyte migration by 50% in a modified Boyden chamber chemotaxis assay [201]. 
This compound has now entered Phase II trials for the treatment of COPD and 
interstitial cystitis.  
 
In addition to mimicking PI3K inhibition using a SHIP-1 activator, we also tested a 
SHIP-1 inhibitor to demonstrate whether relieving the negative regulation of PI3K could 
affect functional responses. 3 α-aminocholestane (3AC) is a selective, small molecule 
inhibitor of SHIP-1, although the site of drug-protein interaction is unclear [202]. 3AC 
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inhibits SHIP-1 with an IC50 value of 10µM, compared to >1mM against SHIP-1 or 
PTEN, as determined using an in vitro phosphatase assay [202]. SHIP-1 inhibition by 
3AC triggers apoptosis of human acute myeloid leukaemia cell line, and may serve to 
increase immunoregulatory capacity [202]. 
 
PTEN is another PI3K negative regulator that converts PI(3,4,5)P3 to PI(4,5)P2. We 
tested an inhibitor of PTEN, dipotassium bisperoxo (5-hydroxypyridine-2-carboxyl) 
oxovanadate (BpV(HOpic)). BpV(HOpic) has a reported IC50 value of 14nM in an in 
vitro phosphatase assay [453]. Other groups have reported that Dictyostelium cells 
lacking PTEN fail to migrate efficiently and show increased frequency of spontaneous 
protrusion and multiple, broad pseudopodia pointing generally but not directly at a 
chemoattractant source [454], [455]. Therefore, it is important to investigate whether 
pharmacological inhibition of PTEN could also affect leukocyte migration in vitro. 
 
Additionally, a focussed study of specific class I PI3K isoforms in cell polarisation and 
spreading will be undertaken to study the roles of individual PI3K isoforms in more 
detail. Isoform-selective inhibitors against p110α (A66), p110β (GSK2636771) and 
p110δ (IC87114) are described with IC50 values in more detail in section 1.2.2 and 
table 1.3. 
 
In summary, this chapter aims to examine the contribution of SFK and PI3K signalling 
to monocyte and neutrophil motility, chemotaxis and actin organisation. We also aim to 
investigate whether the wound cue H2O2 can influence SFK signalling in human innate 
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5.2 Distinct roles for SFK and Syk during innate cell chemotaxis 
 
Our first objective was to identify the contributions of SFK signalling mediators in innate 
cell chemotaxis using the ChemoTx migration assay. Using pharmacological inhibitors 
of SFKs and Syk, we hoped to identify an effect upon migration to known 
chemoattractants. THP-1 monocytes and primary human neutrophils were pre-treated 
with the pan-SFK inhibitor PP2, or the Syk kinase inhibitor piceatannol, for 30 minutes 
before chemotaxis to known chemoattractants was measured using the ChemoTx 
migration assay.  
 
PP2 inhibited both THP-1 monocyte migration to 10nM MCP-1, and primary neutrophil 
migration to 10nM IL-8 (Figure 5.1a+b). PP2 inhibited monocyte migration to MCP-1 
with an IC50 value of approximately 100nM, greater than previously reported values in 
alternative kinase assays [442]. In both cell types, basal migration to plain media was 
also inhibited by pre-treatment with PP2.  
 
Interestingly, MCP-1-mediated THP-1 monocyte migration was significantly enhanced 
following treatment with Syk inhibitor piceatannol, in a concentration dependent and 
bell-shaped manner (Figure 5.1a). Piceatannol increased MCP-1-mediated chemotaxis 
with an EC50 value of approximately 100nM. Pre-treatment with piceatannol had no 
significant effect on basal THP-1 monocyte migration. Conversely, pre-treatment of 
primary human neutrophils with 1µM piceatannol significantly inhibited chemotaxis 
towards 10nM IL-8 (Figure 5.1b). 
 
 
5.3 SFK and H2O2 may signal through a common pathway 
 
We have observed that both exogenous H2O2 and SFK inhibition induce similar 
inhibition of both monocyte and neutrophil chemotaxis to known chemoattractants. SFK 
and H2O2 signalling has previously been linked in studies with zebrafish models of 
inflammation [282], where it was proposed that H2O2 oxidises zebrafish SFK Lyn in 
neutrophils, leading to migration. We have taken a simplistic in vitro approach to 
identify whether SFK and H2O2 could signal via the same pathway in human cells. We 
compared the effect of inhibiting SFKs, or treating cells with exogenous H2O2, alone 
and in combination.  
 
THP-1 monocytes and primary neutrophils were treated with 0.1µM PP2 alone, 10µM 
H2O2 alone, or both 0.1µM PP2 and 10µM H2O2 in combination for 30 minutes before 
being exposed to a chemoattractant in the ChemoTx migration assay. In both cell 
types, all treatment combinations induced very similar inhibition in chemoattractant-
mediated migration to approximately 50% of chemoattractant-induced and basal 
responses. There were no significant differences observed when cells were treated 
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Figure 5.1: Syk inhibition increases THP-1 monocyte chemotaxis but inhibits neutrophil 
chemotaxis, SFK inhibition inhibits both monocyte and neutrophil chemotaxis. (A) THP-1 
monocytes or (B) primary human neutrophils were washed in serum-free media, resuspended 
to 3.2x106 cells/ml and incubated with piceatannol (Syk inhibitor) or PP2 (SFK inhibitor) for 30 
minutes at 37°C before being plated on top of filter membrane above lower chambers 
containing (A) 10nM MCP-1 or (B) 10nM IL-8 or plain media. Migration is expressed as 
chemotactic index (left panels), and as a percentage of control cells (right panels).  Chemotaxis 
across 5µm pore size membrane was determined after a 3 hour incubation at 37°C in 5% CO2 
as previously described. Data presented represents means ± SEM from at least three separate 
experiments. Statistical analyses by two way-ANOVA versus untreated control with Dunnett’s 
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Figure 5.2: Simultaneous SFK inhibition and exogenous H2O2 stimulation does not 
rescue or exacerbate migration in monocytes or neutrophils. A) THP-1 monocytes or (B) 
primary human neutrophils were washed in serum free media, resuspended to 3.2x106 cells/ml 
and incubated with 0.1µM PP2, 10µM H2O2 or both 0.1µM PP2 and 10µM H2O2 together for 30 
minutes at 37°C before being plated on top of filter membrane above lower chambers 
containing (A) 10nM MCP-1 or (B) 10nM IL-8 or plain media. Chemotaxis across 5µm pore size 
membrane was determined after a 3 hour incubation at 37°C in 5% CO2 as previously 
described. Data presented represents means ± SEM from at least three separate experiments. 
Statistical analyses by two way-ANOVA with Tukey’s multiple comparisons post hoc test where 
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5.4 Neutrophil viability is not affected by PP2 and piceatannol 
 
Pharmacological inhibitors of signalling cascades can have non-specific targeting 
effects, and may cause cytotoxicity. It was therefore sensible to establish if the 
concentrations of PP2 and piceatannol selected for these studies were exhibiting such 
an effect on the cells. In the assays described in this chapter, cells could be exposed to 
compounds for times ranging from 30 minutes to 4 hours. Therefore, we chose to 
assay viability over a 4-hour time course. 
 
Using the MTT viability assay, neither PP2 nor piceatannol had any significant effect 









Figure 5.3: Neutrophil viability is unaffected following exposure to PP2 or piceatannol. 
Primary human neutrophils were exposed to increasing concentrations of PP2 (A) or 
piceatannol (Pct) (B) or PBS vehicle control for up to 4 hours. Following culture, cells were 
assessed for viability using MTT assay. Data presented represent means (± SEM) minus plate 
background and normalized to untreated control from at least three independent experiments 
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5.5 Syk inhibition, but not SFK inhibition, potentiates MCP-1-induced THP-1 
monocyte actin organisation 
 
In the ChemoTx migration assay, THP-1 monocytes exhibited contrasting responses 
following SFK inhibition or Syk inhibition. Notably, inhibition of Syk by piceatannol 
resulted in enhanced MCP-1-mediated migration. To investigate the effect of these 
pharmacological inhibitors in more detail, THP-1 monocytes were seeded onto 
fibronectin-coated coverslips. Following treatment, cells were fixed and stained to 
visualise cellular F-actin by confocal microscopy. Quantitative analysis was carried out 
using software that calculates the degree of roundness of each individual cell, to give a 
circularity score that indicates the extent of cell polarisation and elongation, and cell 
surface area, to indicate the degree of cell spreading and flattening. 
 
Confocal microscopy of cellular F-actin revealed that MCP-1-stimulated cells had an 
irregular, elongated morphology, and appeared to be ‘polarised’ compared to untreated 
cells that were much rounder and regularly shaped (Figure 5.4a). This phenotype was 
previously demonstrated in section 4.9. Quantitative analysis revealed that MCP-1-
stimulated cells were significantly less circular (mean circularity: 0.778 versus 0.918) 
and were significantly larger (mean area: 148.4µm2 versus 123.5µm2), compared to 
untreated cells. 
 
Cells treated with 0.1µM PP2 were regular, round and without any visible lamellipodial 
projections. Quantitative analysis revealed no significant difference in circularity 
between PP2-treated and untreated cells (Figure 5.4b). However, PP2-treated cells 
were significantly smaller than untreated cells (mean area: 105.2µm2 versus 
123.5µm2). Treatment of cells with PP2 reversed the MCP-1-mediated decrease in 
circularity (mean circularity: 0.903 versus 0.778) and reversed the MCP-1-mediated 
increase in surface area (mean area: 102.0µm2 versus 148.4µm2) (Figure 5.4b).  
 
Cells treated with 0.1µM piceatannol were also regularly shaped with no clear 
membrane extension or protrusions (Figure 5.4a). Quantitative analysis revealed no 
significant difference in circularity or cell surface area between piceatannol-treated and 
untreated cells (Figure 5.4c). However, piceatannol further potentiated MCP-1-
mediated polarity (mean circularity: 0.698 versus 0.778) but did not affect the MCP-1 







Chapter 5 | SFK and PI3K function in innate immune cells 
170 
Figure 5.4: Piceatannol, but not PP2, potentiates MCP-1 induced THP-1 monocyte 
polarisation and spreading. THP-1 monocytes washed, rested and plated on coverslips 
coated with 10µg/ml fibronectin and allowed to adhere for 30 minutes. Cells were treated with 
either 0.1µM piceatannol or 0.1µM PP2 for 30 minutes, followed by either 10nM MCP-1 or PBS 
for 5 minutes. Following incubation, cells were fixed in 4% PFA, permeabilised with 0.1% Triton-
X and stained with Alexa-Fluor 488 conjugated Phalloidin and DAPI. (A) Representative images 
showing F-actin, scale bar = 20µm. (B) Circularity score (i) and area (ii) for PP2 treated cells 
and (C) circularity score (i) and area (ii) for piceatannol treated cells were calculated using 
CellProfiler software, with at least 100 individual cells analysed per sample, from at least 4 
pooled experiments. Data presented represents mean (± SEM) with statistical analysis by one 
way-ANOVA with Tukey’s multiple comparisons post hoc test where *=p<0.05, **=p<0.01, 
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5.6 Phagocytosis of latex beads and bacteria is inhibited by SFK inhibition 
 
Phagocytosis is a very complex process involving numerous recognition and signalling 
cascades, motility mechanisms, and degradation systems. SFK and Syk kinases have 
been shown to mediate phagocytic activity of glial cells in Drosophila models [287]. 
Here we sought to establish if this was also the case in human innate immune cells, by 
using IgG-opsonised fluorescent latex beads and CFSE-loaded bacteria as fluorescent 
particles for engulfment, and neutrophils and macrophages as phagocytes.  
 
Pre-treatment of primary neutrophils with 0.1µM PP2 significantly inhibited 
phagocytosis of IgG-opsonised latex beads and bacteria (Figure 5.5a+b). This was 
analysed by both flow cytometry, to measure mean fluorescence intensity of viable 
phagocytes, and confocal microscopy, with manual counting of the percentage of cells 
containing at least one particle. PP2 treatment resulted in an approximately 60% 
reduction in the phagocytosis of beads, and an 80% reduction in the phagocytosis of 
bacteria. Similarly, phagocytosis of IgG-opsonised latex beads by macrophages was 
inhibited by pre-treatment with 0.1µM PP2 (Figure 5.5c). PP2 inhibited both the 
proportion of cells engulfing beads and the average number of beads engulfed per cell, 
by approximately 50%. This was determined by confocal microscopy and manual 
counting of phagocytosed beads.  
 
 
5.7 SFK inhibition does not affect ligand-stimulated elevation of intracellular 
calcium 
 
SFK signalling operates in many cellular processes. We have previously observed an 
inhibitory effect of SFK inhibition upon innate cell chemotaxis, polarisation and 
phagocytosis. We next sought to examine whether intracellular Ca2+ ([Ca2+]i) signalling 
was compromised in these cells following similar treatment with the pharmacological 
inhibitor PP2.  Elevation of [Ca2+]i triggered by ligand stimulation is a well characterised 
observation in leukocytes and provides an assessment of signalling potential. To 
measure the responses of ligands in leukocytes pre-treated with PP2 or vehicle, cells 
were loaded with Ca2+ sensor Fluo-4 that produces a fluorescent signal relative to the 
amount of available Ca2+ in the cell.  
 
Primary human neutrophils were loaded with 10µM Fluo-4 and the fluorescence signal 
that reports [Ca2+]i was recorded continuously. After a baseline was established, cells 
were treated with 0.1µM PP2 for 10 minutes. Following incubation, cells were 
stimulated with 10nM IL-8, 10nM fMLP or 10µM H2O2 to induce a transient ligand-
stimulated elevation in [Ca2+]i. In this assay, fMLP induced a significant increase in 
detectable [Ca2+]i, as quantitatively measured by Fmax/F0 (Figure 5.6c). While both IL-8 
and H2O2 also induced an elevation of [Ca2+]i, this was not significantly greater than 
vehicle treated cells (Figure 5.6c). Importantly, pre-treatment with PP2 had no 
significant effect on the extent of [Ca2+]i elevation induced by any of the ligands tested 
(Figure 5.6b), versus vehicle treated cells (Figure 5.6a). Additionally, PP2 did not affect 
the neutrophil response to ionomycin.  
 
To summarise, the defect in chemotaxis in PP2-treated cells is not due to a defective 
calcium response. 






Figure 5.5: Macrophage and neutrophil phagocytosis of latex beads and bacteria is 
inhibited by SFK inhibitor PP2. PMA differentiated THP-1 monocytes or peripheral human 
neutrophils were incubated with 0.1µM PP2 for 30 minutes at 37°C. Cells were washed in warm 
HBSS, mixed with (A) and (C) IgG-opsonised fluorescent latex beads or (B) CFSE (10µM) 
loaded E. coli bacteria, and incubated at 37°C for 30 minutes to allow phagocytosis to occur. 
(A(i)) and (B) Cells were washed 3 times in PBS before fluorescence intensity in the viable 
neutrophil population was measured using flow cytometry. Data represents mean (±SEM) 
fluorescent signal per 10,000 cells normalised to basal or untreated fluorescence, from at least 
three separate experiments. (A(ii))  and (C) Cells were fixed in 4% PFA before being stained 
with DAPI. Samples were immediately imaged using confocal microscopy with 40x oil objective. 
Images were manually scored for neutrophils containing beads, confirmed by orthogonal 
projection imaging. Percent phagocytosis is percentage of total cells imaged containing at least 
one bead. Data presented represents means ± SEM from at least three separate experiments. 
Statistical analyses by unpaired t test where **=p<0.01 and ***=p<0.001. 
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Figure 5.6: Ligand or H2O2 induced intracellular calcium mobilisation in primary human 
neutrophils is not affected by inhibition of SFKs. Primary human neutrophils were isolated 
from peripheral human blood and loaded with 10µM Fluo-4 before being washed in Ca2+-free 
HBSS, resuspended in HBSS and extracellular calcium adjusted to 1mM. Cells were plated in 
black 96 well plates. Fluorescence was measured over time at 37°C using a plate reader (upper 
panels). 0.1µM PP2 (SFK inhibitor) or vehicle was added after baseline established and 
fluorescence signal captured for 10 minutes before 10nM IL-8, 10nM fMLP or 10mM H2O2 was 
added. For all samples, once the response had returned to baseline, 1µM ionomycin was added 
to induce a positive response. Peak change in fluorescence signal is plotted against vehicle 
control (lower panels). Data presented show representative traces from a single experiment and 
peak change graphs represent mean (± SEM) from three separate experiments, samples run in 
duplicate. Statistical analyses by two way-ANOVA with Sidak’s multiple comparisons post hoc 
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5.8 PI3K signalling is required for monocyte and neutrophil chemotaxis 
 
The PI3K signalling cascade is essential for a wide array of cellular functions and has 
been implicated in many inflammatory disease settings. Downstream effects of PI3K 
signalling include activation of migration pathways in response to chemoattractants. 
We next studied the effect of PI3K inhibition on innate cell chemotaxis in the transwell 
migration assay, in order to examine the contribution of PI3K to monocyte and 
neutrophil chemotaxis to known chemoattractants.  
 
Cells were pre-treated with increasing concentrations of pan-isoform PI3K inhibitor 
ZSTK474 for 30 minutes before being plated on porous filters above chemoattractants. 
MCP-1-mediated migration of THP-1 monocytes was significantly inhibited by 
nanomolar concentrations of ZSTK474, to approximately 50% of the untreated control 
cell response (Figure 5.7a). Basal THP-1 migration was also inhibited by ZSTK474. 
Neutrophil migration towards IL-8 was significantly inhibited by pre-treatment with 
ZSTK474 by approximately 60% (Figure 5.7b). Basal neutrophil migration was also 
inhibited by ZSTK474. 
 
Specific pharmacological modulators of other PI3K signalling components have 
recently been developed and offer researchers an alternative approach to manipulate 
PI3K signalling. Such compounds include those targeting the action of endogenous 
PI3K negative regulators, the phosphatases SHIP-1 and PTEN. Here we have 
employed two SHIP-1 modulators: AQX-1, a SHIP-1 activator (hypothesised to mimic a 
PI3K inhibitor), and 3AC, a SHIP-1 inhibitor. A PTEN inhibitor, BpV, was also used to 
study PI3K signalling in monocyte chemotaxis in the transwell migration assay. These 
compounds are described in section 5.1. 
 
THP-1 monocytes were pre-treated with increasing concentrations of AQX-1, 3AC or 
BpV for 30 minutes before being plated on porous filters above 10nM MCP-1. SHIP-1 
activation by AQX-1 resulted in concentration dependent inhibition of MCP-1-mediated 
monocyte migration, which was significant with 30µM AQX-1 (Figure 5.8a). Basal 
migration was also inhibited by AQX-1, although not significantly. Increasing 
concentrations of SHIP-1 inhibitor 3AC induced significant and concentration 
dependent inhibition of MCP-1 mediated monocyte migration with an approximate IC50 
value of 3µM; basal migration was also significantly inhibited by 30µM 3AC (Figure 
5.8b). Finally, increasing concentrations of PTEN inhibitor BpV significantly and 
concentration dependently inhibited monocyte migration towards MCP-1, and also 
inhibited basal migration, significantly with 30nM BpV (Figure 5.8c). 
 
In summary, pan-isoform PI3K inhibition, PTEN inhibition and both SHIP-1 activators 









Figure 5.7: PI3K inhibition inhibits monocyte and neutrophil chemotaxis. (A) THP-1 
monocytes or (B) primary human neutrophils were washed in serum free media, resuspended to 
3.2x106 cells/ml and incubated with increasing concentrations of ZSTK474 (pan-isoform PI3K 
inhibitor) for 30 minutes at 37°C before being plated on top of filter membrane above lower 
chambers containing (A) 10nM MCP-1 or (B) 10nM IL-8 or plain media. Migration is expressed 
as chemotactic index (left panels), and as a percentage of control cells (right panels). 
Chemotaxis across 5µm pore size membrane was determined after a 3 hour incubation at 37°C 
in 5% CO2 as previously described. Data presented represents means ± SEM from at least 
three separate experiments. Statistical analyses by two way-ANOVA versus untreated control 
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Figure 5.8: SHIP-1 inhibition and activation, and PTEN inhibition inhibits THP-1 monocyte 
chemotaxis. THP-1 monocytes were washed in serum free media, resuspended to 3.2x106 
cells/ml and incubated with increasing concentrations of (A) AQX-1 (SHIP-1 activator),  (B) 3AC 
(SHIP-1 inhibitor) or (C) BpV (PTEN inhibitor) for 30 minutes at 37°C before being plated on top 
of filter membrane above lower chambers containing 10nM MCP-1 or plain media. Migration is 
expressed as chemotactic index (left panels), and as a percentage of control cells (right panels). 
Chemotaxis across 5µm pore size membrane was determined after a 3 hour incubation at 37°C 
in 5% CO2 as previously described. Data presented represents means ± SEM from at least 
three separate experiments. Statistical analyses by two way-ANOVA versus untreated control 
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5.9 Contributions of negative regulators of PI3K on actin organisation in 
monocytes 
 
Since both inhibition and activation of the endogenous negative regulators of PI3K 
leads to inhibition of THP-1 monocyte migration, we next extended this investigation to 
examine the effects of these inhibitors on actin organisation and cell spreading. THP-1 
monocytes were plated onto fibronectin-coated coverslips and treated with 10nM BpV 
(PTEN inhibitor), 10µM 3AC (SHIP-1 inhibitor) or 10µM AQX-1 (SHIP-1 activator), or 
vehicle control for 30 minutes before being stimulated with MCP-1 or vehicle. In 
general, 3AC induced the most severe decrease in circularity and increase in cell 
surface area compared to BpV and AQX-1.  
 
BpV alone induced an elongated, irregular morphology with multiple lamellipodia, 
similar to that observed with MCP-1 alone (Figure 5.9a). Compared to untreated cells, 
BpV-treated cells were significantly less circular (mean circularity: 0.566 versus 0.654) 
and had a significantly larger surface area (mean area: 520.8µm2 versus 455.6µm2) 
(Figure 5.9b). Compared to MCP-1-stimulated, untreated cells, THP-1 monocytes that 
were treated with BpV followed by MCP-1 stimulation were smaller (mean area: 
429.6µm2 versus 477.9µm2) and more circular (mean circularity: 0.604 versus 0.551).  
 
3AC-treated cells had a large surface area and an irregular, extended morphology with 
multiple visible projections, similar to the phenotype of MCP-1-stimulated cells (Figure 
5.9a). Compared to untreated cells, 3AC-treated cells were significantly less circular 
(mean circularity: 0.506 versus 0.654) and had a significantly larger surface area 
(mean area: 555.5µm2 versus 455.6µm2) (Figure 5.9b). Cell circularity and mean 
surface area of 3AC-treated, MCP-1-stimulated cells were not significantly different to 
cells stimulated with MCP-1 in the absence of 3AC.  
 
AQX-1-treated cells were irregularly shaped and elongated, but not to the same extent 
as cells treated with MCP-1 alone (Figure 5.9a). Compared to untreated cells, AQX-1-
treated cells were significantly less circular (mean circularity: 0.604 versus 0.654) and 
had a significantly larger surface area (mean area: 517.5µm2 versus 455.6µm2) (Figure 
5.9c). AQX-1 treated monocytes showed a modest but significant inhibition of MCP-1-
mediated elongation (mean circularity: 0.597 versus 0.550), but there was no 
difference in mean cell surface area.  
 
To summarise, all treatments alone increase monocyte polarisation and spreading, 
which is roughly comparable to MCP-1-induced responses. However, BpV and AQX-1 
induce modest but significant reversal of MCP-1 mediated polarisation. 
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Figure 5.9: The effect of modulating PI3K signalling on THP-1 monocyte polarisation and 
spreading. THP-1 monocytes were plated on coverslips coated with 10ug/ml fibronectin and 
treated with 10nM BpV (PTEN inhibitor), 10µM 3AC (SHIP-1 inhibitor) or 10µM AQX-1 (SHIP-1 
activator), or vehicle control. After 30 minutes cells were stimulated with 10nM MCP-1 or vehicle 
control. After 5 minutes cells were fixed in 4% PFA, permeabilised with 0.1% Triton-X and 
stained with Alexa-Fluor 488 conjugated phalloidin and DAPI. Samples were imaged by 
confocal microscopy. (A) Representative images showing F-actin, scale bar = 20µm. (B,C&D) 
circularity score (i) and area (ii) for each treatment group were calculated using CellProfiler 
software, with at least 100 individual cells analysed per sample, from at least 4 pooled 
experiments. Data presented represents mean (± SEM) with statistical analysis by one way-
ANOVA with Tukey’s multiple comparisons post hoc test where *=p<0.05, **=p<0.01, 
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5.10 Contributions of individual class IA PI3K isoforms to actin organisation in 
monocytes 
 
The generation of isoform specific knock-out mouse lines and isoform-specific 
pharmacological compounds has increased our knowledge of PI3K signalling. These 
tools have enabled researchers to investigate the contribution of specific PI3K isoforms 
in disease settings, and have highlighted that p110γ and p110δ isoforms have 
important non-redundant functions in multiple cells of the immune system [193]. Here, 
our aim was to investigate the effect of inhibiting individual class IA PI3K isoforms on 
the ability of human monocytes to organise actin and spread on a substrate in the 
presence and absence of MCP-1.  
 
THP-1 cells were seeded onto fibronectin-coated coverslips and treated with 
compounds or vehicle for 30 minutes followed by 10nM MCP-1 or vehicle for 5 
minutes. Cells were then fixed and stained to visualise cellular F-actin by confocal 
microscopy. Concentrations of inhibitors were chosen based on published data, as 
described in section 1.2.2. Consistent with our previous experiments, MCP-1-
stimulation induced an elongated, irregular cell shape, with visible lamellipodia 
formations (Figures 5.10-11).  
 
Treatment with pan-isoform PI3K inhibitor LY294002 alone did not affect circularity, 
although cells did have significantly smaller surface area compared to untreated cells 
(mean area: 487.2µm2 versus 612.6µm2) (Figure 5.10b). LY294002 treatment 
significantly attenuated MCP-1-mediated elongation (mean circularity: 0.430 versus 
0.381) and significantly decreased the MCP-1-mediated increase in cell surface area 
(mean area: 523.5µm2 versus 690.5µm2). Similarly, treatment with pan-isoform PI3K 
inhibitor ZSTK474 alone did not affect circularity, but cells were smaller than untreated 
cells (mean area: 466.7µm2 versus 612.6µm2) (Figure 5.10c). ZSTK474 treatment 
significantly attenuated MCP-1-mediated elongation (mean circularity: 0.450 versus 
0.381) and significantly decreased the MCP-1-mediated increase in cell surface area 
(mean area: 507.2µm2 versus 690.5µm2). 
 
Monocytes that were treated with PI3K p110α-selective inhibitor A66 did not differ in 
mean circularity or area compared to untreated, unstimulated cells (Figure 5.11b). A66 
treatment significantly increased MCP-1-mediated elongation (mean circularity: 0.453 
versus 0.525), but did not affect the MCP-1-mediated increase in cell surface area. 
Treatment with PI3K p110β-selective inhibitor GSK2636771 did not affect mean 
circularity or surface area compared to basal cells (Figure 5.11c). However, 
GSK2636771 treatment significantly attenuated MCP-1-mediated elongation (mean 
circularity: 0.654 versus 0.525) and attenuated the MCP-1-mediated increase in cell 
surface area (mean area: 364.2µm2 versus 491.3µm2). Monocytes that were treated 
with PI3K p110δ-selective inhibitor IC87114 were significantly more round compared to 
untreated, unstimulated cells (mean circularity: 0.501 versus 0.437) (Figure 5.11d). 
IC87114 treatment significantly attenuated MCP-1-mediated elongation (mean 
circularity: 0.438 versus 0.381) and significantly decreased the MCP-1-mediated 
increase in cell surface area (mean area: 492.8µm2 versus 690.5µm2).  
 
To summarise, pan-isoform, p110δ and p110β, but not p110α, PI3K inhibitors abrogate 
MCP-1-mediated monocyte polarisation and spreading on fibronectin (see summary 
table 5.1). 
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Figure 5.10: The effect of pan-isoform PI3K inhibitors on THP-1 monocyte actin 
organisation. THP-1 monocytes were plated on coverslips coated with 10ug/ml fibronectin and 
treated with 1µM LY294002 (pan-isoform p110 inhibitor), 40nM ZSTK474 (pan-isoform p110 
inhibitor) or vehicle control. After 30 minutes cells were stimulated with 10nM MCP-1 or vehicle 
control. After 5 minutes cells were fixed in 4% PFA, permeabilised with 0.1% Triton-X and 
stained with Alexa-Fluor 488 conjugated phalloidin and DAPI. Samples were imaged by 
confocal microscopy. (A) Representative images showing actin staining (green), scale bar = 
20µm. (B,C&D) circularity score (i) and area (ii) for each treatment group were calculated using 
CellProfiler software, with at least 100 individual cells analysed per sample, from at least 4 
pooled experiments. Data presented represents mean (± SEM) with statistical analysis by one 
way-ANOVA with Tukey’s multiple comparisons post hoc test where *=p<0.05, **=p<0.01, 
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Figure 5.11: The effect of p110α, β and δ-selective PI3K inhibitors on THP-1 monocyte 
actin organisation. THP-1 monocytes were plated on coverslips coated with 10ug/ml 
fibronectin and treated with 30nM A66 (p110α inhibitor), 20nM GSK2636771 (p110β inhibitor), 
70nM IC87114 (p110δ inhibitor) or vehicle control. After 30 minutes cells were stimulated with 
10nM MCP-1 or vehicle control. After 5 minutes cells were fixed in 4% PFA, permeabilised with 
0.1% Triton-X and stained with Alexa-Fluor 488 conjugated phalloidin and DAPI. Samples were 
imaged by confocal microscopy. (A) Representative images showing F-actin, scale bar = 20µm. 
(B,C&D) circularity score (i) and area (ii) for each treatment group were calculated using 
CellProfiler software, with at least 100 individual cells analysed per sample, from at least 4 
pooled experiments. Data presented represents mean (± SEM) with statistical analysis by one 
way-ANOVA with Tukey’s multiple comparisons post hoc test where *=p<0.05, **=p<0.01, 





























































































































































































































































































































































































































































































































































































































 Effect on THP-1 
circularity  
Effect on THP-1 
spreading (area) 
Compound Mechanism - MCP-1 + MCP-1 - MCP-1 + MCP-1 
LY294002 Pan-isoform PI3k 
Inhibitor 
- ! " " 
ZSTK474 Pan-isoform PI3k 
Inhibitor 
- ! " " 
      
A66 p110α inhibitor - - - - 
GSK2636771 p110β inhibitor - ! - " 
IC87114 p110δ inhibitor ! ! - " 
      
BpV PTEN inhibitor " ! ! - 
3AC SHIP-1 inhibitor " - ! - 




Table 5.1: Summary of the actions of PI3K inhibitors and modulators upon THP-1 
monocyte polarisation and spreading on fibronectin. Summary of results from Figure 5.9-
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5.11 Chapter 5 – Summary of Results 
 
• Inhibition of SFKs blocked monocyte and neutrophil chemotaxis, 
chemoattractant-mediated polarisation and spreading, and phagocytosis of 
beads and bacteria. 
• Ligand-stimulated transient intracellular Ca2+ responses in neutrophils are not 
PP2-sensitive. 
• Inhibition of Syk kinase inhibits neutrophil chemotaxis to IL-8 but promotes 
monocyte chemotaxis to MCP-1. 
• Inhibition of Syk kinase potentiated MCP-1-mediated monocyte polarisation. 
• Pharmacological inhibitors of SFK and Syk kinases do not affect neutrophil 
viability. 
 
• Inhibition of PI3Ks blocked monocyte and neutrophil chemotaxis.  
• Activation and inhibition of SHIP-1, and inhibition of PTEN, blocked monocyte 
chemotaxis. 
• p110β and p110δ, but not p110α, PI3K isoforms are involved in monocyte 
polarisation and spreading. 
 
 
5.12 Chapter 5 – Discussion  
 
 
SFKs mediate innate cell migration, polarisation and phagocytosis 
 
Studies with rodent SFK knock-out strains first highlighted the importance of SFK 
signalling in immune cell function. However, the need for a simplistic in vitro model led 
to the design of novel, potent, SFK-selective small molecule inhibitors. Generating 
selective inhibitors for kinases remains a considerable challenge because essentially 
most kinase inhibitors function through competitive binding in a highly conserved ATP 
pocket. Genetic techniques (e.g. RNAi) can inactivate specific genes, but most kinases 
are multi-domain proteins and each domain has an independent function. Small 
molecules have the potential to inhibit kinase catalytic activity without affecting the 
other domains.  
 
The SFK inhibitor PP2 was used to study the role of SFKs in innate cell function. PP2-
treated monocytes and neutrophils displayed significantly impaired chemotaxis towards 
MCP-1 or IL-8 in the ChemoTx migration assay. Furthermore, basal migration of both 
cell types was also inhibited. While considering the previously discussed caveats of 
PP2 (see section 5.1), this would suggest that SFKs contribute to chemoattractant-
mediated and basal migration in these cell types. Our results agree with previously 
published reports demonstrating PP2-mediated inhibition of MCP-1-mediated THP-1 
chemotaxis [140] and IL-8- and fMLP-mediated human neutrophil chemotaxis [142], 
[456] in similar transwell migration models. Notably, Yoo et al (2011) showed that 
micromolar concentrations of PP2 inhibited H2O2-mediated neutrophil chemotaxis in 
the under agarose migration assay [282]. Our observed IC50 value for PP2 (100nM) is 
higher than previously published values for PP2 activity against SFK members [442], 
however these were carried out in cell-free kinase assays. In spite of this, our observed 
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inhibition of chemotaxis at high nanomolar concentrations of PP2 may be due to off-
target inhibition of other kinases.   
 
The effect of SFK inhibition by PP2 on THP-1 monocyte morphology and spreading on 
fibronectin was also studied. Fibronectin is an important ligand for integrins, and will 
induce integrin signalling. MCP-1 triggers the rearrangement of F-actin leading to 
increased adhesion and spreading. This is likely to be mediated by an SFK-dependent 
pathway because pre-treatment with 0.1µM PP2 blocked MCP-1-induced spreading 
and polarisation. Consistent with its actions on actin-mediated processes, PP2 
inhibited neutrophil phagocytosis of IgG-opsonised beads and bacteria, and inhibited 
macrophage phagocytosis of IgG-opsonised beads. IgG-opsonised bead recognition 
will activate FcγR signalling. Hck and Lyn phosphorylate ITAMs in the signalling chains 
of the FcγR complex, which then serve as docking sites for other tyrosine kinases, 
such as Syk [457]. The global inhibitory effect of PP2 on phagocytosis indicates that 
SFKs do not discriminate between the type of particle being detected and engulfed, 
and are therefore likely to be involved in regulating processes downstream of various 
receptors. 
 
We briefly investigated the effect of SFK inhibition on chemoattractant-induced 
intracellular signalling processes. Neutrophil pre-treatment with PP2 did not affect 
ligand- or ionomycin-mediated mobilisation of intracellular calcium, suggesting that this 
is an SFK-independent process. Similarly, PP2 did not affect cell viability with the 
concentrations tested in these experiments, so it is unlikely that potential toxicity is 
influencing our results. 
 
Taken together, our results are consistent with the finding of many others. SFKs 
regulate several actin-dependent processes, for example, Hck has been shown to 
regulate F-actin based membrane protrusions [458], monocyte chemotaxis [149], [459], 
phagocytosis [460], [461] and cellular adhesion [462]. Recently, Sanjuan et al (2006) 
discovered that SFK activation downstream of TLR9 resulted in cytoskeletal changes 
and transcription of effector genes. Upon TLR9 activation by CpG, Pyk2, Vav, Cbl, 
talin, paxillin and vinculin (and PI3K) were all phosphorylated, and they have all been 
described as mediators of actin cytoskeleton rearrangement that promote spreading, 
adhesion and motility. Furthermore, PP2 blocked the phosphorylation of Pyk2 and 
Vav1, and inhibited cellular adhesion [463]. 
 
 
Do SFKs and H2O2 act through a common pathway? 
 
H2O2 has been suggested to act directly on SFKs. This has been demonstrated in vivo 
where wound-generated H2O2 directly oxidises and activates Lyn [282]. However, 
contrary to these reports, our results suggest that exogenous H2O2 is acting in an 
inhibitory manner upon human cell motility. We briefly explored the possibility that SFK- 
and H2O2-mediated signalling occurred in the same pathways using the in vitro 
ChemoTx migration assay. Treatment of monocytes or neutrophils with either PP2 or 
H2O2 alone inhibits migration towards MCP-1 or IL-8 by approximately 50%, thus 
providing a potential window to observe exacerbation or rescue of the phenotype. We 
next treated the cells with PP2 and H2O2 simultaneously and observed the effect on 
chemotaxis. Co-treatment was not significantly different to either treatment alone. If 
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PP2 and H2O2 were acting via different pathways, we would predict the inhibitory 
effects to be additive.  
 
Together, these results confirm that SFK activity is necessary for migration towards a 
chemoattractant. They also support our earlier results indicating that in this assay, 
exogenous H2O2 inhibits migration towards a chemoattractant, in a similar manner to 
inhibition induced by PP2. Observing no change to the phenotype seen when SFK 
inhibition and H2O2 are applied simultaneously suggests that both PP2 and H2O2 could 
be inhibiting migration through a common mechanism. This could be by directly 
targeting SFKs or by targeting downstream mediators of SFK signalling that contribute 
to motility; this cannot be confirmed from this experiment alone. Additionally, the non-
specific nature of PP2 could lead to inhibition of other kinases that are also targets for 
oxidation by H2O2.  
 
Candidate proteins downstream of SFKs that are involved in actin-mediated processes 
and could be targets for inhibitory oxidation by H2O2 identified in vitro include Pyk2, Cbl 
and Vav. SFK-mediated phosphorylation of Pyk2 promotes actin cytoskeletal 
rearrangements that induce adhesion, spreading and lamellipodial formation [146]. Cbl 
interacts with SFKs, Pyk2 and Vav and has been associated with increased 
macrophage motility [147]. Vav is a multi-domain signal integrator and transduces 
signals to cytoskeleton-dependent pathways, including PI3K [464].  
 
 
Syk kinase in migration and spreading 
 
The role of Syk kinase in chemoattractant-mediated migration has not yet been fully 
elucidated. It has been demonstrated that Syk does not play a major functional role in 
chemoattractant signalling in neutrophils or mast cells [167]. Migration of neutrophils 
towards fMLP was not affected in Syk deficient cells, and fMLP initiated normal 
polymerization of cellular actin in the absence of Syk [167]. Another report suggests 
that Syk makes a limited contribution to β2 integrin-mediated migration of neutrophils 
[465]. However, in vivo studies showed that Syk is necessary for firm leukocyte 
adhesion to inflamed endothelia [466]. Gevrey et al (2005) report that Syk is required 
for chemotaxis of a monocyte/macrophage cell line to CX3CL1 [157]. CX3CL1 triggers 
an increase in F-actin and the formation of actin-rich cell protrusions, in addition to Syk 
activation. Syk inhibition by small molecule inhibitors and RNAi impairs the migration of 
a mouse macrophage cell line to CX3CL1 and F-actin reorganisation [157].  
 
When THP-1 monocytes were pre-treated with Syk inhibitor piceatannol and placed in 
the upper compartment of the ChemoTx migration assay above MCP-1, we found that 
chemotaxis was significantly enhanced compared to untreated control cells. Basal 
THP-1 monocyte migration was not significantly affected by piceatannol. These results 
suggest that Syk may be acting in a regulatory manner downstream of MCP-1/CCR2 
activation. This result was unexpected, given that others have demonstrated a role for 
Syk in leukocyte migration and have shown piceatannol activity against Syk with 
IC50=10-15µM [447]. In contrast, both basal and IL-8-mediated primary human 
neutrophil migration was inhibited by ~60-80% when pre-treated with piceatannol, 
compared to untreated cells. This suggests that in neutrophils, Syk is necessary for IL-
8/CXCR1/2 signalling driving migration, and that these receptors may link to ITAM-
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containing motifs, which subsequently recruit Syk. Integrin receptors associated with 
ITAM-containing motifs, for example, may associate with CXCR1/2.  
 
We next studied the effects of piceatannol pre-treatment on THP-1 monocyte actin 
organisation and spreading on fibronectin. We found that while piceatannol did not alter 
monocyte circularity, monocyte area was increased. When monocytes were stimulated 
with MCP-1 in addition to piceatannol pre-treatment, polarisation and spreading was 
not significantly affected. This suggests that Syk may be involved in monocyte 




PI3K and its modulation by negative regulators – effects on migration and actin 
organisation 
 
Our results show that in an in vitro model of chemotaxis, both basal and 
chemoattractant-mediated monocyte and neutrophil migration required PI3K signalling 
and was inhibited by pan-isoform selective inhibitor ZSTK474. These results provide 
more evidence to support the function of ZSTK474 as an anti-inflammatory compound. 
Leukocyte migration was inhibited by 50% with nanomolar range concentrations of 
ZSTK474, which is consistent with other reported IC50 values for ZSTK474 against all 
p110 isoforms [197], as shown in table 1.3.  
 
In order to provide alternative ways to target the PI3K pathway, a SHIP-1 activator 
compound was used to mimic the effects of PI3K inhibition. Using in vitro models, 
others have demonstrated that the SHIP-1 specific activator AQX-1 inhibits monocyte 
chemotaxis to MCP-1 [201]. Our results confirm this – migration of AQX-1-treated THP-
1 monocytes to MCP-1 was significantly impaired compared to untreated cells. Basal 
migration was also inhibited, although this was not statistically significant. This result 
does indeed mimic the response we have demonstrated with the PI3K inhibitor 
ZSTK474.  
 
We also tested the SHIP-1 inhibitor 3 α-aminocholestane (3AC) in this assay, and 
hypothesised that SHIP-1 inhibition would potentially lead to enhanced migration, due 
to relief of negative regulation of PI3K signalling by SHIP-1 in these cells. Interestingly, 
we found that 3AC actually inhibited monocyte basal and MCP-1-mediated migration in 
a similar fashion to AQX-1. Our IC50 value for 3AC (3µM) mirrored those previously 
demonstrated in phosphatase assays [202]. 
 
Inhibition of a second negative regulator of PI3K, PTEN, was hypothesised to again 
induce a migratory phenotype. Our results indicate that, similar to SHIP-1 inhibition, 
basal and MCP-1-mediated migration of BpV-treated monocytes was significantly 
impaired compared to control cells. Interestingly, others have shown that loss of PTEN 
in neutrophils has no impact on neutrophil chemotaxis [467], indicating that the role of 
PTEN in neutrophils and monocytes may be distinct. 
 
As morphological polarisation is a pre-requisite for cell motility, we investigated the 
effects of SHIP-1 and PTEN inhibition/activation on actin organisation and spreading of 
THP-1 monocytes on fibronectin. We found that both the SHIP-1 inhibitor 3AC and the 
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SHIP-1 activator AQX-1 increase basal cell surface area and irregularity, and decrease 
circularity. In response to MCP-1, 3AC and AQX-1-treated monocytes remain broad 
and poorly polarised. This dysregulation of actin organisation may underlie the 
impaired motility of 3AC- and AQX-1-treated THP-1 monocytes. Our results are 
consistent with the findings of a similar study, where resting SHIP-1-/- neutrophils were 
broad, flattened and surrounded by well-developed lamellipodia when seeded on glass 
coverslips [467]. In response to fMLP, SHIP-1-/- neutrophils remained poorly polarised 
with irregular lamellae present on all sides of the cell, and their chemotaxis was 
impaired.  
 
The results discussed here imply that both inhibition and activation of SHIP-1 leads to 
the same functional outcome – impaired migration and polarisation. Several groups 
have also reported opposing phenotypes in SHIP-1 deficient cells [467], [468]. In light 
of these findings, it is apparent that there exists a critical balance between PI(3,4,5)P3 
and PI(3,4)P2, which can be disrupted by SHIP-1 activation or inhibition, or PTEN 
inhibition. Indeed, both substrate (PI(3,4,5)P3) and product (PI(3,4)P2) of SHIP-1 have 
been shown to influence Akt activation and cell survival [175]. Additionally, down- or 
up-regulation of PI(3,4,5)P3 by deletion of PI3Ks or PTEN, respectively, results in 
severely reduced efficiency of chemotaxis in Dictyostelium [455]. It is clear that in order 
for a cell to positively migrate in response to a signal gradient, this balance must be in 
place to control the localisation and expression levels of phospholipids in the cell 
membrane.  
 
By introducing pharmacological tools to disrupt this balance, two outcomes may 
prevail, as illustrated in figure 5.12. Firstly, SHIP-1 activation will lead to enhanced 
dephosphorylation of PI(3,4,5)P3 and accumulation of PI(3,4)P2, leading to loss of 
localised PI(3,4,5)P3-mediated Akt activation and signalling to drive cell motility. 
Additionally, SHIP-1 can also have a masking function, as it can block the recruitment 
of other key signalling enzymes [469]. It has been demonstrated that SHIP-1 can block 
PI3K activity at immune-activating receptors by preventing PI3K recruitment to DAP10 
and DAP12 [470]. Secondly, SHIP-1 inhibition will limit the dephosphorylation of 
PI(3,4,5)P3 and, as the inhibitor is applied exogenously, lead to a de-localised ‘global’ 
increase in PI3K activity, which is not polarised at the leading edge and therefore 
cannot support directed cell migration. This may also be true for the phenotype 
demonstrated by PTEN inhibition, again leading to PI(3,4,5)P3 accumulation.  
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Figure 5.12: Inhibition and activation of SHIP-1 lead to the same functional outcome. 
Under normal conditions, PI3K and SHIP-1 regulate the levels and localisation of PI(3,4,5)P3 
and PI(3,4)P2 to coordinate functional outcomes such as cell migration. The balance between 
PI(3,4,5)P3 and PI(3,4)P2 is vital. Activation of endogenous negative regulator SHIP-1 by 
pharmacological tools such as AQX-1 leads to upregulated dephosphorylation of PI(3,4,5)P3, 
accumulation of PI(3,4)P2 and inhibition of cell migration. Similarly, inhibition of SHIP-1 by 3AC 
leads to downregulation of PI(3,4)P2 signalling and a global increase in PI(3,4,5)P3, preventing 
the cell polarisation and impairing migration. 
 
PI3K class IA isoform characterisation in monocyte polarisation and spreading 
 
Isoform-selective pharmacological inhibitors are becoming increasingly more influential 
not only in our quest for better understanding of PI3K signalling, but also in the 
development of therapeutic entities for use in the clinic. Using a 2D in vitro model of 
cell adhesion, actin organisation and spreading, we have confirmed that MCP-1-
mediated actin reorganisation in THP-1 monocytes is dependent upon PI3K signalling. 
The concentrations of compounds used in these experiments are based upon 
published IC50 values for the inhibitors against enzyme activity (see table 1.3). 
Treatment of cells with two separate pan-isoform inhibitors, LY294002 and ZSTK474, 
abrogated the MCP-1-mediated changes in F-actin and reduced mean surface area.  
 
Vanhaesebroeck et al (1999) reported that LY294002 blocked CSF1-induced actin 
reorganisation and cell migration in a murine macrophage cell line [471], which is 
consistent with our findings in human THP-1 monocytes. We found that ZSTK474 
decreased spreading of unstimulated cells and abrogated MCP-1-mediated elongation 
and spreading in THP-1 monocytes, in a comparable manner to LY294002. ZSTK474 
has been reported to exhibit anti-migratory and anti-adhesive effects on prostate 
cancer cells in vitro [472]. Together with our ZSTK474 migration results, our 
observations provide more evidence for the anti-inflammatory effects of ZSTK474, and 
are consistent with other in vitro studies.  
PI(4,5)P2 PI(3,4,5)P3 PI(3,4)P2 
SHIP-1 PI3K Balanced 
•  PI(3,4P)2  and 
PI(3,4,5)P3 signalling 







SHIP-1 inhibitor - 
Unbalanced 
•  Global increase in 
PI(3,4,5)P3 
•  Loss of PI(3,4)P2 
signalling 






SHIP-1 activator - 
Unbalanced 
•  Loss of PI(3,4,5)P3 
signalling 
•  Migration impaired 
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PI3K isoforms play important and non-redundant roles in immunology and are currently 
of great interest as therapeutic targets. It was therefore prudent to investigate the 
individual contributions of selective PI3K isoforms upon monocyte polarisation and 
spreading in vitro. The PI3Kα-selective inhibitor A66 did not affect basal THP-1 cell 
polarisation or surface area, nor did it affect MCP-1-stimulated responses. This result 
indicated that p110α is unlikely to be involved in regulating actin reorganisation and 
adhesion in monocytes. In support of these findings, Vanhaesebroeck et al (1999) 
reported a specific role of PI3Kδ, but not PI3Kα, in cytoskeletal reorganisation and 
chemotaxis of a macrophage like cell line in response to CSF1 [471].  
 
PI3Kδ is preferentially expressed in cells of hematopoietic origin and has been shown 
to be important in fMLP-directed migration of human neutrophils in an under agarose 
migration assay, but is not involved in random motility [184]. THP-1 monocytes pre-
treated with PI3Kδ-selective inhibitor IC87114 adopted a more rounded morphology 
with markedly fewer lamellipodia than untreated cells. Furthermore, prior exposure to 
IC87114 abrogated MCP-1 mediated actin reorganisation and decreased cell surface 
area. This result suggests that PI3Kδ plays an important role in MCP-1-stimulated 
monocyte spreading and polarisation. Ferreira et al (2006) reported that IC87114 
inhibited diapedesis in human PBMCs and THP-1 cells, and that PI3Kδ activity was 
specifically required for the THP-1 cell adhesion and spreading on VCAM-1 [473]. Their 
flow cytometry analysis revealed that PI3Kδ inhibition decreased the amount of 
conformationally active β1-integrins, and decreased the activation state of Rac1 and 
Cdc42. This report demonstrated the specific necessity of PI3Kδ in regulating 
monocytic integrin activation. Following this, another group reported that Syk-mediated 
translocation of p110δ to the leading edge was involved in β2 integrin-mediated 
migration of neutrophil-like HL60 cells [474]. 
 
PI3Kβ is a class IA PI3K isoform that has reported roles in platelet activation and 
thrombosis [198], as well as in neutrophil activation by immune complexes [185]. It has 
been previously reported that antibodies against p110β reduced macrophage 
lamellipodium formation and membrane ruffling, and reduced directed chemotaxis in 
response to CSF-1 [471]. Indeed, we found that treatment of THP-1 cells with p110β-
selective inhibitor GSK2636771 abrogated MCP-1-mediated actin reorganisation and 
cell spreading, but had no effect on unstimulated cells. These results indicate that, like 
PI3Kδ, PI3Kβ is also involved in mediating MCP-1-induced responses.  
 
To summarise, our results confirm that p110β and p110δ are appropriate targets for 
therapeutics for inflammatory and autoimmune diseases. Kulkarni et al (2011) 
demonstrated that combined deficiency of p110β and p110δ resulted in near-complete 
protection against inflammatory arthritis in a mouse model, to an extent that was 
greater than just p110β deficiency alone [185]. This is indicative of a cooperative role 
for these PI3K isoforms, and represents a novel therapeutic strategy to target two 
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Figure 5.13: Proposed model of SFK and PI3K signalling in innate cell migration and 
actin reorganisation. Chemokine receptor activation by products of inflammation leads to 
association of SFKs with G proteins and subsequent phosphorylation of ITAM-containing motifs 
associated with integrin receptors. Phosphorylated tyrosine residues are recognised and bound 
by the Syk kinase adaptor enzyme. Signalling from GPCRs and integrin receptors leads to actin 
reorganisation and promotes functional processes including migration, phagocytosis and 
adhesion. p110β and p110δ are involved in driving actin-mediated processes downstream of 
chemoattractant receptor activation in cells seeded on fibronectin. While H2O2 can activate PI3K 
and MAPK signalling cascades, it can inhibit migration, possibly by inhibiting signalling 
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Using a Drosophila melanogaster embryonic model of tissue damage, we have shown 
that Src42A activity is involved in driving directed immune cell recruitment to a wound, 
but is not necessary for general cell motility in the absence of a wound. The adaptor 
kinase Shark is also required for directed migration to a wound. Src42A activation may 
lead to Shark activation and signalling as these two kinases have previously been 
shown to interact [287]. We can hypothesise that kinase activity is upregulated 
following inflammatory events because phosphorylated tyrosine residues were 
identified in the vicinity of a wound.  This investigation has not directly identified the 
damage-associated signals generated upon wounding. However, based on previously 
reported studies we can assume that a tissue scale gradient of H2O2 is likely to be 
generated [233], [270]. The formation of a defined gradient of H2O2 is likely to be a key 
factor in driving directed migration, as incubation of unwounded embryos in uniform 
gradients of exogenous H2O2 abrogated immune cell random motility.  
 
The effect of damage-associated signals on human innate immune cells was 
investigated to explore how these processes are conserved across species. H2O2 did 
not induce chemotaxis and inhibited chemoattractant-mediated migration in a transwell 
in vitro model of migration. However, in an under agarose migration assay, H2O2 
induced neutrophil chemotaxis but did not affect chemoattractant-mediated migration. 
Exogenous H2O2 abrogated actin reorganisation and spreading on fibronectin, and 
phagocytosis in vitro. The effect was consistent regardless of cell type, or the ligand-
receptor pathway it was acting on. However, H2O2 induced intracellular calcium 
mobilisation and kinase activity without compromising cell viability. Furthermore, we 
have shown that endogenous ROS formation regulated cell motility and it is possible 
that autocrine H2O2 signalling has important regulatory roles in many cell processes. 
Our studies demonstrate that the effect of H2O2 on human innate cells in vitro is distinct 
from immune cells in vivo following tissue damage. In contrast to exogenous H2O2, 
extracellular ATP activated dynamic chemokinesis, cytoskeletal rearrangement, and 
spreading in vitro, even in the absence of a gradient. Therefore, ATP is a significant 
determinant of the leukocyte contribution to the inflammatory microenvironment by 
influencing migration and recruitment of leukocytes. Our results demonstrate that H2O2 
and ATP are distinct in their effect on cell migration and function, and this could be due 
to sensitivity to gradient formation of either signal. 
 
Our results indicate that SFK activity in human innate cells is important for chemotaxis, 
chemokinesis, actin remodelling and phagocytosis. This demonstrates conservation of 
SFK activity in directed cell migration between zebrafish, Drosophila and human cells 
in response to chemoattractant signals. We have been unable to demonstrate that 
SFKs are involved in human innate cell migration towards H2O2. We can hypothesise 
that H2O2 may inhibit SFK activity resulting in inhibition of migration due to their 
presence in similar pathways. Our results indicate that Syk kinase has different roles in 
monocytes and neutrophils, and is important in mediating responses to 
chemoattractants and the integrin ligand fibronectin. We have demonstrated that PI3K 
signalling is also important in driving directed chemotaxis, and that class IA isoforms 
p110β and p110δ, but not p110α, make a considerable contribution to monocyte MCP-
1-mediated actin reorganisation and spreading on fibronectin in vitro.  
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The Drosophila melanogaster embryonic wound model 
 
Embryo-wide mutation is a considerable drawback of the mutant Drosophila embryos 
used in this thesis. However, several alternative genetic strategies can be used to 
study the roles of Src42A and Shark specifically in hemocytes. Firstly, tissue specific 
re-expression of the wild type gene within the mutant background can generate rescue 
fly lines. Rescue of the wild type hemocyte migration phenotype would imply that gene 
disruption specifically in hemocytes is responsible for impaired migration. Secondly, 
dominant negative fly lines could be engineered. This involves expressing a form of the 
protein of interest that out-competes the resident protein in the same cell, but is 
functionally inactive. This occurs if the dominant negative version can still interact with 
the same elements as the wild type protein, but blocks some aspect of its function. The 
use of dominant negative lines also removes problems associated with embryo-wide 
gene disruption. Finally, using RNAi constructs and the Gal4-UAS system could silence 
the transcription of specific genes in a cell type specific manner.  
 
Pharmacological inhibition of Src42A activity using SFK inhibitor PP2 offers an 
alternative approach to disrupting Src42A activity in Drosophila embryos. PP2 can be 
injected into the embryo before wounding, or incubated following membrane 
permeablisation and the resulting response of hemocytes imaged. However, this 
approach does not selectively target the hemocyte Src42A, so genetic rescue 
experiments will probably be more valuable. Alternatively, Src42A rescue embryos 
could be treated with PP2. Here the mutant background results in inhibition of Src42A 
activity only being possible in the hemocytes.  
 
We have not used ROS reporters (e.g. HyPer) to identify the H2O2 gradient at the 
wound site, or any indicators of redox signalling. Therefore we cannot assume that 
H2O2 is driving Src activity in Drosophila hemocytes. Yoo et al (2011) used an in vitro 
kinase assay to show that Lyn Cys466 was directly activated by oxidation. After 
immunoprecipitation of Lyn, and treatment with 15µM H2O2, only wild type Lyn, but not 
C466A Lyn, could activate the Lyn substrate pSAM68 [282]. We can predict that due to 
the conservation of components between species, it is highly likely that this mechanism 
is operating in Drosophila. An elegant approach would be to use dynamic imaging with 
embryos encoding HyPer to study the H2O2 signal and subsequent activation of protein 
kinase mediators in hemocytes in response to a wound. Additionally, to identify 
whether Drosophila Cys466 coordinates directed hemocyte migration, mutants 
encoding an inactivating point mutation in Cys466 (similar to Yoo et al) could be 
studied in the Drosophila wounding assay.  
 
To establish whether Src42A and Shark have a role in coordinating migration in the 
absence of damage-associated signals, but in the presence of developmental guidance 
cues, it will be essential to also study developmental migration of hemocytes in mutant 
embryos. In light of our observation that the correlation between wound size and 
hemocyte recruitment is weaker in Src42A and Shark mutant embryos, it will be useful 
to count the total hemocyte number in these embryos to establish whether cell number 
is compromised. This may arise due to disruption of hemocyte development and may 
account for the impaired migratory phenotype in the wounding assay. 
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In vitro studies using human cells described in this thesis have demonstrated that PI3K 
signalling makes a comparable contribution to SFK signalling in leukocyte migration. 
Importantly, others have shown that PI3K is also important in hemocyte chemotaxis to 
wounds in the Drosophila embryonic wound model. Drosophila has one class I PI3K, 
termed Dp110. Its role in cell growth and cell survival has been well characterised 
[475]. Using genetic and pharmacological approaches, Wood et al (2006) 
demonstrated that PI3K was essential for chemotaxis towards wounds, but was not 
required for normal dispersal of hemocytes during development [269]. This group 
suggest that in this setting PI3K is required for gradient sensing from a wound and 
subsequent cell polarisation. In light of this it would be interesting to investigate the 
molecular mechanisms that underlie how damage-associate signals lead to PI3K 
activation in hemocytes, and whether this is driven by cooperation with SFK signalling.  
 
 
Limitations of damage-associated signals in in vitro models 
 
H2O2 is a very small, highly diffusible molecule with a short half-life due to its rapid 
reactivity and degradation. Therefore, in migration assays, especially the liquid-phase 
ChemoTx assay, stable gradients of H2O2 are likely to be short-lived. We have not 
monitored the decay of H2O2 in our experiments and therefore it is unclear for how long 
and to what extent H2O2 levels remain elevated after treatment. The differences in 
H2O2 gradient formation between in vivo and in vitro models are likely to greatly 
influence our results, and may account for the contrasting observations we have made. 
Tissue-scale gradients of H2O2 in vivo will activate localised intracellular signalling 
networks that are fundamental to driving directed migration. ‘Global’ stimulation with 
H2O2 will evade the precise nature of localised responses and is unlikely to activate 
defined signalling cascades in a process that is highly dependent on the cells’ ability to 
rearrange intracellular components in one overriding direction. In this case, in vitro 
assays that generate continuous gradients, such as the micropipette chemotaxis assay 
[418], may be more appropriate. 
 
Because we couldn’t be certain that H2O2 gradients were remaining intact during the 
experimental period, we have used bolus-based treatment with uniform concentrations 
of H2O2. A limitation of this approach is that bolus-based studies are typically 
performed with H2O2 concentrations in the upper micromolar or even milimolar range in 
order to overcome high degradation rates and induce a response. This is in contrast to 
the much lower H2O2 concentrations found under physiological conditions in vivo, 
where exogenous concentrations rarely exceed the low micromolar range [305]. The 
sudden and relatively short-lived exposure of cells to high concentrations of H2O2 in a 
bolus experiment may be rather atypical of what happens in vivo. It has been shown 
that bolus and continuous low-level H2O2 exposure can lead to substantially different 
signal transduction and cellular responses [476], [477]. Tang et al (2005) also show 
that milimolar concentrations of H2O2 may have pleiotropic effects on the intracellular 
signalling network and produce highly artificial results [478].  
 
Extracellular ATP activates chemokinesis and causes immediate and dynamic 
responses so it is likely that extracellular ATP is involved in the immediate cellular 
responses to wounds, not only in immune cells but probably also in remaining intact 
epithelial cells that subsequently produce H2O2 and the calcium wave. Because ATP 
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responses are so dynamic they are less likely to rely on gradient formation, compared 
to H2O2 responses where graded signals are possibly more important. However, as 
ATP is a larger molecule than H2O2, and less diffusible/reactive, we may achieve 
longer-lived and more defined gradients of ATP in our migration assay. Compared to 
H2O2, ATP has defined sites of action, ATP-selective receptors, plasma membrane ion 
channels and pumps, and initiates rapid calcium influx. We have also demonstrated 
that ATP-mediated chemokinesis is abrogated by treatment with exogenous H2O2. 
 
There are limitations to current chemotaxis assays that restrict the types of biological 
questions that can be addressed. For example, plate based transmigration chambers 
create unstable chemical gradients, filter cells by size and deformability and make it 
difficult to differentiate between chemokinesis and chemotaxis. The under agarose 
migration assay generates unstable chemical gradients that form in all directions. 
Finally, qualitative analysis is only appropriate for the micropipette assay, because of 
time-lapse imaging and high labour/low throughput. These assays require high cell 
numbers, and, if primary human cells are needed, high volumes of blood, which is 
unsustainable. Recently, more suitable microfluidic platforms have been engineered to 
provide better spatiotemporal control of gradients by decoupling the gradient 
generation and migration aspects of the assay. One example is the kit-on-a-lid-assay 
(KOALA), first reported by Sackmann et al (2012), which uses hydrogel to continuously 
diffuse chemokine without inducing undesired flows [479]. This assay uses cells 




Potential mechanisms of H2O2-induced inhibition of motility 
 
Deformability, the ability to change shape, is driven by reorganisation of the 
cytoskeletal network. Our results indicate that H2O2 could have negative effects on 
deformability because H2O2 inhibits all actin-mediated processes we have studied, but 
H2O2 can activate intracellular signalling cascades, including calcium mobilisation and 
protein phosphorylation. H2O2 does not appear to discriminate between cell types, 
ligands or receptors, or affect receptor expression. Additionally, H2O2 inhibits both 
basal and chemoattractant-mediated chemotaxis, which suggests that H2O2 is unlikely 
to be acting via a receptor (e.g. a GPCR). We can therefore hypothesise that H2O2 is 
affecting a global signalling network that is common to most activating pathways 
regardless of the initiating ligand. The targets of H2O2 are likely to be involved in 
mechanisms that act independently of a signal gradient or polarised intracellular 
signalling network. These include Rac1, which is involved in random motility [228], and 
other members of the Rho family of GTPases and their downstream mediators.  
 
H2O2 can cross cell membranes and rapidly react with iron-rich molecules to yield very 
reactive radicals. Oxygen radicals react with polyunsaturated fatty acids and proteins in 
neutrophils and other cells causing lipid peroxidation and protein degradation [410]. 
Tang et al (2005) report that the cellular localisation of a kinase will affect whether the 
outcome of H2O2-mediated oxidation is positive or negative [478]. SFKs in focal 
adhesion complexes or at the plasma membrane become inactivated after the addition 
of H2O2, whereas those localised to the cytoplasm compartments such as the 
endosome become activated [478]. In light of this, biochemical analysis of the activity, 
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localisation and trafficking of these proteins in response to exogenous, uniform 
concentrations of H2O2 will help to explain the differences we have observed between 
our models. Additionally, more informative viability assays, such as the Annexin V-PI 
assay, which provide more information about the apoptotic or necrotic state of cells, will 
identify any damaging effects of H2O2. 
 
 
Caveats of pharmacological kinase inhibition 
 
We have shown that pharmacological inhibition of SFKs, Syk or PI3K affects innate cell 
responses to inflammatory signals. In general, this pharmacological approach is limited 
by the non-selective nature of the compounds, in particular with regard to the inhibition 
of several SFK members, and potentially other kinases, by PP2. The conserved nature 
of SFK domains makes the design of isoform-specific inhibitors challenging [116]. 
However, other inhibitors of specific protein tyrosine kinases, such as Brc-Abl inhibitor 
imatinib [480], provide hope that specificity can be achieved. In contrast, the 
development of p110-selective inhibitors is encouraging. We have used pan-isoform 
and isoform-selective PI3K inhibitors to characterise the contribution of class IA 
isoforms in monocyte polarisation. As polarisation is a pre-requisite for migration, we 
can infer that p110β and p110δ are likely to be involved in cell motility during 
inflammation.  
 
Selectivity of ATP-competitive inhibitors is restricted by the homology of ATP binding 
pocket across kinases. In addition, ATP-competitors must compete with milimolar 
concentrations of ATP in cells, thus necessitating difficult to obtain affinity and/or very 
high doses to obtain potency in vivo [481]. Kinase inhibitors that bind outside of the 
ATP pocket are of increasing interest, such as one described by Brandvold et al (2012) 
[444]. In addition, Src-I1 is a dual site Src kinase inhibitor that is competitive for both 
ATP- and kinase-binding sites. It has IC50 values of 44nM for Src and 88nM for Lck and 
inhibits VEGFR2 at higher concentrations (IC50 value of 0.32µM) [443].   
 
Genetic silencing of individual kinase isoforms represents an alternative model for 
global suppression of kinase signalling, and could improve selectivity compared to 
pharmacological inhibitors. This may be difficult to achieve in short-lived primary cells. 
However, siRNA-mediated knockdown of Lyn has previously been achieved in the 
THP-1 monocytic cell line [482]. siRNA-mediated knockdown of p110δ has been 
demonstrated in mouse bone marrow-derived eosinophils [483]. 
 
 
The role of damage-associated signals in adhesion-dependent mechanisms 
 
It is possible that the damage-associated signals and kinases investigated in this thesis 
could also be affecting the role of cell adhesion molecules and their signalling 
cascades in our assays. Adhesive cells will engage integrins even in 2D systems, and 
therefore integrins may be an alternative target, for example of H2O2, alongside protein 
kinases in the regulation of cell shape and motility in vitro. Our results show that certain 
integrin-dependent processes, such as spreading and elongation on fibronectin, are 
affected by treatment with a range of chemoattractants. However, these effects are 
also observed in assays that do not contain the integrin ligand fibronectin. Furthermore, 
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while our results indicate that H2O2 does not affect endothelial ICAM-1 expression, this 
is in contrast with many other reports and could be an artefact of our in vitro models. In 
general, the effect of damage-associated signals on leukocyte adhesion is an important 
aspect of immune cell migration and function that should be explored further. 
 
 
Distinctive responses between cell types 
 
Human monocytic cell lines Primary human neutrophils 
• Catalase inhibits chemotaxis to MCP-1 • Catalase potentiates chemotaxis to IL-8 
• H2O2 does not induce transient 
mobilisation of intracellular calcium 
• H2O2 induces a transient increase in 
intracellular calcium 
• MCP-1/LTB4 does not induce 
intracellular ROS generation 
• fMLP induces an increase in 
intracellular ROS 
• ATP pre-treatment potentiates 
migration to MCP-1 
• ATP pre-treatment inhibits migration to 
IL-8 
• Piceatannol pre-treatment potentiates 
migration to MCP-1 
• Piceatannol pre-treatment inhibits 
migration to IL-8 
 
Table 6.1 Differences between monocytic cells and neutrophils 
 
 
Our results show that signal prioritisation is distinct between monocytic cells and 
neutrophils. The key differences are summarised in table 6.1. Briefly, monocytic cell 
chemotaxis was inhibited by catalase, suggesting that migration to MCP-1 requires 
parallel autocrine signalling of H2O2 (similar to a reported case in T cells [327]). 
However, this was not the case with neutrophils, whose response to intermediary 
chemokine IL-8 was potentiated when catalase was present. This indicates that 
endogenously produced H2O2 could skew neutrophil migration prioritisation towards 
end-target or damage-associated cues. We could only generate transient calcium 
signalling in neutrophils in response to H2O2, which suggests that neutrophil 
intracellular calcium signalling mechanisms are more sensitive to redox regulation than 
monocytic cells. Additionally, fMLP-stimulated neutrophils generated considerable 
intracellular ROS, which suggest that FPR activation is linked to NADPH oxidase. 
However, neither MCP-1 nor LTB4 could induce ROS generation in the monocytic cell 
lines. This could be due to inactivity of NOX or lack of coupling between CCR2/BLT1 
and NOX in these cell types. In monocytic cells, co-activation of CCR2 receptors by 
MCP-1 and ATP-receptors by ATP leads to cooperative enhancement of migration 
compared to either stimulus alone. In neutrophils, co-activation of CXCL1/2 receptors 
by IL-8 and ATP-receptors by ATP leads to inhibition of the CXCR1/2-mediated 
migratory response. These distinct results imply that in neutrophils, damage-associated 
extracellular ATP outcompetes intermediary chemokine IL-8. However, in monocytes, 
ATP positively reinforces MCP-1 signalling, leading to greater chemotaxis. Finally, our 
results suggest that Syk is active downstream of neutrophil CXCR1/2 but not monocyte 
CCR2. This implies that CXCL1/2 may cooperate with ITAM-containing motifs through 
which Syk is recruited and signals to promote migration. 
 
These differences could also be due to disparities between immortalised cell lines and 
primary cells. THP-1 and U937 monocytic cell lines are only partially representative of 
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the nature of primary monocytes. These cells lack several important receptors and 
have different cell cycle properties [382], [383], all of which could impact responses in 
this investigation. However, the use of primary human cells carries the risk of donor 
variation, which is sensitive to health, age and genetics. While we have used blood 
from healthy volunteers, we cannot screen for health history or genetic factors, all of 
which could impact responses in this investigation. 
 
 
Summary and future directions 
 
The role of SFKs in mediating immune cell migration to a wound is conserved in 
zebrafish and flies. We have shown that SFKs are important in regulating the in vitro 
effects of immune-related ligands in human immune cells. Our results demonstrate that 
H2O2 inhibits the in vitro effects of immune-related ligands, particularly actin-mediated 
processes. This may be due to redox regulation of downstream mediators that are 
involved in actin regulation. H2O2 did not affect signal prioritisation in opposing 
gradients of chemoattractant. H2O2 and ATP are distinct in their abilities to activate 
immune cells and regulate motility. SFKs and PI3Ks, particularly class IA isoforms 
p110β and p110δ, are likely to be useful therapeutic targets for the treatment of 
inflammatory and autoimmune diseases.  
 
In light of investigations described in this thesis, future experiments should seek to 
address several objectives: 
 
A) Determine the mechanisms by which damage signals activate Src42A in 
Drosophila following tissue damage. Explore the influence of multiple cues and 
how they may be prioritised in this setting.  
B) Determine the interactions of Src42A, Syk and other inflammatory mediators in 
Drosophila hemocytes following tissue damage. 
C) Optimise in vitro models of leukocyte chemotaxis for the study of small, highly 
diffusible molecules, such as H2O2. 
D) Characterise the signalling properties of kinases in the presence of defined 
gradients of damage-associated signals. How are protein activation, localisation 
and substrate binding capacity regulated? 
E) Investigate the contribution of adhesion molecules in processes activated by 
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Figure A1: No primary controls for endothelial EA.hy926 monolayer ICAM-1 
expression. Confocal images of indicated fluorescent secondary antibodies from 
EA.hy926 monolayers. Monolayers were processed for immunofluorescence as 
outlined in chapter 2.2.8 with the exception that there was no primary antibody step. 






































Movie S3.2(a-d): Time lapse movies of developmental stage 15 Drosophila embryonic 
hemocyte wound response in (a) WT, (b) Src42Amyri, (c) Src42AK10108 and (d) Src42AE1 
fly lines. Images were captured every 2 minutes. Each movie is representative of at 
least three separate embryos per genotype. Scale bar = 100µm.  
Stills from these movies are used in Figure 3.2: Src42A mutant embryos show 
reduced hemocyte directionality and velocity in Drosophila embryos. 
 
 
Movie S3.3(a-d): Time lapse movies of developmental stage 15 Drosophila embryonic 
hemocyte random migration in (a) WT, (b) Src42Amyri, (c) Src42AK10108 and (d) Src42AE1 
fly lines. Images were captured every 60 seconds. Each movie is representative of at 
least three separate embryos per genotype. Scale bar = 100µm.  
Stills from these movies are used in Figure 3.3: Random migration of hemocytes is 
not compromised in Src42A mutant Drosophila embryos. 
 
 
Movie S3.6(a-d): Time lapse movies of developmental stage 15 Drosophila embryonic 
hemocyte random migration in WT embryos treated with (a) PBS, (b) 10nM H2O2, (c) 
10µM H2O2 and (d) 10mM H2O2. Images were captured every 30 seconds. Scale bar = 
20µm. 
Stills from these movies are used in Figure 3.6: Exogenous H2O2 impairs hemocyte 
random migration in Drosophila embryos. 
 
 
Movie S4.8(a-d): Time lapse movies of primary human neutrophil chemokinesis on 
fibronectin-coated coverglass chambers in response to uniform gradients of (a) PBS, 
(b) 10nM IL-8, (c) 10nM fMLP and (d) 10µM H2O2. Images were captured every 30 
seconds. Each movie is representative of at least three separate experiments per 
treatment group. Scale bar = 20µm. 
Stills from these movies are used in Figure 4.8: Neutrophil chemokinesis is 
increased by stimulation with IL-8 and fMLP but not with H2O2. 
 
 
Movie S4.32(a-c): Time lapse movies of THP-1 monocytic cells seeded on fibronectin 
coated coverglass chambers in response to uniform gradients of (a) 10nM MCP-1, (b) 
0.3mM ATP and (c) 10µM H2O2. Images were captured every 30 seconds. Scale bar = 
10µm. 
Stills from these movies are used in Figure 4.32: Time lapse imaging of THP-1 
monocytes seeded on fibronectin reveals changes in shape following stimulation 
with different agonists. 
 
